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Summary of thesis 
 
Parkinson’s disease (PD) is the second most prevalent neurodegenerative with an 
estimated prevalence of 1% in people older than 60 years and rising to 3% in people 
older than 80 years (Lee and Gilbert 2016). Currently, the exact aetiology of PD is not 
known, there is no cure and there are no therapeutic interventions that can possibly 
delay disease progression. The symptoms can be controlled or managed by treatment, 
physical therapy and/or surgical procedures however these cause side effects and 
complications. Therefore, there is an increasing need for understanding the underlying 
pathophysiology of the disease which will aid in developing therapeutic treatments that 
help alleviate symptoms without side effects while minimizing the requirement for 
medications.  
 
The aim of this thesis was to explore selected white matter connections of the basal 
ganglia circuitry and investigate their changes in PD thereby potentially increasing our 
understanding of the underlying pathophysiology in PD. Results from my PhD show 
selective compensatory and neurodegenerative differences in selected motor and non-
motor white matter pathways in PD patients compared to healthy controls. For the first 
time, I describe and develop an anatomical protocol for in vivo segmentation of two 
basal ganglia-cerebellar tracts and demonstrate their spatial independence and their 
cortical connections. Results from my investigation of the main cerebellar pathways 
and the two basal ganglia-cerebellar tracts show that the cerebellar input and output 
structures are involved in the pathophysiology of PD. My results pave way for future 
studies to further explore and delineate the specific compensatory and 
neurodegenerative processes of these white matter pathways in PD.  
 
 
 
 
 
 
 
 
iii 
 
DECLARATION 
 
This work has not been submitted in substance for any other degree or award at this or any 
other university or place of learning, nor is being submitted concurrently in candidature for any 
degree or other award. 
 
Signed …………………………… (candidate)   Date ………………….…………….……… 
 
 
STATEMENT 1 
 
This thesis is being submitted in partial fulfillment of the requirements for the degree of PhD 
 
 
Signed……………………………… (candidate) Date ………………………….…………… 
 
 
STATEMENT 2 
 
This thesis is the result of my own independent work/investigation, except where otherwise 
stated, and the thesis has not been edited by a third party beyond what is permitted by Cardiff 
University’s Policy on the Use of Third Party Editors by Research Degree Students. Other 
sources are acknowledged by explicit references.  The views expressed are my own. 
 
 
Signed……………………………(candidate)      Date …………………….………………… 
 
 
STATEMENT 3 
 
I hereby give consent for my thesis, if accepted, to be available online in the University’s Open 
Access repository and for inter-library loan, and for the title and summary to be made available 
to outside organisations. 
 
 
Signed……………………………(candidate)  Date ………………………………………… 
 
 
STATEMENT 4: PREVIOUSLY APPROVED BAR ON ACCESS 
 
I hereby give consent for my thesis, if accepted, to be available online in the University’s Open 
Access repository and for inter-library loans after expiry of a bar on access previously 
approved by the Academic Standards & Quality Committee.  
 
 
Signed ……………………………(candidate)       Date ………………………………….…… 
 
 
iv 
 
Acknowledgements 
“Let us not become weary in doing good, for at the proper time we will reap a harvest 
if we do not give up.”     Galatians 6:9 (The Bible, NIV) 
 
 
I would like to express my sincere gratitude to my PhD supervisors, Prof. David Linden 
and Dr. Claudia Metzler-Baddeley, and to Cardiff University for funding my PhD 
through the Cardiff University's Overseas Research Scholarship. 
 
Thanks to… 
… Prof. David Linden, for your encouraging support and guidance throughout my PhD. 
Thank you for the opportunity to learn and grow as a researcher, and for sharing your 
expertise.  
… Dr. Claudia Metlzer-Baddeley, for your support and advice during my PhD. Thank 
you for sharing your expertise and your data, thereby making this work possible. Thank 
you also for the extra bit of financial cover via the part-time research assistant job.  
… Dr. Leena Subramanian, for sharing your carefully collected data, without which 
this thesis would not have been possible.  
… Dr. Tobias Bracht for your help with my first steps into diffusion tractography and 
analysis.  
… Dr. Nils Muhlert for your help with the subcortical volumes analysis.  
… Dr. Cyril Charron for taking the time to fix (most of) the IT, data and technical 
problems encountered during my PhD.  
… Peter Hobden, for clarifying MRI basics through your book MRI Gold Publications 
'Introduction to Brain Research MRI'. 
… Dr. Ilona Lipp, my favourite collaborator, for the delicious cakes, hot chocolate 
motivation breaks and for scripting the spatial overlap measures and tract probability 
maps.  
… Naomi Warne, my BFF, for cheering me on since the beginning of this PhD journey. 
Thank you also for proof reading my thesis on short notice.  
… to all my friends and colleagues, for your support. 
 
Finally, I’m eternally indebted and grateful to my supportive mum and dad. My 
heartfelt thanks to you both, I could not have done this without your constant love, 
prayers, encouragement and understanding. Thanks to my wonderful sisters, who have 
(patiently) listened to my long hours of ranting on the phone. Thank you for being there 
for me, even though you were all (literally) 8483 kilometres away from me. Special 
thanks to my church family at City Church Cardiff, for being a home away from home.  
 
“Now to Him who is able to do immeasurably more than all we ask or imagine, 
according to His power that is at work within us, to Him be glory in the church and in 
Christ Jesus throughout all generations, for ever and ever! Amen.”       
                     Ephesians 3:20-21(The Bible, NIV) 
v 
 
Data collection and Funding 
I was supported by funding from Cardiff University's Overseas Research Scholarship 
(2014-2017).  
The Parkinson’s disease patient data were collected as part of the study "Real-time 
fMRI Neurofeedback for Treatment of Parkinson's Disease" (NCT01867827). These 
data were collected by Dr. Leena Subramanian and Prof. David Linden. Thanks to Prof. 
Huw Morris, Dr Alistair Church, Dr Biju Mohammed, Dr Chris Thomas and Mrs 
Debbie Davies for their help with patient recruitment.  
The matched healthy controls data were from an aging study which was supported by 
funding from the Medical Research Council, UK, via a Clinician Scientist Fellowship 
to Dr. Michael J. O'Sullivan. (G0701912). These data were collected by Dr. Claudia 
Metzler- Baddeley.  
The young healthy participants were from a working memory study which was funded 
by Wellcome Trust New Investigator Award to Prof. Derek Jones (Grant number 
502341). This data was collected by Dr. Claudia Metzler- Baddeley.  
Many thanks to all patients, carers and control participants for their participation. 
  
 
10 middle aged healthy participants’ data were collected by me within my free PhD 
scanning allowances under Ethics number EC.14.09.09.3843R2 (08/09/2015). These 
participants’ data were collected as part of larger study into midlife risk of Alzheimer’s 
disease and were not included within this thesis. Prof. David Linden and I acquired 
permission to analyse data from the Parkinson’s Progressive Markers Initiative (PPMI) 
database to perform a replication analysis. I downloaded and partially pre-processed a 
sub-sample of patients and healthy control data from the PPMI database. However, due 
to several technical and data storage difficulties the processing and analysis of this data 
was not completed within the time frame of the PhD and was therefore not included 
within this thesis.    
 
 
 
 
vi 
 
Thesis Impact 
Chapter 3 has been published as a journal article  
 
Mole, J.P., Subramanian, L., Bracht, T., Morris, H., Metzler-Baddeley, C. and Linden, D.E.J. 
(2016). Increased fractional anisotropy in the motor tracts of Parkinson’s disease suggests 
compensatory neuroplasticity or selective neurodegeneration. European Radiology 26:3327–
3335. 
 
Chapter 4 has been submitted as a journal article and is currently under review 
 
Mole, J.P., Lipp, I., Subramanian, L., Metzler-Baddeley, C. and Linden, D.E.J. (2017). 
Anatomy of the dentato-rubro-thalamic tract (DRTT) and the subthalamo-ponto-cerebellar 
tract (SPCT): A diffusion tractography approach. Brain Structure and Function. Under review 
 
Chapter 5 is currently in preparation for submission as journal article 
Mole, J.P., Subramanian, L., and Linden, D.E.J., Metzler-Baddeley, C (2017). White matter 
alterations of the cerebellar pathways in Parkinson’s disease. Neuroimage Clinical.  
 
Conference publications 
Mole, JP; Subramanian, L; Morris, H; Metzler-Baddeley, C; Linden, D. (2016) White matter 
of the cerebellar pathways in Parkinson’s disease: A deterministic tractography study. 
Organisation for Human Brain Mapping (OHBM) Abstract, 2043 
[https://ww5.aievolution.com/hbm1601/index.cfm?do=abs.viewAbs&abs=2000] 
Mole, JP; Subramanian, L; Bracht, T; Morris, H; Metzler-Baddeley, C; Linden, D. (2015) 
Structural connectivity of motor pathways in Parkinson’s disease. British Neurosci. Assoc. 
Abstr., Vol. 23: Page 344 ISSN 1345‐8301 2015 
[https://www.bna.org.uk/media/resources/files/BNA2015-Abstract-Book.pdf] 
vii 
 
 
Abbreviations  
PD: Parkinson’s disease 
MHC: Matched Healthy Controls 
YHP: Young Healthy Participants 
BG: Basal ganglia  
CST: Corticospinal tract 
SMA-PUT: Supplementary motor area-putamen tract 
THAL-MC: Thalamus-motor cortex tract 
UNF: Uncinate Fasiculus 
slMFB: supero-lateral medial forebrain bundle 
FA: Fractional anisotropy 
MD: Mean diffusivity  
RD: Radial diffusivity  
AD: Axial diffusivity 
dRL: damped Richardson-Lucy 
HMOA: Hindrance modulated orientational anisotropy   
DRTT: Dentato-rubro-thalamic tract 
SPCT: Subthalamo-ponto-cerebellar tract  
MCP: Middle cerebellar peduncle  
SCP: Superior cerebellar peduncle 
ICP: Inferior cerebellar peduncle  
 
viii 
 
 
List of Figures and Tables 
 
Figure 1.1  Sub-structures of the basal ganglia ............................................................................... 7 
Figure 1.2 Normal basal ganglia input and output pathways ......................................................... 8 
Figure 1.3  Five parallel circuits of the basal ganglia  .................................................................. 11 
Figure 1.4  Somatotopic organisation of the BG motor circuitry .................................................. 13 
Figure 1.5  Basal ganglia-thalamo-cortical pathway in normal and Parkinson’s disease ............. 15 
Figure 1.6  Braak staging of PD pathology ................................................................................... 16 
Figure 1.7 Unfolded view of the cerebellar cortex showing the fissures, lobules, lobes and its 
somatotopy .................................................................................................................. 21 
Figure 1.8  Overview of cerebellar anatomy and function ............................................................ 22 
 
Figure 2.1 Protons aligned along the magnetic field B0 .............................................................. 28 
Figure 2.2 T1 and T2 signal ......................................................................................................... 29 
Figure 2.3 T1 and T2 contrasted images of a representative human brain in the axial view ....... 30 
Figure 2.4 Diffusion weighted spin echo sequence ...................................................................... 31 
Figure 2.5  T1, FA, DWI and FA colour coded images of a single slice axial view of a 
representative subject .................................................................................................. 32 
Figure 2.6 The diffusion tensor and its quantitative measures ..................................................... 33 
Figure 2.7  Tractography based on Diffusion Tensor Imaging ..................................................... 35 
Figure 2.8 Fiber ODFs reconstructed from the in vivo data for adjacent voxels in the pons…... 37 
Table 2.1  Demographics of the Young healthy participants (YHP), Parkinson’s disease (PD) 
patients and Matched healthy controls (MHC)  .......................................................... 39
  
Table 3.1 Demographics of the PD patients and MHCs  ............................................................ 50 
Figure 3.1  Reconstructed motor tracts ......................................................................................... 51 
Figure 3.2 Anatomical landmarks for CST .................................................................................. 52 
Figure 3.3 Anatomical landmarks for THAL-MC tract ............................................................... 53 
Figure 3.4 Mask accuracy for THAL-MC tracts .......................................................................... 54 
Figure 3.5 Anatomical landmarks for SMA-PUT tract ................................................................ 55 
Figure 3.6 Mask accuracy for SMA-PUT tract ............................................................................ 56 
Figure 3.7  Reconstructed non-motor tracts .................................................................................. 57 
Figure 3.8 Anatomical landmarks for UNF .................................................................................. 58 
Figure 3.9 Anatomical landmarks for the slMFB ......................................................................... 59 
Table 3.2 Inter-rater reliability tests ............................................................................................ 61 
ix 
 
Table 3.3  Multivariate effects ..................................................................................................... 62 
Table 3.4  Univariate group effects .............................................................................................. 63 
Table 3.5 Subcortical volumes analysis results .......................................................................... 64 
 
Figure 4.1  The DRTT tract along with the ROIs in axial, sagittal and coronal views of T1 
anatomical scan of a representative participant .......................................................... 77 
Figure 4.2  Regions of interest and reconstruction of the SPCT for a representative participant in 
coronal view ................................................................................................................ 78 
Figure 4.3  Alternative ROIs used for reconstruction of DRTT and SPCT .................................. 79 
Table 4.1 Number of successful reconstructions of the DRTT and SPCT tracts ........................ 82 
Figure 4.4 DRTT and SPCT anatomical connections shown as probability maps in axial slices in 
the YHC group ............................................................................................................ 83 
Figure 4.5  The probability maps in axial slices, showing the probability (in percent) of the DRTT, 
SPCT, CST, ICP, SCP and MCP tracts in the YHC group ................................................................... 84 
Figure 4.6 Circuits interconnecting the cerebellum and the basal ganglia including the cerebral 
cortex connections ...................................................................................................... 85 
Table 4.2 Spatial overlap ............................................................................................................ 86 
Figure 4.7 Matrix plots representing the overlaps as group-averaged dice scores between the tracts 
in each group ............................................................................................................... 87
  
Table 5.1 Demographics of the PD patients and MHCs for the cerebellar analyses ................ 100 
Figure 5.1  Reconstruction of the Middle Cerebellar Peduncle (MCP)  ..................................... 101 
Figure 5.2 Reconstruction of the Superior Cerebellar Peduncle (SCP)  .................................... 102 
Figure 5.3  Reconstruction of the Inferior Cerebellar Peduncle (ICP)  ....................................... 103 
Figure 5.4  Reconstructed full and segmented DRTT and SPCT ................................................ 104 
Table 5.2  Results from the MANCOVAs for the main cerebellar tracts .................................. 106 
Table 5.4 Post-hoc ANCOVAs for the main cerebellar tracts .................................................. 107
  
 
 
 
 
 
1 
 
Table of Contents 
 
Summary of Thesis …………………………………………………………………………………… ii 
Declaration …………………………………………………………………………………………… iii 
Acknowledgements …………………………………………………………………………………... iv 
Data collection and Funding ………………………………………………………………………….. v 
Thesis Impact ………………………………………………………………………………………… vi 
Abbreviations ………………………………………………………………………………………... vii 
List of Figures and Tables ………………………………………………………………………...... viii 
Table of Contents ………………………………………………………………………………………1 
 General Introduction ........................................................................................................... 4 
1.1 Basal ganglia ........................................................................................................................... 7 
1.1.1 Sub-structures of BG ....................................................................................................... 7 
1.1.2 Input and Output nuclei ................................................................................................... 8 
1.2 BG circuitry .......................................................................................................................... 10 
1.2.1 Foundational research on the BG loops ........................................................................ 10 
1.2.2 Motor circuit ................................................................................................................. 12 
1.3 Parkinson’s disease ............................................................................................................... 15 
1.3.1 BG circuitry in PD ........................................................................................................ 15 
1.3.2 Braak’s staging of PD pathology .................................................................................. 16 
1.3.3 PD symptoms and the BG model .................................................................................. 17 
1.4 Cerebellum ............................................................................................................................ 21 
1.4.1 Anatomy ........................................................................................................................ 21 
1.4.2 Cerebellar circuitry ....................................................................................................... 23 
1.4.3 Cerebellum in PD .......................................................................................................... 24 
1.5 Main white matter connections for investigation .................................................................. 26 
 General Methods ............................................................................................................... 27 
2.1 Magnetic Resonance Imaging ............................................................................................... 28 
2.2 Diffusion MRI Imaging and Tractography ........................................................................... 31 
2.2.1 Background ................................................................................................................... 31 
2.2.2 Tractography ................................................................................................................. 35 
2.3 MRI data acquisition and processing .................................................................................... 39 
2.3.1 Data cohorts .................................................................................................................. 39 
2.3.2 Structural MRI scanning ............................................................................................... 40 
2.3.3 Diffusion MRI scanning ................................................................................................ 40 
2 
 
2.3.4 Diffusion MRI pre-processing ...................................................................................... 40 
2.3.5 Tractography ................................................................................................................. 41 
2.3.6 Anatomical methods ..................................................................................................... 42 
2.3.7 Clinical and behavioural measures from the PD cohort ................................................ 42 
 Comparison of selective motor and non-motor pathways in Parkinson’s disease ............ 44 
3.1 Abstract ................................................................................................................................. 45 
3.2 Background and Rationale .................................................................................................... 47 
3.3 Aims ...................................................................................................................................... 49 
3.4 Materials and Methods .......................................................................................................... 50 
3.4.1 Participants .................................................................................................................... 50 
3.4.2 Tractography ................................................................................................................. 50 
3.4.3 Subcortical volumes analysis ........................................................................................ 59 
3.4.4 Statistical Analysis ........................................................................................................ 60 
3.5 Results ................................................................................................................................... 61 
3.5.1 Inter-rater reliability ...................................................................................................... 61 
3.5.2 Multivariate effects ....................................................................................................... 62 
3.5.3 Univariate group effects ................................................................................................ 63 
3.5.4 Subcortical volumes analysis ........................................................................................ 64 
3.6 Discussion ............................................................................................................................. 66 
3.6.1 Neurodegenerative models ............................................................................................ 66 
3.6.2 Neuroplastic models ...................................................................................................... 67 
3.6.3 Subcortical volumes ...................................................................................................... 67 
3.6.4 Methodological considerations ..................................................................................... 68 
3.7 Conclusion ............................................................................................................................ 69 
 Anatomy of the dentato-rubro-thalamic tract (DRTT) and the subthalamo-ponto-
cerebellar tract (SPCT) ......................................................................................................................... 70 
4.1 Abstract ................................................................................................................................. 71 
4.2 Background and Rationale .................................................................................................... 73 
4.3 Aims ...................................................................................................................................... 75 
4.4 Materials and Methods .......................................................................................................... 76 
4.4.1 Data cohorts, MRI acquisition and processing ............................................................. 76 
4.4.2 Tractography protocols ................................................................................................. 76 
4.4.3 Statistical Analysis ........................................................................................................ 80 
4.5 Results ................................................................................................................................... 82 
4.5.1 Tract probability maps .................................................................................................. 82 
4.5.2 Spatial overlap between tracts ....................................................................................... 85 
4.5.3 Inter-rater reliability of tract reconstruction .................................................................. 87 
4.6 Discussion ............................................................................................................................. 88 
3 
 
4.6.1 Tract probability maps .................................................................................................. 88 
4.6.2 Spatial overlap............................................................................................................... 89 
4.6.3 Inter-rater reliability ...................................................................................................... 90 
4.6.4 Consistent reconstruction across data sets .................................................................... 91 
4.6.5 Limitations .................................................................................................................... 91 
4.7 Conclusion ............................................................................................................................ 92 
 Investigating microstructural differences in the white matter of the main cerebellar and 
basal ganglia-cerebellar pathways in Parkinson’s disease .................................................................... 93 
5.1 Abstract ................................................................................................................................. 94 
5.2 Background and Rationale .................................................................................................... 96 
5.3 Aims ...................................................................................................................................... 99 
5.4 Materials and Methods ........................................................................................................ 100 
5.4.1 Data cohorts, MR acquisition and processing ............................................................. 100 
5.4.2 Reconstruction of the major cerebellar pathways ....................................................... 100 
5.4.3 Statistical Analysis ...................................................................................................... 104 
5.5 Results ................................................................................................................................. 106 
5.5.1 Microstructural differences ......................................................................................... 106 
5.6 Discussion ........................................................................................................................... 109 
5.6.1 Increased FA in the Right SCP and Right ICP ........................................................... 109 
5.6.2 Increased HMOA in the right SCP.............................................................................. 110 
5.6.3 DRTT and SPCT ......................................................................................................... 111 
5.6.4 Limitations and future directions ................................................................................ 113 
5.7 Conclusion .......................................................................................................................... 114 
 General discussion .......................................................................................................... 115 
6.1 Summary of findings ........................................................................................................... 116 
6.2 Limitations and future research in PD ................................................................................ 118 
6.3 Wider clinical relevance of investigated BG white matter connections ............................. 120 
6.4 Conclusion .......................................................................................................................... 121 
 References ....................................................................................................................... 122 
 Supplementary material .................................................................................................. 157 
8.1 Chapter 3 Supplementary material ...................................................................................... 157 
8.2 Chapter 4 Supplementary material ...................................................................................... 162 
8.3 Chapter 5 supplementary material ...................................................................................... 171 
 
 
  
4 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 General Introduction 
  
5 
 
 
Parkinson’s disease (PD) is the second most prevalent neurodegenerative disease with 
an estimated prevalence of 1% in people older than 60 years, rising to 3% in people 
older than 80 years (Lee and Gilbert 2016). PD is named after James Parkinson who 
gave the first description of the disease in ‘An essay of the Shaking Palsy’ in 1817 
(Goetz 2011). The four main symptoms of PD are tremor, bradykinesia (slowness of 
movement), rigidity and postural instability (Jankovic 2008; Andalib et al. 2014). 
Currently, the exact aetiology of PD is not known, there is no cure and there are no 
therapeutic interventions that have been shown to delay disease progression. The 
symptoms can be managed by drug treatment and/or surgical procedures. Medications 
cause adverse side effects such as nausea, hallucinations, delusions, impulse control 
disorders, dyskinesia (Fernandez 2012) and other complications with their long term 
usage, which affect the quality of daily life. Surgical procedures such as Deep Brain 
Stimulation (DBS) can cause intracranial haemorrhage, infection and seizures (Kleiner-
Fisman et al. 2006). It is therefore important to gain further understanding of the 
underlying pathophysiology of the disease, so that therapeutic treatments that help 
alleviate symptoms with minimal side effects can be developed.  
The main pathophysiological feature associated with the motor symptoms of PD is the 
loss of substantia nigra dopaminergic neurons of the basal ganglia (Fearnley and Lees 
1991). This loss affects structures of the basal ganglia circuitry such as the putamen and 
the thalamus which are connected to regions of the cortex such as the supplementary 
motor area and the motor cortex (Wichmann and Dostrovsky 2011). There is increasing 
evidence that the cerebellum is also involved in motor and non-motor symptoms of PD 
(Wu and Hallett 2013) and studies have also revealed direct anatomical connections 
between the basal ganglia and the cerebellum in non-human primates (Hoshi et al. 
2005; Bostan and Strick 2010). However, the roles of these structures and their white 
matter connections have not yet been researched in PD. 
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Therefore, the aim of this thesis was to explore selected white matter connections of 
the basal ganglia circuitry and investigate their changes in PD using advanced diffusion 
MRI methods, thereby increasing our understanding of the underlying pathophysiology 
in PD. The current chapter provides an introduction to the basal ganglia circuitry and 
Parkinson’s disease. Chapter 2 gives an introduction to diffusion MRI, and an overview 
of methodology used in this thesis. Chapter 3 explores the differences in diffusion 
metrics in selected motor and non-motor tracts in Parkinson’s disease. Chapter 4 
provides an anatomical protocol for the reconstruction of the anatomical connections 
between the basal ganglia and the cerebellum using diffusion tractography and assesses 
their spatial overlap with the main cerebellar tracts (the middle, inferior and superior 
cerebellar peduncles) and the corticospinal tract. Chapter 5 investigates the differences 
in the microstructural diffusion metrics in the main cerebellar tracts and basal ganglia-
cerebellum connections in Parkinson’s disease. Finally, Chapter 6 presents a summary 
and integration of the findings set out in this thesis. The wider clinical relevance of the 
studied white matter connections and future directions of current work are also 
discussed in Chapter 6. 
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1.1 Basal ganglia 
The basal ganglia (BG) are a collection of deep grey matter nuclei that are located 
within the white matter of the cerebral hemispheres. The BG consists of the caudate 
nucleus, putamen, globus pallidus, nucleus accumbens, substantia nigra and the 
subthalamic nuclei (Blumenfeld 2010). The thalamus is an oval shaped structure 
located behind the BG just above the brain stem on either side of the third ventricle. 
Parts of it serves as a relay station for sensory pathways, and the motor portion of the 
thalamus is functionally related to the BG and sometimes subsumed under the BG. The 
subthalamic nucleus of the ventral thalamus and the substantia nigra of the 
mesencephalon are also functionally related to the BG.  
1.1.1 Sub-structures of BG 
Figure 1.1 Sub-structures of the basal ganglia (Blumenfeld 2010) 
The caudate nucleus is an elongated C-shaped curved cell mass that is in direct contact 
with the lateral ventricle throughout its extent. The putamen is a large nucleus forming 
the lateral portion of the BG and it is anteriorly and ventrally connected to the caudate 
forming the striatum (Figure 1.1). The caudate and the putamen have similar 
histological and embryological profiles. Their histological structure is characterised by 
medium-sized neurons with 75% of these being medium spiny projection neurons 
(Blumenfeld 2010). The caudate and putamen are interconnected by cell bridges 
distributed among bundles of the internal capsule, giving rise to the term “striatum”. 
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The globus pallidus lies medial to the putamen and means “pale globe” because of the 
myelinated fibres that pass through this region, which appear paler than the caudate and 
putamen on sections of the post mortem brain. The putamen and globus pallidus 
together form the lenticular or lentiform nucleus (lentil-shaped) with the putamen 
forming the outer part and the globus pallidus forming the inner part.  
The nucleus accumbens includes the ventral parts of the head portion of the caudate 
and the putamen. The nucleus accumbens and the medium sized cells of the olfactory 
tubercle together form the ventral striatum (Nieuwenhuys et al. 2008). The subthalamic 
nucleus is an oval shaped component of the subthalamus, which lies lateral to the 
hypothalamus and medial to the internal capsule. The substantia nigra, is latin for “black 
substance” because of its darker appearance on post mortem slices due to high levels 
of neuromelanin in dopaminergic neurons (Rabey and Hefti 1990). It is composed of 
two parts; the ventral, pars reticulata and the dorsal, pars compacta.  
1.1.2 Input and Output nuclei 
 
Figure 1.2 Normal basal ganglia input and output pathways  
M1- Motor cortex, PMC- Primary motor cortex, SMA – Supplementary motor area, CMA – Cingulate 
motor area, CM – Centromedian nucleus of thalamus, VA/VL – Ventro anterior and ventro lateral nuclei 
of thalamus, GPe – Globus pallidus external, GPi - Globus pallidus internal, SNc – Substantia nigra pars 
compacta, SNr – Substantia nigra pars reticulata, STN – Subthalamic nucleus, PPN – Pedunculopontine 
nucleus, D1, D2 - Dopamine receptor subtypes, Indir – Indirect pathway, Dir – Direct pathways. Black 
arrows are inhibitory connections and grey arrows are excitatory connections. Arrow thickness indicates 
the strength of the activity. Taken from (Wichmann and Dostrovsky 2011).  
The input structures of the BG are the caudate, putamen, and nucleus accumbens. They 
receive input from the cerebral cortex (Figure 1.2), and from the thalamus, subthalamic 
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nucleus and other brain stem structures. Most of these cortical inputs to the striatum are 
excitatory and use glutamate as their neurotransmitter. The output structures are the 
internal segment of the globus pallidus, substantia nigra pars reticulata, and ventral 
pallidum, and they project back to the cerebral cortex via the thalamus (Middleton and 
Strick 2000). The outputs leave from the substantia nigra pars reticulata and the internal 
segment of the globus pallidus to the ventro anterior and ventro lateral nuclei of 
thalamus. The thalamic nuclei then relay these outputs to parts of the cerebral cortex 
(Figure 1.2). These output pathways are inhibitory and use the neurotransmitter gamma 
aminobutyric acid (GABA). The intrinsic nuclei within the BG comprise the lateral 
position of the globus pallidus, subthalamic nucleus and the substantia nigra pars 
compacta, which are interconnected by local circuit projections and are also connected 
to the input and output nuclei (Figure 1.2).  
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1.2 BG circuitry  
Anatomical knowledge of the basal ganglia circuitry has been based on animal tracing 
studies and human post mortem work. Since invasive fibre tracking techniques are not 
possible in humans, anatomical studies exploring the presence of the parallel circuitry 
of the BG loops in humans have been largely based on primate-human extrapolations 
suggested by Alexander and colleagues (Alexander et al. 1986). It should be noted that 
the BG circuitry is highly complex with sub-structures within the BG having 
projections to and from other BG nuclei. Hence, the focus of this literature review is a 
brief overview of the topographical evidence of segregated and overlapping 
connections to and from the sub-structures of the BG, and the frontal and cortical 
regions, with specific focus on the motor circuitry for the purposes of this thesis.  
1.2.1 Foundational research on the BG loops 
The anatomical models of the organisation of BG circuits have undergone major 
revisions since their initial descriptions; it was primarily thought that the BG served as 
a “funnel”, integrating and channelling information from the cerebral cortex to the 
thalamus and back to the motor cortex (Allen and Tsukahara 1974). Evidence for 
anatomical and functional segregation of influences from the cortex to the BG-thalamo-
cortical circuits from anatomical and physiological findings has challenged and 
changed these initial views. DeLong and colleagues suggested that there were two 
loops; (i) a ‘motor loop’ that receives inputs from the sensory and motor areas that pass 
through the putamen and project back to the premotor areas; and (ii) an ‘association 
loop’ receiving input from the association areas passing through the caudate and 
returning back to the prefrontal areas (DeLong et al. 1984). Further evidence reinforced 
the principle that inputs from the BG are transmitted to segregated topographic portions 
of the frontal lobe. Alexander and colleagues proposed the organisation of the cortico-
BG-thalamo-cortical (CBTC) circuits as a model of five parallel circuits; where, in 
addition to the motor circuit, there are four other circuits designated as ‘oculomotor’, 
‘dorsolateral prefrontal’, ‘lateral orbitofrontal’ and ‘anterior cingulate’ circuits. 
(Alexander et al. 1986) as shown in Figure 1.3.  
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The basic design for each pathway is thought to be similar; each circuit contains non-
overlapping parts of the striatum, globus pallidus, thalamus, substantia nigra and cortex. 
Each circuit receives multiple and partially overlapping cortical inputs, which are 
integrated to pass through pallidum and substantia nigra, then to a specific portion of 
the thalamus, and then back to a separate/single cortical area. The initial description of 
funnelling inputs into the BG has been retained, however, here this would be the 
funnelling of inputs from functionally related and anatomically interconnected regions 
within the segregated circuits. The term circuit in this context does not refer to a closed 
pathway without any other substantial inputs or outputs, but refers to a closed loop 
within each circuit despite the presence of other inputs and outputs. Anatomical 
evidence to support the circuits primarily came from primate studies and post mortem 
human tissue work (Alexander et al. 1986; Alexander and DeLong 1985; Vitek et al. 
1994). For the purposes of this thesis, this will be discussed in relation to the motor 
circuitry of the BG.  
1.2.2  Motor circuit 
In the motor circuit, the putamen mostly receives substantial projections from the motor 
(Künzle 1975) and somatosensory cortices (Kunzle 1977). The motor and 
somatosensory ‘leg’ areas of the cortex are monosynaptically connected to the 
dorsolateral putamen while the ‘face’ area projects to the ventromedial region of the 
putamen and the ‘arm’ regions project to a region in between (Figure 1.4). The putamen 
also receives topographically organised projections from area 5 and lateral area 6 
including the arcuate premotor area (APA) and from the supplementary motor area 
(SMA) in a model derived from non-human primate data (Jones et al. 1977; Selemon 
and Goldman-Rakic 1985). Striatal projections from the SMA were traced by 
anterograde label injections into the rostral ‘face’ region with the resulting terminals 
ending in the ventromedial putamen (Brinkman and Porter 1979; Muakkassa and Strick 
1979). Therefore, as shown in Figures 1.3 and 1.4, the motor circuit has a combination 
of ‘open’ and ‘closed loops’ in which somatotopically organised influences from the 
SMA, APA, motor cortex (MC) and somatosensory cortex (SC) travel through the 
circuits and are then ultimately project back to the SMA.  
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Figure 1.4 Somatotopic organisation of the BG motor circuitry 
Here, the motor circuit is indicated by red arrows connecting the regions that modulate leg movements. 
It is somatotopically organised throughout the loop, with the regions representing leg movements lying 
dorsal and medial, those representing face movements lying ventral and lateral, and those representing 
arm movements lying in-between. The somatotopic arrangement of the primary motor cortex is generally 
maintained in the striatopallidal and subthalamic nuclei. GPe=globus pallidus pars externa. GPi=globus 
pallidus pars interna. STN=subthalamic nucleus. Figure from Obeso and colleagues and Rodriguez-Oroz 
and colleagues (Rodriguez-Oroz et al. 2009)    
The cortical terminal of the motor circuit, the SMA, has an important role in the 
programming and the control of movements. In primates, it projects not only to the 
APA and MC (Muakkassa and Strick 1979; Schell and Strick 1984) but also directly to 
the spinal cord (Biber et al. 1978; Murray and Coulter 1981; Palmer et al. 1981; 
Macpherson et al. 1982). Micro-stimulation of the SMA in the monkey has been shown 
to produce limb movements (Macpherson et al. 1982) and single cell studies in 
behaving primates have shown discharge in relation to limb movements (Brinkman and 
Porter 1979; Tanji and Kurata 1979) and during the preparation of these movements 
(Tanji et al. 1980). However, there is also evidence that the BG and the putamen are 
directly involved in preparation and planning of limb movements (Alexander 1987). 
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Several studies in awake behaving primates confirmed the somatotopic organisation of 
putamen as suggested by the topographical organisation of corticostriatal projections 
(Crutcher and DeLong 1984; Alexander et al. 1985; Liles 1985). Ordered somatotopic 
distribution of the motor inputs within areas of the BG and the thalamus has been 
consistently described in primates (Wichmann et al. 1994; Vitek et al. 1994; Takada et 
al. 2001; Takada et al. 1998; DeLong et al. 1983; Nambu et al. 1996). Segregated 
somatotopy of movement related neurons was shown in sensorimotor areas of the 
monkey striatum (Takada et al. 1998), GPi and GPe (DeLong 1971; DeLong et al. 1985) 
and the thalamus (Vitek et al. 1994). A segregated loop that connects the primary motor 
cortex (M1), SMA, the premotor cortex (PMC), and cingulate motor areas (CMA) with 
the motor areas of the thalamus and the BG facilitates the processing of motor 
information (Alexander and Crutcher 1990; Alexander et al. 1986; Takada et al. 2001; 
Smith et al. 1998; Romanelli et al. 2005). 
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1.3 Parkinson’s disease 
Parkinson’s disease (PD) is characterised by the irreversible depletion of dopaminergic 
neurons in the substantia nigra pars compacta (SNc) a structure located in the mid brain 
(Fearnley and Lees 1991) with projections that are relayed in the putamen and lead to 
the thalamus and motor cortex as shown in (Figure 1.5).  
1.3.1 BG circuitry in PD 
 
Figure 1.5 Basal ganglia-thalamo-cortical pathway in normal and Parkinson’s disease.  
M1- Motor cortex, PMC- Primary motor cortex, SMA – Supplementary motor area, CMA – Cingulate 
motor area, CM – Centromedian nucleus of thalamus, VA/VL – Ventro-anterior and ventro-lateral nuclei 
of thalamus, GPe – Globus pallidus external, GPi - Globus pallidus internal, SNc – Substantia nigra pars 
compacta, SNr – Substantia nigra pars reticulata, STN – Subthalamic nucleus, PPN – Pedunculopontine 
nucleus, D1, D2 - Dopamine receptor subtypes, Indir – Indirect pathway, Dir – Direct pathways. Black 
arrows are inhibitory connections and grey arrows are excitatory connections. Arrow thickness indicates 
the strength of the activity. Taken from (Wichmann and Dostrovsky 2011).  
Disturbance in the BG circuitry occurs after the loss of around 80% of the nigral 
dopaminergic neurons that have projections to the striatum (Bernheimer et al. 1973). 
According to the most prevalent model of BG dysfunction in PD (Bergman et al. 1990), 
this leads to a decrease in the activation of the cortex and causes the motor symptoms 
of the disease to arise. In the normal circuitry, as shown in the black arrows (Figure 
1.5), inhibitory signals are sent when the D1 receptors are activated in the direct output 
pathway from the putamen to the globus pallidus internus (GPi) and the substantia nigra 
pars reticula (SNr) (Wichmann and Dostrovsky 2011). The D2 receptors activate the 
indirect pathway and send inhibitory signals from the putamen to the globus pallidus 
externus (GPe) which in turn causes inhibitory signals to be sent to the subthalamic 
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nucleus (STN), which sends excitatory signals to the globus pallidus internus (GPi). 
The direct and indirect pathways to the GPi and SNr therefore help to modulate the 
transmission of signals to the ventro-anterior and ventro-lateral nuclei of the thalamus 
which in turn have excitatory connections to the cortex (Figure 1.5) (Alexander and 
Crutcher 1990; Albin et al. 1989). In PD, due to the reduced dopaminergic projections 
from the SNc, the activation of the D1 and D2 receptors in the putamen is reduced, 
causing reduction in the inhibitory signals to the GPi via the direct pathway. The GPi 
now also receives increased excitatory signals via the indirect pathway, causing 
increased inhibitory signals to the thalamus which in turn causes reduced excitatory 
signals to the cortex (Figure 1.4). After the description of this classic model of BG 
disruption in the 1990s, there has been a tremendous increase in clinical and 
experimental studies in PD.  
1.3.2 Braak’s staging of PD pathology 
Though the crucial pathology of PD is loss of SNc dopaminergic neurons, from the 
neuroanatomical work by Braak it has become clear that PD is not just a 
neurodegenerative disease of the BG system, as there are stages in which other regions 
of the brain undergo PD-related changes as well (Figure 1.4) (Braak et al. 2003).  
 
Figure 1.6 Braak staging of PD pathology.  
Pathogens come into contact with olfactory and/or enteric nervous system (ENS) neurons, which trigger 
the α-Synuclein aggregation (Stages 1 and 2). The aggregated α-Synuclein spreads toward the central 
nervous system (CNS) via the olfactory bulb and the vagus nerve, eventually, arriving at the substantia 
nigra (Stages 3 and 4). And then spreads to the neocortex and the prefrontal cortical regions (Stages 5 
and 6) (Halliday et al. 2011).  
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A consistent feature of PD pathology is the appearance of intercellular protein 
aggregates known as Lewy bodies in the dorsal motor nucleus of the vagus (DMV) 
within the medulla oblongata in post mortem analysis (Rietdijk et al. 2017). Baark’s 
staging postulates that α-synuclein (a major component of the Lewy body pathology) 
in the olfactory tract (Beach, White, et al. 2009; Hubbard et al. 2007) and the enteric 
nervous system (ENS) (Wakabayashi et al. 1988; Heiko Braak, De Vos, et al. 2006; 
Shannon et al. 2012) cause gastrointestinal and olfactory problems (Doty 2012). There 
is clinical evidence that these occur during the earlier stages of PD before the onset of 
motor symptoms and disease diagnosis creating the pre-motor symptoms of the disease 
(Bloch et al. 2006; Abbott et al. 2007; Ross et al. 2008a; Braak et al. 2003; Shannon et 
al. 2012). This has also been substantiated in animal models where α-synuclein 
aggregates were found in gastrointestinal tracts of animal models (Hallett et al. 2012; 
Natale et al. 2010; Wang et al. 2012; Drolet et al. 2009; Kelly et al. 2014). The α-
synuclein pathology spreads from the ENS to the central nervous system (CNS) via the 
vagal nerve (Tredici et al. 2010; Del Tredici and Braak 2008) and the DMV in the 
medulla oblongata (Takeda et al. 1993; Del Tredici et al. 2002; Jellinger 2004; Hely et 
al. 2008; Del Tredici and Braak 2008). This then spreads within the CNS from the lower 
brain stem regions towards the SN and eventually the neocortex and prefrontal cortex 
(Halliday et al. 2008; Del Tredici et al. 2002; Bloch et al. 2006; Braak et al. 2003) 
(Figure 1.6).  
Despite evidence from in vitro, in vivo and clinical studies, not all PD patients adhere 
to the proposed pattern of α-synuclein spread within the Braak’s stages such as those 
with young onset and long disease duration (Jellinger 2008; Kalaitzakis et al. 2009; 
Halliday et al. 2008). Recent studies have also suggested that neuronal loss and glial 
cell activation should be added to pathological studies in PD progression, as SNc 
neuronal loss shows linear relationship with motor symptoms (Greffard et al. 2006), 
while Lewy body aggregation only shows a trend towards a positive correlation with 
the motor symptoms (Beach, Adler, et al. 2009).  
1.3.3 PD symptoms and the BG model 
The cardinal symptoms of PD are resting tremor (shaking hands at rest), bradykinesia 
(slowness of movement), and rigidity (unnatural stiffness of the muscles) (Jankovic 
2008). All the main symptoms of PD are known to be directly related to SNc 
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dopaminergic loss, and are mainly associated with the disruption of the BG motor 
circuitry. The onset of motor features correlates with loss of dopamine in the posterior 
putamen which is the motor region of the striatum (Rodriguez-Oroz et al. 2009).  
Bradykinesia is characterised by reduction in the speed and amplitude of initiation and 
execution of movements up to a complete cessation (Jankovic 2008; Rodriguez-Oroz 
et al. 2009). Bradykinesia is a defect of the BG motor circuitry involving the structures 
of STN, GPi and GPe (Nambu et al. 1998; Kita 2005). It also involves the recruitment 
of cortical neurons and BG connections with the SMA and prefrontal cortices known 
for their involvement in time processing in animals and humans (Meck 2006; 
Jahanshahi et al. 2006) for adjusting initiated movement (Escola et al. 2003; Mink and 
Thach 1991; Boraud et al. 2000). In PD, there is increased difficulty in self-initiated 
movements than externally triggered movements and this fits in well with the BG model 
of PD which modulates areas such as SMA which is involved in self-initiated actions 
(Redgrave et al. 1999; Escola et al. 2003). Rigidity is caused by increased slow and 
sustained muscle stretching in PD patients (Andrews et al. 1972) and it is mediated 
through the primary motor cortex suggested by increased primary cortex excitability in 
humans (Lefaucheur 2005; Mir et al. 2005) and animals (Goldberg et al. 2002). 
However, the relationship between dopamine deficiency, increased BG output and its 
relation to primary motor cortex excitability and rigidity is not fully understood. Tremor 
is characterised by 4-6Hz activity at rest in the limbs. STN and GPi rhythmic and 
synchronous neuronal firing rates correlate with tremor in monkeys and in PD patients 
(Rodriguez et al. 1998; Bevan et al. 2002). The ventral intermediate nucleus (Vim) and 
cerebellar activation is also known to associated with tremor (Rodriguez-Oroz et al. 
2009).  
However, the BG model does not fully and clearly explain PD symptoms. Increased 
neuronal activity in the STN/GPi-SNr and the subsequent inhibition of thalamocortical 
projections does not explain the origin of tremor and rigidity (Rodriguez-Oroz et al. 
2009). Levodopa-induced dyskinesia are eliminated by GPi lesions (pallidotomy), 
which is not compatible with a model that relates excessive GPi/SNr inhibition and 
reduced BG output activity with dyskinesia (Obeso, Rodríguez-Oroz, et al. 2008; 
Obeso, Marin, et al. 2008). Similarly thalamic lesions (thalamotomy) which causes 
disruption of the motor circuitry does not aggravate bradykinesia nor produces new 
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motor symptoms (Magrinelli et al. 2016). Therefore, the manifestation of the motor 
symptoms of PD suggests a more complex pathophysiological origin.  
Dopamine levels can be adjusted temporarily by the administration of levodopa, a 
precursor of dopamine that crosses the blood brain barrier and can be metabolised to 
dopamine in the brain (Fahn 2015). Levodopa treatment, which is the current 
therapeutic standard in PD, targets the BG temporarily by increasing the amount of 
dopamine in the BG (caudate and putamen) and improving movement related functions 
(Mirdamadi 2016). Surgical treatment options available are DBS (Williams 2015), 
thalamotomy (Linhares and Tasker 2000) and pallidotomy (Lozano and Lang 1998), 
these are typically given when medications are not adequate in controlling the 
symptoms of the disease or have caused unacceptable side effects; however, recent 
research suggest that DBS may be specially effective in treatment in the earlier course 
of the disease (Hacker et al. 2015). The ventral intermediate nucleus (VIM) found at 
the centre of the thalamus is implicated as being the part of the circuit that generates 
tremor, it is therefore a target for thalamotomy and DBS (Rodriguez-Oroz et al. 2009).   
Although PD is predominantly described and clinically classified as a motor disorder, 
there are a number of non-motor symptoms that occur during the progression of the 
disease including deficits in smell, mood, sleep, cognition and autonomic function 
(Goldman and Postuma 2014; van Rooden et al. 2009). Cognitive dysfunction is present 
in 20-40% of PD patients even in early PD but are often overshadowed by the motor 
symptoms (Foltynie et al. 2004; Muslimović et al. 2005; Elgh et al. 2009).  
The specific neuroanatomical basis for the non-motor symptoms of Parkinson’s disease 
remain unknown. Studies that explored olfactory disturbances in PD support that these 
symptoms are associated with Braak stage 1, where degeneration of neurons in the 
olfactory bulb and anterior olfactory nucleus occurs (Montgomery et al. 1999; Ross et 
al. 2008b). And within the Braak staging 1 and 2, the pathological changes in the lower 
brainstem, the pedunculopontine nucleus and the thalamocortical pathways are thought 
to mediate the sleep disturbances associated with PD  (Rye 2004; Saper et al. 2001). 
Pallidosubthalamic projections within the basal ganglia circuitry have been regarded as 
anatomical base for most of the non-motor functions within PD in deep brain 
stimulation studies of the subthalamic nucleus (Karachi et al. 2005; Chaudhuri et al. 
2006).  
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Non-motor symptoms such as anxiety, apathy and anhedonia in PD are associated with 
neuronal degeneration and decreased reward processing in projections between the 
ventral tegmentum and nucleus accumbens and in frontal-subcortical areas (Brown and 
Pluck 2000; Robbins and Everitt 1996; Kunig et al. 2000). The prefrontal cortex and 
the limbic loop are implicated in the cognitive symptoms of PD (Heiko Braak, Rub, et 
al. 2006), with decline in cognitive symptoms correlating with neuropathological stage 
of PD (Braak et al. 2005).   
Resting state functional connectivity studies have shown that certain brain regions such 
as the ipsilateral orbito-frontal area was negatively correlated with the severity of non-
motor symptoms (Yoo et al. 2015). Dysfunction in PD resting state extends beyond the 
sensorimotor network to include fronto-parietal and visual areas as well (Prodoehl et 
al. 2014). Cognitive deficits in PD also correlated with decreased functional 
connectivity of medial frontal area, temporal lobe, inferior parietal cortex and posterior 
cingulate areas (A Tessitore et al. 2012; Disbrow et al. 2014).  
Due to the specific involvement of the above mentioned grey matter areas, two white 
matter tracts of interest; the uncinate fasiculus and the medial forebrain bundle were 
chosen for the purposes within this thesis. The uncinate fasiculus connects the 
orbitofrontal cortex with the anterior temporal lobes (Von Der Heide et al. 2013; 
Highley et al. 2002) and these brain regions as shown above are known to influence 
non-motor and cognitive symptoms in PD (Yoo et al. 2015; Alessandro Tessitore et al. 
2012; A Tessitore et al. 2012; Disbrow et al. 2014; Papagno et al. 2011).  The medial 
forebrain bundle connects the ventral tegmental area to the forebrain and the frontal 
lobe, and these brain areas as shown above as well as the bundle itself has been shown 
to be involved in reward processing alterations such as anhedonia and depression in PD 
(Coenen et al. 2012; Bracht et al. 2015; Brown and Pluck 2000; Robbins and Everitt 
1996; Kunig et al. 2000).   
PD is therefore a complex disorder with a wide range of motor and non-motor 
symptoms which may include various regions and pathways of the brain even though 
the main pathological feature is the degeneration of the BG system.  
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1.4 Cerebellum  
1.4.1 Anatomy 
The cerebellum is located below the cerebrum, behind the brainstem and is connected 
to both of these structures (Nieuwenhuys et al. 2008). It has two lateral cerebellar 
hemispheres and the medial vermis, and is classically divided into three lobes; an 
anterior lobe, a larger posterior lobe and a smaller flocculonodular lobe. The three 
cerebellar lobes are anatomically separated by 2 transverse fissures, the primary fissure 
separating the anterior and the posterior lobe and the posterolateral fissure between the 
posterior and flocculonodular lobe. The cerebellum has 10 further subdivisions or 
transverse lobules labelled by Roman numerals (lobules I-X) as shown in Figure 1.7 
where the unfolded view of the cerebellar cortex also shows the fissures, lobules, lobes 
and its somatotopy (Roostaei et al. 2016). The cerebellum consists of highly convoluted 
outer layer of grey matter also known as the cerebellar cortex, that surrounds the 
branches of white matter which in turn surround the deep cerebellar nuclei 
(Nieuwenhuys et al. 2008; Ramnani and Owen 2004). 
  
Figure 1.7 Unfolded view of the cerebellar cortex showing the fissures, lobules, lobes and its somatotopy 
(Roostaei et al. 2016). 
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The deep cerebellar nuclei are the dentate, interposed and the fastigial nuclei, with the 
dentate nucleus being the largest of them. The cerebellar cortex and the deep cerebellar 
nuclei are interconnected to extra cerebellar structures through the superior, inferior and 
middle cerebellar peduncles (Catani et al. 2008). All input and output connections from 
and to the cerebellum pass through these peduncles. An overview of cerebellar anatomy 
and function is shown in Figure 1.8.  
The cerebellum has diverse and varied functions ranging from motor planning and 
execution to higher-order cognitive and emotional functions such as time perception, 
working memory, language, executive functioning and emotional processing (Ramnani 
2006; Schmahmann 1996; O’Callaghan et al. 2016; Buckner et al. 2013; Balsters and 
Ramnani 2011; Koziol et al. 2014; Roostaei et al. 2016).  It is also known to regulate 
balance, posture, motor coordination and cognitive functions (Nieuwenhuys et al. 2008; 
Ramnani 2006). 
 
Figure 1.8 Overview of cerebellar anatomy and function  
A shows the classical lobular divisions, B shows the classic connectivity patterns and C shows anatomical 
clusters with their putative functions (Makris et al. 2005).  
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1.4.2 Cerebellar circuitry  
The cerebellum has direct and indirect connections to various brain regions including 
the brain stem, the spinal cord and various cerebral subcortical and cortical regions. The 
cerebellar circuitry is also organised similar to the BG circuitry in parallel and partially 
overlapping circuits. This circuitry originates from the motor, association and 
paralimbic regions of the cerebral cortex, with organised projections towards the 
pontine nuclei as fibres from the frontal, temporal, parietal and occipital regions 
(Schmahmann 1996; Stoodley and Schmahmann 2009; Glickstein et al. 1985; Ramnani 
and Owen 2004; Ramnani 2012).  
The pontine nuclei project to distinct cerebellar input nuclei which are in turn connected 
to cerebellar output nuclei that project back to the contralateral cortical regions via the 
ventrolateral nucleus of the thalamus (Middleton and Strick 2001; Middleton and Strick 
2000; Ramnani 2006). These cortico-cerebellar loops have functional distinctions with 
the ‘motor’ cerebellum comprising lobules V, VI, VIIb and VIII which project to pre 
and post central gyrus (cortical motor regions), and the ‘cognitive’ cerebellum 
containing Crus I and II which project to prefrontal and parietal cortices (Kelly and 
Strick 2003; Hoover and Strick 1999; O’Reilly et al. 2010; Balsters et al. 2014; Balsters 
and Ramnani 2011). 
It is now known that both the BG and the cerebellum modulate the activity of largely 
overlapping cerebral cortical areas through multisynaptic loops, which were previously 
assumed to be anatomically and functionally separate (Wu and Hallett 2013). Studies 
show direct and distinct interconnections between the BG and the cerebellum in animals 
(Bostan et al. 2010; Hoshi et al. 2005) and similar connections have been described in 
humans (Jeong et al. 2012; Mollink et al. 2016; Fenoy et al. 2017; Calabrese et al. 
2015).  
The motor and cognitive regions output to distinct topographical regions in the 
sensorimotor and associative striatum via the dentate nucleus through projections 
towards the thalamus after decussating at the red nucleus (Meola et al. 2016; Mollink 
et al. 2016; Jeong et al. 2012; Jang and Kwon 2015; Calabrese et al. 2015; Kwon et al. 
2011; Anthofer et al. 2017). And the STN has projections towards the contralateral 
cerebellar cortex via the pontine nuclei (Sweet et al. 2014; Bostan et al. 2010). 
Projections from the associative, limbic and motor territories of the STN terminate in 
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the motor and non-motor regions of the cerebellum (Bostan et al. 2013). These 
pathways that show BG and cerebellum interconnections show integration of a range 
of BG and cerebellum functions.  
1.4.3 Cerebellum in PD   
Increasing evidence suggests that the cerebellum may play certain roles in the PD 
pathophysiology. Cerebellar atrophy and volumetric changes have been reported in PD 
with these changes being attributed to motor and non-motor functions. Reduced 
cerebellar volume in the left cerebellum of PD patients compared to healthy controls 
and in patients with tremor at the quadrangular lobe was reported suggesting a role of 
cerebellum in tremor (Borghammer et al. 2010; Benninger et al. 2009). PD cerebellar 
atrophy has been associated with cognitive deficits and markers of disease severity 
(Pereira et al. 2009; Nishio et al. 2010; Yoo et al. 2015).  
Another recent resting state functional connectivity study also found that cerebellar 
atrophy can cause pathological loss of connectivity with large-scale cortical networks 
and contribute to motor and cognitive changes in PD (O’Callaghan et al. 2016). 
Cerebellar grey matter changes correlated with reduced connectivity between the 
cerebellum and sensorimotor, dorsal attention and default networks while showing 
increased connectivity with the frontoparietal network (O’Callaghan et al. 2016).  
Additionally, olfactory (K. Y. Zhang et al. 2011) and cognitive (Camicioli et al. 2009; 
Nishio et al. 2010; Pereira et al. 2009) related structural changes have also been 
reported in PD cerebellum. Dopaminergic degeneration has been reported to produce 
pathological changes in the cerebellum in PD patients and in animal models. In rat and 
monkey lesion models, degeneration of nigrostriatal dopaminergic neurons causes 
dysfunction of both the basal ganglia-thalamic and cerebello-thalamic pathways 
(Rolland et al. 2007). Post mortem brain tissue from PD patients showed reduced 
dopamine receptors in the cerebellum (Hurley et al. 2003).  
Cerebellum has also been shown to play a role in PD symptoms such as gait 
disturbances (Schweder et al. 2010), tremor (Helmich et al. 2012), dyskinesia (Koch et 
al. 2009) and non-motor symptoms (Wu and Hallett 2013). PD resting tremor has been 
linked to changes in the BG and the cerebello-thalamo-cortical motor loop, and a recent 
functional MRI studied showed that the BG influences the tremor amplitude and the 
cerebello-thalamo-cortical loop is effectively influenced through the motor cortex and 
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not the cerebellum, suggesting that PD tremor arises in the BG and it’s propagated via 
the cerebello-thalamo-cortical loop (Dirkx et al. 2016).  
Furthermore, functional MRI studies reveal hyperactivity of the cerebellum in PD 
(Magrinelli et al. 2016; Jahanshahi et al. 2010; Yu et al. 2007a; Koch et al. 2009; Gao 
et al. 2017; Wu et al. 2009). In hypokinetic PD patients, the hyperactivity of the 
cerebello-thalamo-cortical circuit has been proposed to compensate for the 
hypoactivation of striato-thalamo-cortical circuit, while in PD tremor subtype, 
cerebello-thalamo-cortical circuit dysfunction is thought as a physiopathologic 
mechanism for rest tremor (Dirkx et al. 2016). Studies have also shown decreased α-
synuclein levels in the cerebellum in PD (Westerlund et al. 2008; Fuchs et al. 2008; 
Solano et al. 2000). Therefore, converging evidence suggests the importance of the 
cerebellum and the cerebellar interconnections with the BG in PD.  
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1.5 Main white matter connections for investigation 
In summary, from the literature above it is clear that the BG and the cerebellum form 
networks with the cortical areas and the thalamus and these are affected by the PD 
pathology. It is known that the motor symptoms of PD only arises after 80% of 
dopamine in the striatum is depleted and compensatory process have been suggested to 
occur within and outside the BG which should be reflected in the architecture of the 
fibre tracts connecting motor cortex, basal ganglia and thalamus (Bezard et al. 2003).  
The study of the white matter architecture of BG interconnections have been omitted in 
research into PD which provides the novelty and rationale for studying the white matter 
connections between the SMA and the putamen, and the thalamus and the premotor 
cortex in relation to BG circuitry in PD (Chapter 3). The corticospinal tract is the major 
motor tract and it is the pyramidal pathway from the primary motor cortex travelling 
through the cerebral hemispheres including the posterior internal capsule, which lies 
between the globus pallidus and the thalamus, the brain stem (crossing at the bottom of 
the medulla) and the lateral part of the spinal cord (Jang 2014). Therefore, the 
corticospinal tract was also added as the motor tract of interest for investigation in 
Chapter 3. Non-motor symptoms and their related white matter connections have also 
been overlooked in PD, which provides the rationale for including the uncinate 
fasiculus and the medial forebrain bundle for additional investigation in Chapter 3.   
Despite converging evidence that the cerebellum plays a role in PD pathogenesis and 
the evidence showing direct connections between the BG and the cerebellum, no studies 
have looked at the white matter connections of the cerebellum and its interactions with 
the BG in PD. Therefore in Chapter 4, these connections were mapped out in healthy 
participants to provide an anatomical investigation and protocol for delineate the BG-
cerebellum interconnections. And in Chapter 5, these connections and the main 
cerebellar pathways were investigated in the first diffusion tractography study of their 
alteration in PD. The work within this thesis closes the gaps in knowledge in PD were 
previous neuroimaging studies have overlooked the white matter connections of the BG 
and also the interconnections between the BG and the cerebellum while also provide an 
anatomical protocol for future studies in PD and other brain disorder to reconstruct and 
study these white matter connections.  
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2.1 Magnetic Resonance Imaging 
Magnetic Resonance Imaging (MRI) uses the principle of applying radio frequency 
(RF) pulses to excite hydrogen nuclei (protons) within a tissue of interest and recording 
the energy released while they return back to their relaxed state. Hydrogen nuclei 
possess a magnetic dipole with a corresponding north and south pole, these dipoles also 
referred to as spins, align themselves to an externally applied magnetic field.  Therefore, 
when a magnetic field is applied on a tissue, the protons within that tissue align 
themselves parallel to the direction of the magnetic field as shown in (Figure 2.1). This 
net magnetic field direction is referred to as B0 and the net alignment of all the protons 
along this direction as M0. 
 
Figure 2.1 Protons aligned along the magnetic field B0. 
The excited protons spin around their axis and higher magnetic fields cause faster spins 
and vice versa. When an RF pulse that matches the frequency of the spin hits the 
protons, the protons absorb the energy and deflect or fall out of alignment with the 
magnetic field into a higher energy state (Figure 2.2a). The protons then recover back 
into alignment along B0 while releasing the absorbed energy. This process is called as 
magnetic recovery, the time taken to recover is called T1 and the MR signal measured 
as the T1 signal (Figure 2.2b). RF pulses also help coordinate the protons magnetic 
fields so that they wobble in time together (in phase) and as they begin to relax, the 
wobble becomes uncoordinated (out of phase). This process of returning back to 
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uncoordinated wobbling is called as magnetic relaxation, the time taken to relax is 
called T2 and the MR signal is measured as T2 signal (Figure 2.2c).  
 
Figure 2.2 T1 and T2 signal 
a) 90° RF pulse hits a proton causing it to fall in alignment with magnetic field. b) Proton gets back to 
low energy state by releasing energy as the T1 signal. c) Proton falls out of phase and give rise to the T2 
signal.  
In practice, the MR scanner produces a series of short RF pulses followed by longer 
periods of waiting to measure the MR signal that comes back. The signal that come 
backs is called the magnetic echo, the time between the RF pulse and the resulting 
magnetic echo is called as the echo time (TE). When double RF pulses are used, the 
image obtained is called a spin echo MRI image. The time between consecutive RF 
pulses is called as repetition time (TR). When extra magnets in the scanner called as 
the magnetic gradient systems, are rapidly switched ‘on’ and ‘off’, the image formed is 
called a gradient echo MRI image. MRI images are made up of pixels usually 
represented as a matrix, and the more pixels, the higher the resolution which gives more 
structural detail in the MRI image.  
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By manipulating the TE and the TR, different contrasts of MR images can be obtained. 
T1 and T2 times vary within different tissue in the brain (grey matter, white matter and 
cerebrospinal fluid) this causes different contrasts to the MR images as shown in Figure 
2.3. 
 
Figure 2.3 T1 and T2 contrasted images of a representative human brain in the axial view. 
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2.2 Diffusion MRI Imaging and Tractography 
2.2.1 Background 
Diffusion is the process of transporting matter by the random motion of molecules, also 
called as Brownian motion. And about 30 years ago, Le Bihan and colleagues made it 
possible to image the apparent diffusion of water molecules in the human brain (Le 
Bihan et al. 1986). Since then diffusion MRI has become a standard for understanding 
various brain diseases such as multiple sclerosis, dementia, traumatic brain injury, 
stroke, schizophrenia etc. (Oppenheim et al. 2004; Assaf and Pasternak 2008; Ciccarelli 
et al. 2008; Le Bihan and Johansen-Berg 2012; Dijkhuizen et al. 2012). Diffusion 
weighted imaging (DWI) uses the property of Brownian motion of water molecules (Le 
Bihan et al. 2001) to provide image contrasts based on the rate of diffusion (differences 
in magnitude of water diffusion) within the brain. The degree/rate of MR signal loss is 
dependent upon the degree/rate of diffusion (diffusivity), with higher diffusivity areas 
(E.g.: CSF) resulting in more MR signal loss and lower diffusivity areas (E.g.: white 
and grey matter areas) resulting in lower MR signal loss. This degree of the MR signal 
loss can be enhanced by increasing the strength and duration of the diffusion-encoding 
gradients which are characterised by the b value (s/mm2).  
 
Figure 2.4 Diffusion weighted spin echo sequence (Winston 2012a) 
The b value is defined by the Stejskal-Tanner equation: 
 
Where, γ is the gyromagnetic ratio, G, δ, Δ correspond to the amplitude, duration and 
interval of the diffusion gradient, respectively (Figure 2.4). Two dimensional DWI 
images/maps of the diffusion rates are generated by calculations from a combined 
analysis of the two images acquired with different b values (b = 0 and b = 1000 s/mm2) 
(Huisman 2010). A representative participant’s T1 and DWI images are shown in 
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(Figure 2.5 A, B), respectively. The apparent diffusion coefficient (ADC) is the 
measure of the rate of diffusion, a representative ADC map can be seen in (Figure 2.5 
B), where high diffusivity areas appear hyperintense and low diffusivity areas are 
hypointense.  
 
Figure 2.5 T1, DWI, FA and FA colour coded images of a single slice axial view of a representative 
subject. 
A tensor is a mathematical vector which describes both direction and magnitude, 
therefore in diffusion tensor imaging (DTI), the DWIs are acquired in many 
orientations/directions to calculate the overall dominant direction and magnitude of 
water molecule diffusion within each voxel. DTI allows the calculation of the shape 
and orientation of the diffusion in space, which is the tensor graphically represented as 
the ellipsoid in Figure 2.6.  
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Figure 2.6 The diffusion tensor and its quantitative measures 
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Therefore, DTI gives a 3D measurements with three principal diffusivities 
(eigenvalues, λ
1
, λ
2
, λ
3
 in Figure 2.6) which are associated with the three mutually 
perpendicular principal directions (eigenvectors, Dxx, Dyy, Dzz). The tensor has three 
degrees of freedom and is represented by a 3×3 symmetric matrix (Dxx, Dxy, Dxz, 
Dyx, Dyy, Dyz, Dzx, Dzy, Dzz). The sampling of the tensor is performed by repeating 
diffusion-weighted sequence along different directions and one measurement is usually 
a low b-value or a zero b value.  
However, diffusion is a three-dimensional property differing between brain areas and 
influenced by the various microstructural architecture as well as physiological factors 
with the various brain structures. When the movement of the water molecules is 
completely unhindered and they can move freely and equally in all three directions, the 
diffusion is isotropic and the 3D shape is represented by a sphere (E.g.: in the CSF). 
When the movement of the molecules is hindered, the diffusion becomes anisotropic 
(E.g.: in the white matter tracts) and this 3D shape is graphically represented as an 
ellipsoid (Figure 2.6). In the white matter tracts, diffusion happens predominantly along 
34 
 
the direction parallel to the long axis of the tracts (axonal bundles) and is more restricted 
along the directions perpendicular to the direction.  
Various quantitative measurements can be extracted using the information from the 
directional restriction of diffusion along the three axes. The main quantitative measures 
extracted from this information are Fractional Anisotropy (FA), Axial Diffusivity (AD), 
Radial Diffusivity (RD) and Mean Diffusivity (MD) as shown in (Figure 2.6). 
Fractional anisotropy (FA) is a scalar measure of the degree of anisotropy and its value 
ranges from 0 to 1, with values approaching 0 reflecting isotropic tissue and values 
approaching 1 reflecting anisotropic tissue. It is a normalised measure of diffusion 
along all the three directions derived by the following formula (Pierpaoli and Basser 
1996)   
 
FA values can also represented as degree of anisotropy maps and (Figure 2.4 C) shows 
high FA values as bright (e.g.: corpus callosum, internal capsule) and low FA value 
regions e.g.: CSF or grey matter. Mean diffusivity (MD) is a measure of the average 
diffusion along all three directions. Axial or Longitudinal diffusivity (AD/L1) is a 
measure of diffusion along the axial direction or direction of the largest eigenvector 
along the axonal bundle. Radial Diffusivity (RD) is measure of diffusion perpendicular 
to the axial direction or axonal bundle. (Pierpaoli et al. 1996; Song et al. 2002; 
Hagmann et al. 2006).  
As DTI also gives the principal direction of the diffusion, colour-coded FA images 
depicting the direction of largest eigenvector can be derived where the red, green, and 
blue colours are assigned to the right-left, anterior-posterior, and superior-inferior 
directions of the fibre orientations, respectively (Pierpaoli et al. 1996) (Figure 2.4 D). 
MRI measurement of water diffusion in brain tissue provides information about the 
composition, microstructure, architectural organisation and physical properties of the 
constituents of the tissue in a non-invasive manner without the use of contrasting 
agents. Therefore, DTI has made it possible to visualise in vivo white matter 
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connections in the human brain and to investigate their white matter properties. The 
importance of white matter microstructure and it’s organisation in unravelling the 
mysteries of cognition and disease is now widely recognised, particularly how white 
matter is vulnerable to neuropathological defects and neurodegenerative diseases.  
2.2.2 Tractography 
Using the information from the diffusion tensors or ellipsoids, the principal direction 
of the apparent diffusion can be determined for each voxel. With the development of 
mathematical algorithms that allow the connection of ellipsoids one voxel after another 
along their principal directions, it is possible to depict the trajectory of the apparent 
diffusion along white matter fibre tracts as shown in Figure 2.7. Mathematical methods 
were developed to extract and visualise coherently ordered fibre tract trajectories within 
each voxel followed in discrete steps to form tracts. In this way, diffusion tensor based 
tracking allows the visual representation of diffusion directions along white matter 
pathways (Derek K Jones et al. 1999; Pierpaoli et al. 1996; Mori et al. 1999; Catani et 
al. 2002).  
 
Figure 2.7 Tractography based on Diffusion Tensor Imaging [modified from book (Jones 2010)] 
However, DTI based tractography has limitations; in particular, it is unable to resolve 
multiple fibre orientations within voxels (Alexander 2013; Von Dem Hagen and 
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Henkelman 2002). Therefore, several alternative methods to overcome the challenges 
posed by DTI have been developed, such as Diffusion Spectral Imaging (Wedeen et al. 
2005), Q-ball imaging (Tuch 2004), persistent angular structure MRI (PAS-MRI) 
(Jansons and Alexander 2003) and spherical deconvolution (SD) (Anderson 2005; 
Tournier et al. 2004) methods. The data acquisition time for DSI is quite restrictive 
producing partially acquired data which don’t provide sufficient data to reconstruct the 
full diffusion propagator. Q-ball imaging is a variant of DSI, which allows fibre 
orientation peaks to be derived from data acquired at a single b-value however these 
peaks are not very sharp. The PAS-MRI and the SD methods both attempt to sharpen 
the fibre orientation peaks however the PAS-MRI methods have longer computation 
time due to non-linear estimation requirements. Among these methods, the SD based 
tractography has been shown to resolve the DTI problem of crossing fibres with a good 
angular resolution, it also has a relatively short acquisition time similar to standard DTI 
clinical protocols and have reasonable computational analysis times (Huisman 2010; 
Jones 2004). Given that there are crossing fibres in about 90% of the voxels of the brain, 
allocation of voxel-based findings to specific tracts can be highly speculative (Jeurissen 
et al. 2013). The SD method is based on the assumption that the diffusion signals within 
a voxel can be modelled as a spherical convolution between the fibre orientation 
distributions (FOD) and the fibre orientation density function (fODF) which describes 
the common signal profile from the white matter fibres within a voxel (Tournier et al. 
2004). Therefore the FOD is said to provide a better estimation of fibre bundles within 
each voxel as it does not require modelling of the diffusion process itself and does not 
require prior information about the likely number of different fibre populations present 
within each voxel. An example of SD based fODFs reconstructed in the pons is shown 
in Figure 2.8.  
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Figure 2.8 Fibre ODFs reconstructed from the in vivo data for adjacent voxels in the pons. A shows an 
axial FA map at the level of the pons. B shows a magnified section of the FA map, coloured according 
to the anatomic direction of the major eigenvector of the diffusion tensor (red: left–right, green: anterior–
posterior, blue: inferior–superior). C shows the fibre ODFs reconstructed from the voxels highlighted in 
the direction map, also coloured according to orientation. [modified from (Tournier et al. 2004) ]  
Tractography done using only the tensor information from the DTI method is unsuitable 
due to problems with the crossing fibres, however the SD based methods can resolve 
up to 3 peaks reliably which is very important as most of the voxels within the brain 
are known to have crossing fibres (Jeurissen et al. 2013). Even though the SD method 
overcomes these limitations of the DTI method, it is known to be affected by isotropic 
partial volume effects which is likely to produce artefactual tractography results 
(Ciccarelli et al. 2008; Schonberg et al. 2006). The modified damped Richardson-Lucy 
(dRL) algorithm was developed to overcome these challenges of false positives, partial 
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volume effects, crossing fibres and spurious tracking (Dell’acqua et al. 2010). The  dRL 
algorithm has been shown to reduce false positive fibre orientations while preserving 
angular resolution therefore making it robust in estimating the fibre orientations of 
white matter tracts are close to the cortex, thereby providing accurate description of 
white matter organization (Dell’acqua et al. 2010).  
There are two main types of tractography methods: Deterministic and Probabilistic. In 
probabilistic tracking, a seed point (a chosen voxel) is assumed to have connections 
across all points but only those connections that have some minimal cost function are 
taken as most probable connections and pursued to create the fibre tract (Behrens et al. 
2003; Jones and Pierpaoli 2005). The disadvantage of this method is that the frequently 
travelled connection ultimately becomes the most probable one and the cost function 
restricting the direction or coherence of the nerve fibre may not be useful in giving an 
actual representation of a fibre tract.  In deterministic tracking, the fibres are launched 
from a defined region of interest in all directions until specified termination conditions 
are met (Mori et al. 1999; Basser et al. 2000). All ellipsoids or spherical convolutions 
that pass those conditions create the continuous trajectories that form a fibre tract, 
making it computationally less expensive than probabilistic tracking. The disadvantage 
of this strategy is that one cannot be sure whether the fibre tract may represent an actual 
or even a probable white matter pathway, therefore caution needs to be taken when 
performing deterministic tracking without prior knowledge of anatomical pathways.  
Tractography has been shown to be able to generate tracts that are anatomically 
plausible when compared with post mortem sectioning results (Jellison et al. 
2004).Tractography is not only non-invasive and time saving, but it helps to visualise 
white matter tracts in the brain, segment specific tracts for studying and understanding 
them better. Tractography elucidates the white matter anatomy to inform neurosurgery 
of brain tumours and other lesions (Ulmer et al. 2014) or deep brain stimulation (Torres 
et al. 2014) and also enables to find the differences between healthy and diseased white 
matter microstructure (Ciccarelli et al. 2008) thereby helping to understand the 
underlying neuropathology and disease mechanisms.  
For the purposes of this thesis, a whole brain deterministic tractography based on the 
dRL algorithm was employed for the tractography analyses of the chosen white matter 
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pathways of interest guided by previous post mortem, animal tracing and/or human 
diffusion imaging studies. 
2.3 MRI data acquisition and processing 
2.3.1 Data cohorts  
Previously collected data from three different studies were utilised for the analyses 
within this thesis. The first cohort was a group of 26 patients with Parkinson’s disease 
(PD) who took part in a trial that compared functional magnetic resonance imaging 
(fMRI)-based neurofeedback and exercise intervention with a gaming console over 12 
weeks (Subramanian et al. 2016). Here the data used for the analyses here is from the 
baseline scan, which were unaffected by the intervention. Two PD patients’ scans had 
to be excluded from the final analysis due to corrupted data files. The second cohort 
used in this thesis was from a study that looked at the effects of ageing on white matter 
microstructure (Metzler-Baddeley et al. 2011). This study used the same diffusion 
imaging protocol as the PD intervention study and were included to provide 26 age and 
gender matched healthy control (MHC) individuals. The third cohort is a group of 20 
young healthy participants (YHP), acquired as part of a study into white matter 
plasticity following working memory training (Metzler-Baddeley et al. 2016; Metzler-
Baddeley et al. 2017). These studies were approved by the local NHS research ethics 
committee for the patient study and the ethics committee of the School of Psychology 
for the healthy aging and cognitive training studies. All patients and participants 
provided written informed consent. The demographics information of all three groups 
is shown in Table 2.1.  
Table 2.1 Demographics of the Young healthy participants (YHP), Parkinson’s disease (PD) patients 
and Matched healthy controls (MHC)  
 YHP 
(n=20) 
PD  
(n=24) 
MHC 
(n=26) 
Differences between 
PD and MHC 
Age 25.4 ± 4.84 63.42 ± 10.82 64.88 ± 8.06 P = 0.5918, Two 
sample t-test 
Sex (M:F) 12:8 22:2 17:9 P = 0.06, Chi squared 
test 
No of diffusion 
directions 
60 30 30 - 
H & Y Stage NA 1.75 ± 0.47 NA - 
MOCA NA 26.54 ± 2.01 NA - 
LEDD (mg) NA 537.64 ± 340.69 NA - 
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Abbreviations: MOCA –The Montreal Cognitive Assessment; H & Y - Hoehn & Yahr Stage; LEDD – 
Levodopa Equivalent Daily Dose; YHP- Young Healthy Participants; PD- Parkinson’s disease patients; 
HC – Healthy Controls; M - Male; F - Female; R – Right; L - Left  
2.3.2 Structural MRI scanning 
All data were collected at the Cardiff University Brain Research Imaging Centre 
(CUBRIC) on a 3T GE Signa HDx system (General Electric Healthcare) with eight 
head coils. T1-weighted structural scans were acquired using an oblique-axial, 3D fast 
spoiled gradient recalled sequence (FSPGR) with the following parameters: 178 slices; 
TE = 3 ms, TR = 7.9 ms, voxel size 1.0×1.0×1.0 mm3, 256×256 Field of view (FOV), 
acquisition time of 6 minutes. These T1 structural images were acquired for correcting 
geometrical echo planar imaging (EPI) distortion by co-registration with the diffusion 
MRI data, for grey matter anatomical landmarks for localization of regions of interest 
for the tractography and for the subcortical volume analyses.  
2.3.3 Diffusion MRI scanning 
Diffusion weighted MRI data were acquired using a peripherally gated twice-refocused 
pulse-gradient spin-echo echo-planar imaging sequence providing whole oblique axial 
(parallel to the commissural plane) brain coverage. Data were acquired from 60 slices 
of 2.4 mm thickness, with a field of view 23 cm, and an acquisition matrix of 96 x 96 
(yielding isotropic voxels of 2.4 x 2.4 x 2.4 mm, reconstructed to a resolution of 1.9 x 
1.9 x 2.4 mm). Echo time (TE) was 87 ms and parallel imaging (ASSET factor = 2) was 
used. Diffusion encoding gradients (b = 1,200 s/mm2) were applied as the optimal b-
value for deriving good estimates of fractional anisotropy, mean diffusivity and fibre 
orientation is 750-1300 s/mm2 (D K Jones et al. 1999). The gradients were applied 
along 30 isotropically-distributed directions for the PD group and MHC group and 60 
isotropically-distributed directions for YHP group using an optimized gradient vector 
scheme (Jones et al. 2002; D K Jones et al. 1999). Three or six non-diffusion weighted 
images were acquired for the 30 or 60 directions respectively. The 60 direction scan 
was cardiac gated and took approximately 30 minutes while the 30 directions scan took 
a total acquisition time of 15 minutes. 
2.3.4 Diffusion MRI pre-processing 
Echo planar imaging (EPI) which is the technique used to acquire the images of the 
brain plane by plane can be affected by inhomogeneity in the magnetic field and this 
causes distortions in the intensity of each image obtained, and the strong gradients that 
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are used for diffusion encoding create eddy currents (EC) that causes geometric 
distortions to the images, particularly in areas adjacent to the sinuses i.e. frontal and 
anterior temporal lobe regions (Jezzard et al. 1998; Irfanoglu et al. 2012).  
The data were corrected for these EC and EPI distortions by registering each image 
volume to the high resolution T1 weighted anatomical images (Irfanoglu et al. 2012). 
DWI data were also corrected for non-linear distortions induced by the diffusion-
weighted gradients and artefacts due to head and subject motion with appropriate re-
orienting of the encoding vectors (Leemans and Jones 2009).  A single diffusion tensor 
model was fitted (Basser et al. 1994) to the data in order to compute quantitative 
parameters such as FA, MD, RD, AD. The Damped Richardson-Lucy Algorithm (dRL) 
was used to estimate the fibre orientation density function (fODF) in each voxel for 
whole brain tractography (Dell’acqua et al. 2010). Correction for free water 
contamination of the diffusion tensor based estimates was applied, before extracting the 
diffusion properties (FA, RD, AD and MD) along the tracts  (Pasternak et al. 2009; 
Metzler-Baddeley et al. 2012). This was done because aging and neurodegeneration are 
associated with grey and white matter tissue loss which produces partial volume effects 
(PVE) which in turn causes artificial decreases in FA and increase in MD due to the 
contamination from cerebrospinal fluid (CSF) (Metzler-Baddeley et al. 2012).. Hence 
all the diffusion parameters extracted from the tracts in this study were corrected for 
the PVE using the Free Water Elimination (FWE) method (Vos et al. 2011).  
2.3.5 Tractography 
Whole brain deterministic tractography was performed in ExploreDTIv4.8.3 (Leemans, 
Jeurissen, Sijbers, et al. 2009) using the spherical deconvolution based dRL algorithm 
following peaks in the fODF reconstructed from dRL (Dell’acqua et al. 2010; Jeurissen 
et al. 2013). For each voxel in the data set, streamlines were initiated along any peak in 
the fODF that exceeded amplitude of 0.05. This enables multiple fibre pathways to be 
generated from any voxel. Each streamline was continued in 0.5 mm steps following 
the peak in the ODF that subtended the smallest angle to the incoming trajectory. The 
termination criterion was set to an angle threshold greater than 45 degrees; thereby 
streamlines that had angles above this threshold were excluded from the final tracts. 
Three-dimensional fibre reconstructions of the specific tracts were then obtained by 
applying waypoint region of interest (ROI) gates (“AND”, “OR” and “NOT” gates 
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following Boolean logic) to isolate specific tracts from the whole brain tractography 
data. ROIs were drawn manually on either the T1 anatomical images or colour-coded 
fibre orientation maps in native space guided by known anatomical landmarks.  
All white matter pathways reported in this thesis were reconstructed using this 
methodology. These were: the corticospinal tract, the uncinate fasiculus, the supero-
lateral medial forebrain bundle, the white matter connection between the supplementary 
motor area and putamen and the white matter connection between the thalamus and 
motor cortex reported in Chapter 3, the dentato-rubro-thalamic tract and the 
subthalamo-ponto-cerebellar in Chapter 4 and the middle, inferior, and superior 
cerebellar peduncles in Chapter 5.    
2.3.6 Anatomical methods  
Anatomical landmarks were identified on either the T1 anatomical images or colour-
coded fibre orientation maps in native space depending on the tract of interest with 
ExploreDTIv4.8.3 (Leemans, Jeurissen, Sijbers, et al. 2009). The identification of these 
anatomical landmarks were not reliant on any one specific anatomical atlas or piece of 
literature but rather a combination of animal tracing studies, human post mortem and 
human diffusion imaging based studies. Therefore the anatomical landmarks and 
accuracy of tract reconstruction for each tract within this thesis is provided in detail in 
their respective chapters. The special case for reconstruction of the white matter 
connection between the supplementary motor area and putamen and the white matter 
connection between the thalamus and motor cortex reported in Chapter 3, was the use 
of the Anatomical Automatic Labelling (AAL) atlas in the Montreal Neurological 
Institute (MNI) space with FSL (Jenkinson et al. 2012; Smith et al. 2004). The AAL 
atlas was used to create masks for the regions of thalamus, motor cortex, supplementary 
motor area and the putamen which were then used for the segmentation of the individual 
tracts were derived by reconstructing the connections between the chosen masks. 
2.3.7 Clinical and behavioural measures from the PD cohort  
The following clinical and behavioural measures from the PD cohort were also utilised 
within this thesis to explore their potential correlations with the extracted diffusion 
metrics:  
(i) The Movement Disorder Society-Unified Parkinson’s Disease Rating Scale 
(MDS-UPDRS) (Goetz et al. 2008) was performed when patients were in their 
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“off medication” state where they were requested not to take their medication 
for 12 hours before the assessment. The MDS-UPDRS full scale measured non-
motor experiences of daily living, motor experiences of daily living and motor 
complications in addition to the motor examination (which was videotaped for 
later evaluation). Here the baseline off-medication MDS-UPDRS scores were 
utilised.   
(ii) PD disease duration has been shown to correlate negatively with the uptake of 
dopamine transporters in the bilateral striatum, caudate and putamen (Benamer 
et al. 2000; Hsiao et al. 2014). PD patients with longer disease duration also 
presented with reduced cerebral blood flow to the bilateral motor cortex, the 
thalamus, subthalamic nucleus and the basal ganglia (Kapitan et al. 2009). As 
these structures are involved in investigated tracts of interest, duration since PD 
diagnosis (in months) was also added. 
In patients with PD, well executed and skilled hand movements that are crucial for daily 
life are affected. Bradykinesia, one of the main symptoms of PD, is characterised by 
the slowness of initiation and progressive reduction on speed and amplitude of a 
repetitive action (Gibb and Lees 1988). Resting tremor of the hands during voluntary 
movements may also contribute to the difficulty in performing such a task (Dovzhenok 
and Rubchinsky 2012; Abdo et al. 2010). The SMA known to be involved in motor 
preparation and motor tasks (Picard and Strick 2003) was activated when participants 
imagined performing a complex sequence of finger movements (Samuel et al. 2001; 
Roland et al. 1980) while the primary motor cortex was activated when subjects 
actually performed the sequence (Inuggi et al. 2011). This provides the rationale for 
exploring correlations between the motor white matter connections of interest with the 
following two behavioural tasks: 
(iii) The correct number of finger sequence responses and reaction time scores from 
a motor sequence task adapted and modified from a previous study (Tamas 
Kincses et al. 2008). 
(iv) The total number of finger taps per minute for each hand were calculated. The 
finger tapping was measured using a wooden board with an electronic counter 
attached for counting the number of taps (Subramanian et al. 2011).   
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3.1 Abstract  
Objective 
To determine the differences in the white matter microstructure of selected motor 
pathways and non-motor pathways and of volumetric measures of the subcortical 
structures in Parkinson’s disease (PD) compared to age-matched healthy controls 
(MHC). 
Methods 
Diffusion weighted imaging data of 24 PD patients and 26 MHCs were analysed and 
deterministic tractography analysis using the spherical deconvolution-based damped 
Richardson-Lucy algorithm was performed. Additionally, subcortical volume analyses 
was also performed.  
Results 
There was significantly increased fractional anisotropy (FA) in the motor pathways of 
PD patients: the bilateral corticospinal tract (right; corrected p=0.0003, left; corrected 
p=0.03), bilateral thalamus-motor cortex tract (right; corrected p=0.02, left; corrected 
p=0.004) and the right supplementary area-putamen tract (corrected p=0.001) 
compared to MHCs. There was also significantly decreased FA in the right uncinate 
fasiculus (corrected p=0.01) and no differences of FA in the bilateral supero-lateral 
medial forebrain bundles (p>0.05) of PD patients compared to MHCs. There were no 
subcortical volume differences (p>0.05) between the PD patients and MHCs.  
Conclusion 
Increased FA values in the motor tracts in PD may reflect neurodegeneration or 
compensatory reorganisation of neural circuits indicative of adaptive or extended 
neuroplasticity. These results can inform biological models of neurodegeneration and 
neuroplasticity in PD.  
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Key points  
1. Fractional anisotropy was higher in motor pathways of PD patients compared to 
healthy controls. 
2. Fractional anisotropy was lower in the uncinate fasciculus while there was no change 
in the fractional anisotropy of PD patients compared to healthy controls.  
3. Increased fractional anisotropy could suggest adaptive neuroplasticity or selective 
neurodegeneration.  
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3.2 Background and Rationale 
The motor symptoms in PD only arise after approximately 80% depletion of striatal 
dopamine and it has long been thought that compensatory plasticity must occur both 
within and outside the basal ganglia as the pathology progresses (Bezard et al. 2003). 
Such compensatory processes, as well as any long-range deficits arising from 
degeneration of the basal ganglia pathways, are expected to ultimately be reflected in 
the architecture of the fibre tracts connecting motor cortex, basal ganglia and thalamus.  
To date most diffusion MRI based studies on PD have only considered changes within 
defined regions of interest (ROI) in grey matter (Meijer et al. 2013) or have conducted 
whole-brain analysis of white matter microstructure using tract based spatial statistics 
(TBSS) (Rae et al. 2012). These approaches are prone to partial volume effects and 
entail difficulties of spatial alignment across participants. Given that there are crossing 
fibres in about 90% of the voxels of the brain, allocation of voxel-based findings to 
specific tracts can be highly speculative (Jeurissen et al. 2013). The dRL based SD 
algorithm improves fibre tracking in areas of complex fibre architecture and regions 
affected by partial volume (Dell’acqua et al. 2010). Therefore, deterministic 
tractography using the dRL algorithm which is more sensitive to detect group 
differences than whole brain and group-wise voxel-based approaches and produces 
anatomically plausible white matter tracts (Jeurissen et al. 2013) was chosen for 
analysis.  
The following motor pathways were reconstructed to investigate motor related changes 
in PD; (i) the corticospinal tract (ii) fibre connections between the thalamus and the 
motor cortex (iii) fibre connections between the SMA and the putamen. The 
corticospinal tract (CST) is crucial for self-initiated movements and thus putatively 
involved in bradykinesia in PD (Phillips et al. 2014; Jang 2014). Post mortem and 
diffusion MRI studies show direct white matter fibre connections from the SMA to the 
striatum (Vergani et al. 2014). The thalamus, a relay centre for sensory and motor 
information, conveys motor inputs from the basal ganglia to the cortex and decreased 
dopaminergic innervation to the thalamus is assumed to contribute to the 
pathophysiology of PD (Lindenbach and Bishop 2013). These structures and their 
connections are not only part of the BG motor circuitry affected in PD (Bergman et al. 
1990), but also known to be mediating effective treatments options in PD (Mirdamadi 
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2016; Williams 2015; Rodriguez-Oroz et al. 2009; Sweet et al. 2014; Calabrese et al. 
2015; Linhares and Tasker 2000). It has been proposed that these connections are 
relevant for motor performance in PD (Mink 1996) and thus are closely related to PD 
pathophysiology, symptoms, and potentially also their remediation.  
The following non-motor pathways were also reconstructed to investigate any potential 
changes as PD is a diverse disease with motor and non-motor symptoms; (iv) the 
uncinate fasiculus and (v) the supero-lateral medial forebrain bundle.  
The uncinate fasiculus connects the orbitofrontal cortex with the anterior temporal lobes 
and is assumed to be involved in language, emotional processing and episodic memory 
(Von Der Heide et al. 2013; Highley et al. 2002). These connecting brain regions are 
known to influence non-motor and cognitive symptoms in PD (Yoo et al. 2015; 
Alessandro Tessitore et al. 2012; A Tessitore et al. 2012; Disbrow et al. 2014; Papagno 
et al. 2011).  The medial forebrain bundle connects the ventral tegmental area to the 
forebrain and the frontal lobe, and these brain areas as well as the bundle itself has been 
shown to be involved in reward processing alterations such as anhedonia and depression 
in PD (Coenen et al. 2012; Bracht et al. 2015; Brown and Pluck 2000; Robbins and 
Everitt 1996; Kunig et al. 2000).  Due to their involvement in PD, these non-motor 
tracts were included as comparison tracts to examine specific changes in motor 
compared to non-motor pathways known to be involved in PD. 
Additionally, studies have detected subcortical volume differences in PD patients 
compared to healthy controls (Rosenberg-Katz et al. 2016; Gerrits et al. 2016; Lee et 
al. 2011; Nemmi et al. 2015; Geng et al. 2006; Menke et al. 2014; Lisanby et al. 1993). 
Therefore, subcortical volume analysis was included to study any potential grey matter 
subcortical volumes changes that may also help in understanding their contribution to 
the disease pathology in addition to any white matter microstructure changes.  
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3.3 Aims 
The primary aim was to determine the differences in selected motor pathways and non-
motor pathways of the basal ganglia in PD patients compared to healthy controls. The 
second aim was to investigate any potential group differences in the subcortical 
volumes. 
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3.4 Materials and Methods 
3.4.1 Participants 
Table 3.1 Demographics of the PD patients and MHCs 
 
PD  
(n=24) 
MHC 
(n=26) 
Analyses 
Age 63.42 ± 10.82 64.88 ± 8.06 P = 0.5918, Two sample t-test 
Sex (M:F) 22:2 17:9 P = 0.06, Chi squared test 
Handedness (R:L) 20:4 24:2 P = 0.3293, Chi squared test 
H & Y Stage 1.75 ± 0.47 NA - 
UPDRS score 25.04 ± 11.01 NA - 
MOCA 26.54 ± 2.01 NA - 
LEDD (mg) 537.64 ± 340.69 NA - 
PD – Parkinson’s disease; MHC - Healthy controls; MOCA – The Montreal Cognitive Assessment; H 
& Y - Hoehn & Yahr Stage; UPDRS – Unified Parkinson’s Disease Rating Scale (pre-intervention and 
off medication); LEDD – Levodopa Equivalent Daily Dose; M - Male; F - Female; R – Right; L - Left  
Please refer to the Chapter 2 General Methodology for full details of the MR data 
acquisition, diffusion MR pre-processing and the deterministic tractography algorithms 
used. The tracts of interest were reconstructed in the PD patient group and the MHC 
group, see Table 3.1 for demographics.  
3.4.2 Tractography 
3.4.2.1 Corticospinal tract (CST)  
For the segmentation of the CST, the primary motor cortex was identified in the axial 
slice of a T1-weighted anatomical image using a “SEED” region (in blue) (Figure 3.1 
A. (i)). Further, an “AND” region (in green) was drawn in the brain stem (identified as 
the blue colour of the pons in the anterior part of the brain stem) in the axial slice of an 
FA image (Figure 3.1 A. (ii)). The CST of a representative subject on a sagittal slice of 
a T1 image is shown in (Figure 3.1 A (iii)). 
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Figure 3.1 Reconstructed motor tracts  
A. Corticospinal tract. A. (i) Axial slice of T1 image showing “SEED” region. A. (ii) Axial slice of FA 
image showing “AND” region. A. (iii) Sagittal slice of T1 image showing the reconstructed CST. B. 
Reconstructed supplementary area-putamen tract and C. Thalamus-motor cortex tract on sagittal slices 
of T1 image. 
Anatomical landmarks and tract accuracy were quality assessed by manually checking 
through each CST on both hemispheres for each participant in all groups. The 
anatomical landmarks for the CST were the primary motor cortex identified by the 
inverted omega Ω symbol in the axial slice of a T1 image (Figures 3.1A (i) and 3.2 A), 
the pons identified by the blue colour of the pons in the anterior part of the brain stem 
in an axial slice of an colour coded FA image and  FA image (Figures 3.1A (ii) 3.2 B) 
and the CST passing through the internal capsule identified below the thalamus in a 
coronal slice of T1 image (Figure 3.2 C and D), showing the front and reverse views 
respectively. 
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Figure 3.2 Anatomical landmarks for CST 
A. Axial slice of T1 image showing the inverted omega (Ω) landmark. B. Axial slice of FA image 
showing the pons regions in the brain stem. C. Coronal slice showing the front view of the CST passing 
through the internal capsule just below the thalamus, going towards the primary motor cortex. D. Coronal 
slice showing the reverse view of the CST passing through the pons and the internal capsule.  
3.4.2.2 Thalamus-motor cortex (THAL-MC) and Supplementary area-putamen (SMA-
PUT) tracts 
The ROIs for segmentation of THAL-MC and SMA-PUT tracts were derived by 
creating masks chosen from the Anatomical Automatic Labelling (AAL) atlas in the 
Montreal Neurological Institute (MNI) space. These masks were warped to the 
individual native space of each subject using inverse parameters derived from warping 
the T1 image to the AAL template using FSL FLIRT (Jenkinson et al. 2012; Smith et 
al. 2004). These masks were then used as “SEED” and “AND” regions in 
ExploreDTIv4.8.3 (Leemans, Jeurissen, Siibers, et al. 2009) for segmenting out the 
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respective tracts. The reconstructed THAL-MC and SMA-PUT tracts also included 
their connections towards the brain stem beyond the thalamus and putamen, 
respectively. These were then segmented using the Splitter tracts tool within 
ExploreDTI4.8.3. The splitter tracts tool is used to segment portions of a reconstructed 
tract by drawing SEED and AND ROIs to specify the location of segmentation. This 
was used here to include only the portion of the THAL-MC at the level of the thalamus 
towards the motor cortex, and portion of the SMA-PUT at the level of the putamen 
towards the SMA for extracting the diffusion metrics from these tracts. The final SMA-
PUT and THAL-MC tracts in a sagittal slice of a T1 image of a representative subject 
are shown in (Figure 3.1 B) and (Figure 3.1 C), respectively. 
 
Figure 3.3 Anatomical landmarks for THAL-MC tract 
A. Coronal slice T1 image showing THAL-MC tract split at the level of the thalamus. B. Coronal slice 
of T1 image showing THAL-MC tract split at the level of the thalamus with tract moving towards the 
motor cortex. C. Coronal slice of T1 image showing full THAL-MC tract between thalamus and the 
motor cortex.  
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Anatomical accuracy of the THAL-MC tract was verified by checking that the tract 
after the splitting began at the level of the thalamus (Figure 3.3 A) and then moved 
towards the motor cortex (Figure 3.3 B, C). The accuracy of the ROI masks were 
checked by overlaying them with the tract and the colour coded FA image to verify that 
they covered the thalamus and the motor cortex regions and that the tracts themselves 
passed originate or terminate in these ROI masks. (Figure 3.4) 
 
Figure 3.4 Mask accuracy for THAL-MC tracts 
A. Sagittal slice of colour coded FA image with ROI mask for thalamus and THAL-MC tract overlaid 
on the ROI mask. B. Sagittal slice of colour coded FA image with ROI mask for motor cortex and THAL-
MC tract overlaid on the ROI mask. C. Sagittal slice of colour coded FA image with ROI mask of motor 
cortex and full THAL-MC tract overlaid on it.  
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Figure 3.5 Anatomical landmarks for SMA-PUT tract 
 A. Coronal slice of T1 image showing the putamen and caudate nucleus. B. Coronal slice of T1 image 
 showing Putamen and SMA-PUT tract split at this level as well a portion of the tract going towards the 
 SMA. C. Coronal slice of T1 image showing full SMA-PUT tract split at the level of the putamen and 
 going towards the SMA.  
Anatomical accuracy for the SMA-PUT tracts was verified by checking that the tract 
after splitting began at the level of the putamen and then moved towards the SMA 
(Figure 3.5). The accuracy of the ROI masks were checked by overlaying them with 
the tract and the colour coded FA image to verify that they covered putamen and SMA 
regions and that the tracts themselves originated or terminated in these ROI masks 
(Figure 3.6).  
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 Figure 3.6 Mask accuracy for SMA-PUT tract 
 A. Coronal slice of colour coded FA image with ROI mask for putamen and the SMA-PUT tract overlaid 
 on it. B. Coronal slice of colour coded FA image with ROI mask for SMA and the SMA-PUT tract 
 overlaid on it. C. Axial slice of colour coded FA image with ROI mask for putamen and the SMA-PUT 
 tract overlaid on it. D. Axial slice of colour coded FA image with ROI mask for SMA with the SMA-
 PUT tract overlaid on it.   
3.4.2.3 Uncinate Fasiculus (UNF)  
For segmentation of the UNF, the most posterior slice in the coronal view of a T1 image 
where the frontal and the temporal lobes are separated was chosen which is 
approximately at the height of the nucleus accumbens. The “SEED” region (in blue) 
was drawn around the temporal lobe (Figure 3.7 D. (i)) and the “AND” region (in green) 
was drawn around the region lateral to the caudate and the putamen (Figure 3.7 D. (ii)). 
The UNF tract of a representative subject on a sagittal slice of a T1 image is shown in 
(Figure 3.7 D (iii)). Anatomical accuracy for the uncinate was verified by checking if 
the tracts pass through the ROIs and that the spurious and unwanted fibres were 
removed from them (Figure 3.8).  
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3.4.2.4 Supero-lateral medial forebrain bundle (slMFB) 
For reconstruction of the slMFB one horizontal “AND” region was placed surrounding 
the ventral tegmental area. The anatomical borders for this AND region were laterally 
the substantia nigra, anteriorly the mammillary bodies and posteriorly the red nucleus 
(Figure 3.7 E. (i)). Another “AND” region was drawn surrounding caudate and putamen 
on a coronal section at the height of the nucleus accumbens (Figure 3.7 E. (ii)) (Bracht 
et al. 2015). The slMFB tract of a representative subject on a sagittal slice of a T1 image 
is shown in (Figure 3.7 E. (iii)). Anatomical accuracy for the slMFB was verified by 
checking if the tracts pass through the ROIs and that the spurious and unwanted fibres 
were removed from them (Figure 3.9). 
 
Figure 3.7 Reconstructed non-motor tracts  
D. Uncinate fasiculus tract. D. (i) Coronal slice of T1 image showing “SEED” region for uncinate 
fasiculus segmentation. D. (ii) Coronal slice of T1 image showing “AND” region. D. (iii) Sagittal slice 
of T1 image showing reconstructed uncinate fasiculus tract. E. Supero-lateral medial forebrain bundle. 
E. (i) Axial slice of T1 image showing “AND” region. C. (ii) Coronal slice of T1 image showing “AND” 
region. E. (iii) Sagittal slice of T1 image showing reconstructed supero-lateral medial forebrain bundle.  
Each reconstructed tract was visually inspected and any obvious outlier streamlines that 
were not consistent with their known anatomy were excluded by drawing “NOT” 
regions and the entire procedure was performed separately for both hemispheres. 
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Figure 3.8 Anatomical landmarks for UNF 
A. Coronal slice of T1 image showing anatomical landmarks of caudate and putamen for the AND region, 
and the frontal lobe for the SEED region with the UNF passing through them. B. Sagittal slice of T1 
image showing frontal part of the UNF passing through the AND region in the frontal lobe. C. Axial 
slice of T1 image showing temporal part of UNF passing through the SEED region in the temporal lobe. 
D. Sagittal slice of T1 image showing temporal part of the UNF passing through the SEEN region in the 
temporal lobe.  
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Figure 3.9 Anatomical landmarks for the slMFB 
A. Coronal slice of T1 image showing the caudate and putamen surrounded by the AND region and the 
frontal part of the slMFB passing through it. B. Axial slice of T1 image showing AND region drawn 
laterally to the substantia nigra, anteriorly to the mammillary bodies and posteriorly to the red nucleus. 
C. Sagittal slice of T1 image showing the full slMFB passing through both the AND regions.  
3.4.3 Subcortical volumes analysis 
The volumes of subcortical brain structures were measured using FSL's FIRST software 
(FMRIB Image Registration and Segmentation Tool) (Patenaude et al. 2011; Jenkinson 
et al. 2012). The structures of the thalamus, caudate, putamen, pallidum, hippocampus, 
amygdala, nucleus accumbens and ventricles were extracted for both the hemispheres 
and their volumes measured for all T1-weighted MR images of the PD patients and 
MHCs. The extracted volumes were normalised using the scaling factor obtained from 
brain tissue normalization for subject head size, using SIENAX (Structural Image 
Evaluation using Normalization of Atrophy) (Smith et al. 2004).  
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3.4.4 Statistical Analysis 
All the statistical analyses were carried out in the R statistical software v2.15.3 (R Core 
Team 2014). Before data analysis, all variables were checked for Gaussian distribution 
using Shapiro-Wilk test (p<0.05) and were transformed using appropriate 
transformations if necessary. 
A multivariate analysis of covariance (MANCOVA) was performed in each hemisphere 
for each of the five tracts separately with FA, MD, AD and RD as dependent variables 
and group (PD and MHC) as independent variable, along with age and gender as 
covariates. These analyses were corrected for multiple comparisons using False 
Discovery Rate (FDR) correction (p<0.01). Significant results were further analysed 
using post-hoc univariate ANOVAs also corrected for multiple comparisons using FDR 
correction (p<0.05). The inter-rater reliability of diffusion metrics derived from the 
manually reconstructed tracts was investigated using the inter class correlation 
coefficient (ICC).  
For the subcortical volumes analysis, two sample t-tests were carried out comparing the 
corrected subcortical volumes of the PD patients and MHCs.  
Post hoc correlations were also performed in the PD group between metrics in tracts 
that showed significant group differences and the following clinical and behavioural 
measures: off medication baseline Unified Parkinson’s Disease Rating Scale (UPDRS) 
scores, duration since diagnosis (in months), scores from a standard finger tapping task 
and a four button finger sequence task measuring the correct number of responses and 
reaction time.  
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3.5 Results 
For all PD patients and MHCs, reliable reconstruction results of all investigated fibre 
tracts was obtained.  
3.5.1 Inter-rater reliability  
For inter-rater reliability testing, a subset of four subjects from the PD group and MHC 
group were randomly selected by two researchers (T.B and C.M.B) experienced in 
tractography. FA values were extracted and tests were performed independently and 
separately using the IRR package in the R statistical software. Inter-rater correlations 
coefficients (ICC) for the tracts are presented in Table 3.2. 
Table 3.2 Inter-rater reliability tests 
JPM and TB ICC p-value 
L-CST 0.998 3.07e-21 
R-CST 0.999 3.25e-22 
L-UNF 1 9.6e-27 
R-UNF 1 9.6e-27 
JPM and CMB    
L-CST 1 5.99e-26 
R-CST 1 2.44e-29 
L-UNF 0.998 3.67e-20 
R-UNF 0.998 3.67e-20 
L-CST- Left corticospinal tract, R-CST-Right corticospinal tract, L-UNF- Left uncinate fasiculus, R-
UNF- Right uncinate fasiculus, ICC – Inter-rater correlation coefficients   
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3.5.2 Multivariate effects 
The MANCOVAs demonstrated a significant effect of group (PD and MHC) on the 
multivariate diffusion metrics (FA, MD, AD and RD) in the CST, SMA-PUT, THAL-
MC and UNF, but not in the slMFB (Table 3.3).  
Table 3.3 Multivariate effects 
Tract 
 
F statistic Pillai's trace P-value 
Right CST Group F(4,43)=4.6907 0.3 0.003132 *** 
Age F(4,43)=3.3356 0.23 0.018252 
Gender F(4,43)=3.1088 0.22 0.024736 
Left CST Group F(4,43)=8.5394 0.44 3.66E-05 *** 
Age F(4,43)=2.7190 0.2 0.04189 
Gender F(4,43)=2.5850 0.19 0.05026 
Right SMA-PUT Group F(4,43)= 6.4230 0.38 0.000363 *** 
Age F(4,43)=10.5065 0.48 1.00E-05 *** 
Gender F(4,43)=0.5654 0.04 0.730037 
Left SMA-PUT Group F(4,43)=4.8551 0.31 0.002546 *** 
Age F(4,43)=5.5182 0.34 0.001123 *** 
Gender F(4,43)= 0.3259 0.02 0.859045 
Right THAL-MC Group F(4,43)=4.7410 0.31 0.002939 *** 
Age F(4,43)=4.4941 0.29 0.00402 *** 
Gender F(4,43)=0.6916 0.06 0.601839 
Left THAL-MC Group F(4,43)=5.5699 0.34 0.001054 *** 
Age F(4,43)=4.4365 0.29 0.004326 *** 
Gender F(4,43)=1.4269 0.11 0.241373 
Right UNF Group F(4,43)=5.7824 0.28 0.002011 *** 
Age F(4,43)=2.5327 0.15 0.069178 
Gender F(4,43)=3.2413 0.18 0.030894 
Left UNF Group F(4,43)=5.0908 0.32 0.001898 *** 
Age F(4,43)=3.8483 0.26 0.009263 
Gender F(4,43)=2.6825 0.19 0.044023 
Right slMFB Group F(4,43)=1.2095 0.1 0.320719 
Age F(4,43)=5.1433 0.32 0.001778 *** 
Gender F(4,43)=1.9735 0.15 0.115659 
Left slMFB Group F(4,43)=1.1442 0.09 0.348703 
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Age F(4,43)=4.3186 0.28 0.005032 *** 
Gender F(4,43)=3.2387 0.23 0.020777 
CST - Corticospinal tract, SMA-PUT - Supplementary motor area-putamen tract, THAL-MC - 
Thalamus-motor cortex tract, UNF - Uncinate fasiculus, slMFB - supero-lateral medial forebrain bundle.  
*** = FDR corrected p < 0.01 
3.5.3 Univariate group effects 
Post hoc analyses showed significantly increased FA and AD in right CST, and 
significantly increased FA in the left CST of the PD patients compared to MHC (Table 
3.4). In PD patients, there was significantly increased FA and AD in the right SMA-
PUT tracts and significantly increased AD in the left SMA-PUT tracts. Similarly, there 
was significantly increased FA in both right and left THAL-MC tracts and increased 
AD in the left THAL-MC tracts of the PD patients compared to MHCs (Table 3.4). 
Conversely, in the UNF of PD patients, there was significantly decreased FA and 
significantly increased RD in the right UNF, and significantly increased MD and 
significantly increased RD in the left UNF (Table 3.4). 
Table 3.4 Univariate group effects  
Tract Metric HC (n=26) 
mean ± SD 
PD (n=24) 
mean ± SD 
F statistic FDR Corrected      
p-value 
Right 
CST 
FA 0.54 ± 0.025 0.58 ± 0.024 F(1,48)=24.32 0.0003264 *** 
MD (10–3) 0.71 ± 0.018 0.72 ± 0.032 F(1,48)=2.601 0.134 
RD (10-3) 0.46 ± 0.022 0.45 ± 0.028 F(1,48)=4.068 0.0751 
AD (10-3) 1.21 ± 0.048 1.25 ± 0.072 F(1,48)=16.24 0.0012672 *** 
Left 
CST 
FA 0.53 ± 0.027 0.56 ± 0.030 F(1,48)=12.25 0.0032544 *** 
MD (10-3) 0.72 ± 0.023 0.73 ± 0.024 F(1,48)=2.098 0.1699 
RD (10-3) 0.48 ± 0.025 0.47 ± 0.025 F(1,48)=3.138 0.106 
AD (10-3) 1.20 ± 0.045 1.26 ± 0.058 F(1,48)=7.556 0.0179328 
Right 
SMA-
PUT 
FA 0.42 ± 0.041 0.47 ± 0.029 F(1,48)=20.63 0.0006016 *** 
MD (10-3) 0.71 ± 0.024 0.73 ± 0.034 F(1,48)=4.459 0.06392 
RD (10-3) 0.53 ± 0.027 0.52 ± 0.026 F(1,48)=2.486 0.138742857 
AD (10-3) 1.07 ± 0.06 1.15 ± 0.071 F(1,48)=16.47 0.0012672 *** 
Left 
SMA-
PUT 
FA 0.44 ± 0.041 0.46 ± 0.036 F(1,48)=3.695 0.084201739 
MD (10-3) 0.72 ± 0.024 0.74 ± 0.033 F(1,48)=6.4 0.027764706 
RD (10-3) 0.54 ± 0.033 0.54 ± 0.028 F(1,48)=0.08 0.7775 
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PD- Parkinson’s disease patients, MHC-Healthy Controls. CST - Corticospinal tract, SMA-PUT - 
Supplementary motor area-putamen tract, THAL-MC - Thalamus-motor cortex tract, UNF - Uncinate 
Fasiculus. FA – Fractional Anisotropy, MD – Mean Diffusivity, RD – Radial diffusivity and AD – Axial 
diffusivity.  *** = FDR corrected (p < 0.01), SD - Standard deviation. 
3.5.4 Subcortical volumes analysis  
There were no significant volume differences between PD patients and MHCs in the 
FSL FIRST analysis of subcortical and ventricular volumes (Table 3.5).  
Table 3.5 Subcortical volumes analysis results  
Sub-cortical 
structures 
PD (mean ± SD) MHC (mean ± SD) t-value df P-
value 
L-Amygdala 1812.24 ± 235.03 1759.77 ± 242.49   0.1275 48.89 0.8991 
L-Caudate 4700.76 ± 504.54 4583.12  ±  458.61 -0.008 45.85 0.9931 
L-Globus 
pallidus 
1912.32 ± 183.76 1861.65 ± 206.15 0.2403 39.58 0.8113 
L-Hippocampus 4901.72 ± 635.04 4872.85  ± 759.49 -0.532 47.25 0.5969 
AD (10-3) 1.10 ± 0.045 1.16 ± 0.075 F(1,48)=10.32 0.006258667 *** 
Right 
THAL
-MC 
FA 0.49 ± 0.031 0.52 ± 0.036 F(1,48)=13.96 0.0017984 *** 
MD (10-3) 0.69 ± 0.018 0.70 ± 0.027 F(1,48)=1.353 0.2672 
RD (10-3) 0.48 ± 0.024 0.46 ± 0.025 F(1,48)=6.618 0.0264 
AD (10-3) 1.10 ± 0.044 1.16 ± 0.071 F(1,48)=8.312 0.01344 
Left 
THAL
-MC 
FA 0.47 ± 0.030 0.51 ± 0.036 F(1,48)=17.4 0.0012672 *** 
MD (10-3) 0.71 ± 0.022 0.71 ± 0.027 F(1,48)=0.721 0.412 
RD (10-3) 0.51 ± 0.027 0.49 ± 0.027 F(1,48)=6.13 0.029 
AD (10-3) 1.11 ± 0.042 1.16 ± 0.076 F(1,48)=10.64 0.00593 *** 
Right 
UNF 
FA 0.43 ± 0.024 0.41 ± 0.019 F(1,48)=14.36 0.0017984 *** 
MD (10-3) 0.77 ± 0.018 0.78 ± 0.024 F(1,48)=3.56 0.0869 
RD (10-3) 0.57 ± 0.018 0.59 ± 0.022 F(1,48)=13.91 0.001798 *** 
AD (10-3) 1.11 ± 0.048 1.14 ± 0.049 F(1,48)=2.934 0.1147 
Left 
UNF 
FA 0.42 ± 0.039 0.40 ± 0.024 F(1,48)=3.973 0.0755 
MD (10-3) 0.75 ± 0.017 0.77 ± 0.021 F(1,48)=15.13 0.0016 *** 
RD (10-3) 0.57 ± 0.028 0.59 ± 0.024 F(1,48)=10.11 0.00634 *** 
AD (10-3) 1.18 ± 0.043 1.15 ± 0.051 F(1,48)=4.512 0.06392 
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L-Nucleus 
accumbens 
663.48 ± 188.68 624.12  ± 121.88 0.6446 37.98 0.523 
L-Putamen 5073.24 ± 515.06 5154.19  ± 558.31 -1.33 47.65 0.1899 
L-Thalamus 7919.24 ± 734.17 7865.15  ± 743.50 -0.556 36.35 0.5812 
L-Ventricles 10996.24 ± 
3795.60 
13036.96  ± 
4124.85 
-1.924 48.95 0.0602 
Brain stem 27039.76 ± 
2420.41 
25368.85  ± 
2447.38 
1.5628 45.16 0.1251 
R-Amygdala 1778.8 ± 295.89 1737.65  ± 303.74 0.0859 45.95 0.9319 
R-Caudate 5024.16 ± 645.34 4845.38  ± 536.10 0.3984 40.29 0.6924 
R-Globus 
pallidus 
1875.92 ± 236.54 1865.81  ± 227.78 -0.408 38.18 0.6855 
R-Hippocampus 5044.4 ± 518.01 5001.35  ± 672.08 -0.382 48.03 0.7037 
R-Nucleus 
accumbens 
504.44 ± 145.58 519.15  ± 105.40 -0.529 40.78 0.5996 
R-Putamen 4915.4 ± 809.16 4968.69  ± 643.96 -1.017 41.88 0.3148 
R-Thalamus 7706.88 ± 686.55 7650.62  ± 700.39 -0.524 39.15 0.603 
R-Ventricles 10087.52 ± 
4117.54 
11598.62  ± 
4338.02 
-1.370 48.86 0.1767 
R – Right, L – Left, SD - Standard Deviation 
There were no significant results from the correlation analyses as well (see 
supplementary table 3.3 and supplementary table 3.4).  
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3.6 Discussion 
This is the first comprehensive deterministic tractography study of motor and non-
motor tracts in PD. I found increased FA in the cortico-basal ganglia and CSTs, which 
may indicate compensatory mechanisms or structural changes related to altered pallido-
thalamic activity in PD. Patients with early stage PD relative to age-matched controls 
demonstrated a specific increase in FA and AD in the white matter of motor tracts which 
was not present for two non-motor comparison tracts.  
In the previous literature, neurodegenerative disorders have generally been associated 
with decreased FA in the major pathways, which has been attributed to primary white 
matter degeneration, demyelination, reduced gliosis or axonal damage as a result of 
grey matter loss (Concha et al. 2006; Assaf 2008; Lebel et al. 2008). Diffusion tensor 
based ROI and whole brain analyses in PD have shown reduced FA or increased MD 
in a priori regions such as the substantia nigra and putamen (Rae et al. 2012; Meijer et 
al. 2013; Schwarz et al. 2013). Thus only the finding of decreased FA and increased 
RD in the UNF, but not the findings of increased FA and AD in the CST and cortico-
basal ganglia tracts, would be compatible with a general neurodegenerative process.  
3.6.1 Neurodegenerative models 
These findings may reflect selective neurodegeneration. AD, which is the measure of 
diffusion in the principal fibre direction is sensitive to the number of axons and their 
coherence (Takahashi et al. 2000) while RD, the measure of diffusion perpendicular to 
the principal diffusion direction is thought to reflect decreased myelination (Song et al. 
2002). Therefore, in the current data the results of elevated FA in combination with 
elevated AD could suggest selective neurodegeneration causing lower neural 
branching, decreases of axonal diameter and thus higher coherence along the principal 
orientation. Increased FA in theses tracts may also occur as a primary pathogenic 
consequence of altered pallido-thalamic activity in PD. A combined diffusion tensor 
and histology based study of rat model of traumatic brain injury showed that increase 
in FA in the cortical regions was correlated with gliosis (Budde et al. 2011). It has been 
suggested that FA is more related to axonal package density and less to myelination 
(Winston 2012b). Along these lines, the results from the current data could suggest a 
higher axonal package density of motor pathways as there was no significant 
differences in RD in the current study. 
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3.6.2 Neuroplastic models 
Alternatively, these findings might reflect early compensatory mechanisms associated 
with increases in axonal density in pathways of the cortico-basal-ganglia-thalamo-
cortical loop. Such compensatory changes might preserve neural functions despite loss 
of the dopaminergic input (Bezard et al. 2003). A recent study in PD showed increase 
in striato-cortical connectivity mediated by levodopa intake (Herz et al. 2015), hence  
it could also be suggested that increased FA in the SMA-PUT and THAL-MC tracts 
may be an adaptive response to abnormal dopaminergic modulation and levodopa 
intake.  
The results are consistent with the suggested compensation stages of PD where 
structures outside the basal ganglia, especially the SMA, would undergo changes to 
counterbalance the putative abnormal activity in the thalamus and basal ganglia (Bezard 
et al. 2003). Considering the long time-course from the onset of PD-related pathology 
to the onset of clinical symptoms (H Braak et al. 2006), the subcortical and cortical 
motor pathways may well have undergone compensatory and adaptive structural and 
functional reorganisation long before PD patients have been diagnosed clinically. Such 
a model would be supported by the observation (Supplementary Table 3.1) that changes 
in the diffusion metrics were not confined to the hemisphere contralateral to the side of 
dominant symptoms.   
Recent evidence from PD rodent models showed axonal sprouting as compensatory 
mechanism (Arkadir et al. 2014), but this has not be studied in detail outside the 
nigrostriatal system. Based on the present findings, there may be compensatory 
sprouting in motor tracts in response to decreased input from thalamus and striatum as 
a consequence of PD pathology. The results could also suggest that sprouting should 
also be assessed in corticospinal and thalamo-cortical motor tracts, both in animal 
models and in human brains post-mortem.   
3.6.3 Subcortical volumes 
There were no differences in the subcortical volumes between the PD patients and the 
MHCs. This finding is inconsistent with previous studies that had similar sample sizes 
and PD patients’ disease stages to our current cohort but reported smaller volumes of 
the subcortical structures in PD compared to healthy controls (Rosenberg-Katz et al. 
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2016; Lisanby et al. 1993; Gerrits et al. 2016; Lee et al. 2011; Nemmi et al. 2015; Geng 
et al. 2006; Menke et al. 2014).  
3.6.4 Methodological considerations 
Diffusion metrics are highly sensitive to white matter microstructural changes, 
however, they are non-specific indices with complex measures; hence one has to be 
cautious when inferring any specific biological mechanisms underlying changes in 
these measures (Jones et al. 2013). Before interpreting the current findings in terms of 
putatively increased structural connections in PD the possibility that they are influenced 
by methodological artefacts should be eliminated. The dRL algorithm was used, and 
this reduces the number of spurious fibre orientations that can produce artefactual 
reconstructions of tracts and is robust in mapping cortical connectivity (Dell’acqua et 
al. 2010). In patient and clinical studies, presence of degeneration makes the estimated 
tract reconstructions prone to isotropic partial volume effects (Ciccarelli et al. 2008) 
but the spherical deconvolution methods makes it possible to obtain accurate white 
matter fibres that are corrected for partial volume effects and crossing fibres. 
Additionally, there was higher number of reconstructed streamlines in PD patients than 
in MHCs in the motor tracts and the UNF (Supplementary Table 3.2) even though only 
the motor tracts showed increased FA whereas the UNF showed decreased FA. Thus it 
can be excluded that higher FA values were driven by the increase in number of 
reconstructed streamlines or number of occupied voxels or tract volume.  
Because FA is a normalised measure it can be affected by changes in any of the 
compartments of white matter. For a better understanding of the specific contributions 
of axonal microstructural changes and myelination to changes in the white matter 
architecture in PD, future studies can apply complex diffusion microstructural models 
such as Composite Hindered and Restricted Model of Diffusion (CHARMED) or 
AxCaliber (Assaf 2008). However, their clinical application in patients with movement 
disorders is limited by the long duration of scanning protocols. Recently developed 
myelin water fraction mapping and quantitative magnetization transfer techniques 
could also be used in future studies to better quantify myelination (Levesque et al. 
2010).  
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3.7 Conclusion 
This first comprehensive deterministic tractography study of motor and non-motor 
tracts in PD revealed increased FA in the cortico-basal ganglia and CSTs, which may 
indicate compensatory mechanisms or structural changes related to altered pallido-
thalamic activity in PD. Tractography analysis should be incorporated in future 
longitudinal imaging studies of PD in order to evaluate the role of white matter changes 
in neurodegenerative and neuroplastic processes.    
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 Anatomy of the dentato-rubro-thalamic tract (DRTT) and 
the subthalamo-ponto-cerebellar tract (SPCT) 
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4.1 Abstract 
Objective 
Evidence from animal tracing studies shows direct anatomical connections between the 
basal ganglia and the cerebellum. Although the presence of similar connections in 
humans have been reported in a few studies using diffusion MRI, the anatomy of these 
pathways and their reliable reconstruction has not been demonstrated yet. 
Methods 
Anatomical protocols were developed to delineate the two white matter tracts that 
connect the basal ganglia and the cerebellum: the dentato-rubro-thalamic tract (DRTT) 
and the subthalamo-ponto-cerebellar tract (SPCT), in young healthy adults with high 
angular resolution diffusion data using deterministic diffusion MRI tractography. The 
feasibility of transferring this protocol to clinical studies of diffusion MRI data from a 
cohort of Parkinson’s disease patients and their matched healthy controls was also 
demonstrated. 
Results 
In all groups, the two tracts were reliably reconstructed using the developed anatomical 
protocols. The tracts obtained closely correspond to the previously described 
anatomical pathways of the DRTT and the SPCT. The cortical connections of the 
reconstructed tracts and their spatial overlap with the major cerebellar pathways and 
the corticospinal tract were also derived. 
Conclusion 
The findings from this study are thus consistent with the presence of direct anatomical 
connections between the basal ganglia and the cerebellum. Furthermore, the spatial 
independence and cerebellar-cortical connections of these tracts were demonstrated for 
the first time. These tracts have clinical research application and will help to understand 
the role of the cerebellum in neuropsychiatric and neurodegenerative disorders.  
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Key points 
1. An anatomically guided tractography protocol was developed to reconstruct the DRTT 
and the SPCT using deterministic diffusion MRI tractography. 
2. Successfully demonstrated feasibility of transferring the developed tractography 
protocol to standard diffusion imaging protocols in a cohort of PD patients and their 
matched healthy controls.  
3. The spatial independence of the DRTT and the SPCT was assessed and the cortical 
connections were also described. 
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4.2 Background and Rationale 
The loops that connect the basal ganglia and the cerebellum have long been thought to 
be anatomically and functionally distinct while interacting with each other only at the 
level of the cerebral cortex (Doya 2000). In primates, there are efferent connections 
from cerebellar nuclei to subdivisions of the thalamus which in turn project to motor, 
premotor and basal ganglia areas (Percheron et al. 1996; Sakai et al. 1996). However, 
recent neuronal tracing studies in non-human primates have found direct projections 
from the dentate nucleus not only to the thalamus but also to the dorsal striatum (Hoshi 
et al. 2005). Reciprocal inter-connections between the basal ganglia and the cerebellum, 
notably between the sub-thalamic nucleus and the cerebellar cortices have also been 
demonstrated (Bostan et al. 2010). These studies reveal direct anatomical connections 
between the basal ganglia and the cerebellum, suggesting close interactions that may 
influence aspects of motor, affective and cognitive functions known to be mediated by 
these structures (Wu and Hallett 2013).  
There are two anatomical connections that are crucially implicated in the cerebellar 
output to the basal ganglia and the basal ganglia output to the cerebellum. The cerebellar 
output to the basal ganglia through the dentato-rubro-thalamic-tract (DRTT) was 
delineated through rabies virus injection into the sensorimotor area of the putamen of 
macaque monkeys and retrograde transneuronal transport (Hoshi et al. 2005). Their 
findings showed clear pathways (disynaptic projections) connecting the striatum, which 
is the input region of the basal ganglia, and the dentate nucleus, which is the output 
nucleus of the cerebellum, through the thalamus. In humans, the DRTT has been 
described as an ascending tract carrying the main efferent pathway from the cerebellum 
(Parraga et al. 2016). It ascends from the dentate nucleus through the superior cerebellar 
peduncle towards the red nucleus (with axon collaterals to this nucleus) (Surova et al. 
2015) and decussates in the midbrain to reach the thalamus. 
The basal ganglia output to the cerebellum, also known as subthalamo-ponto-cerebellar 
tract (SPCT), was described in a follow-up study in 2010 (Bostan and Strick 2010) by 
injecting rabies virus into the cerebellar cortex of non-human primates. From the 
injection site, retrograde transport was observed to first-order neurons that innervate 
the injection from the pontine nuclei, then to second-order neurons in the subthalamic 
nucleus (STN) that make synaptic connections with the first order neurons (Bostan et 
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al. 2010). In humans, the SPCT has so far been described in one study as a tract 
originating in the sub-thalamic nucleus and travelling through the pons into the 
contralateral cerebellar cortex (Sweet et al. 2014). 
It has been a challenge to translate these tracing studies in non-human primates to 
human anatomy. Diffusion MRI tractography is presently the only technique that allows 
for in vivo and non-invasive investigation of white matter connections in humans. The 
importance of tractography is increasingly being recognised in neurology and 
neurosurgery and particularly important for the characterisation of the anatomical 
position of such white matter connections (Sweet et al. 2014; Coenen et al. 2015; Hana 
et al. 2016; Anthofer et al. 2017; Fenoy et al. 2017). Whilst some of these pathways, 
such as the main cerebellar peduncles, have been fairly well characterized in the 
literature (Stieltjes et al. 2001; Leitner et al. 2015; Rodriguez-Mena et al. 2017), 
research into the DRTT and SPCT has been scarce.  
Some recent diffusion MRI studies have considered these two tracts (Kwon et al. 2011; 
Sweet et al. 2014; Calabrese et al. 2015; Surova et al. 2015; Hana et al. 2016; Meola 
et al. 2016), but so far, a comprehensive characterization of their anatomy with regards 
to cortical connections and relation to other cerebellar tracts, has not been conducted 
yet. One reason for this is, that these tracts are thin, long and multi-synaptic, and cross 
over to the contra-lateral hemisphere, making them prone to crossing fibres especially 
at the decussating regions and are therefore not straightforward to reconstruct using 
tractography. The dRL algorithm as described in Chapter 2 accounts for this problem. 
However, this issue was further resolved by first reconstructing the tracts in a high 
angular resolution diffusion imaging (HARDI) (Tuch et al. 2002) sample with 60 
gradient directions, as the increase in number of directions for diffusion data acquisition 
may resolve the problem of crossing fibres (Behrens et al. 2003; Chung et al. 2011). 
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4.3 Aims 
The primary aim of this study was to describe and develop an anatomically guided 
tractography protocol to reconstruct and delineate the DRTT and the SPCT using 
deterministic diffusion MRI tractography in HARDI (60 directions) dataset from a 
cohort of young healthy participants. The second aim of the study was to demonstrate 
feasibility of transferring this tractography protocol to diffusion imaging protocols  
commonly acquired in clinical studies (scans acquiring 30 directions), by 
reconstructing the DRTT and SPCT in a dataset from patients with Parkinson’s disease 
and their matched healthy controls.   
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4.4 Materials and Methods 
4.4.1 Data cohorts, MRI acquisition and processing 
All three data cohorts previously described in Table 1 of Chapter 2 – General 
methodology were used. Also please refer to Chapter 2 – General methodology for 
detailed MRI acquisition and processing protocols.  
4.4.2 Tractography protocols 
4.4.2.1 DRTT  
The dentate nucleus was identified in the axial view of the brain infero-lateral to the 
fourth ventricle, where the temporal lobe is still visible and the slice cuts through the 
middle of the basilar pons and an ROI was drawn as shown in Figure 4.1 (A). The 
thalamus was identified in the axial view and a second ROI was drawn contralateral to 
the AND region of the dentate nucleus as shown in Figure 4.1 (C). The red nucleus is 
located in the midbrain, infero-medial to the thalamus, infero-lateral to the 3rd ventricle 
and posterior to the cerebral peduncle. The decussation point of the DRTT was 
identified along with the red nucleus and the substantia nigra in the diffusion principal 
direction colour coded image, and another ROI was drawn (Figure 4.1 (B)). This 
procedure was repeated for the other hemisphere and for all participants. The full DRTT 
of a representative participant is shown in (Figure 4.1 (D & E)) and the right and left 
DRTTs are shown in (Supplementary Figure 4.1).  
Anatomical landmarks to check the accuracy of tract reconstruction was the dentate 
nucleus, the decussation point in the midbrain at the level of the red nucleus and the 
thalamus (Figure 4.1). These landmarks were chosen as the ROIs based on animal 
tracing studies (Hoshi et al. 2005; Wu and Hallett 2013) and human diffusion 
tractography studies (Parraga et al. 2016; Surova et al. 2015) described in the 
introduction section.  
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Figure 4.1 The DRTT tract along with the ROIs in axial, sagittal and coronal views of T1 anatomical 
scan of a representative participant.  
A shows the DRTT tract from the dentate nucleus, B shows the DRTT decussating in the mid brain and 
C shows the DRTT passing through the thalamus in the axial view. D shows the entire DRTT with its 
cortical projections on a sagittal slice and E shows the entire DRTT with its cortical projections on a 
coronal slice.   
4.4.2.2 SPCT  
The subthalamic nucleus is small biconvex-shaped nucleus modulating the basal 
ganglia output and is located inferior to the thalamus and superior to the substantia 
nigra, and lateral to the internal capsule (Hamani et al. 2004). For the reconstruction of 
the SPCT, the subthalamic nucleus was identified in the coronal view and a ROI was 
drawn as shown in (Figure 4.2 (A)). The second ROI was drawn around the 
contralateral pons region surrounding the decussation of the SPCT into the cerebellar 
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hemispheres (Figure 4.2 (B)). This procedure was repeated for the other hemisphere 
and for all participants.  
Anatomical landmarks to check for accuracy of tract reconstruction was the SPCT 
passing through both the ROIs and also the decussation at the level of the pons. 
 
Figure 4.2 Regions of interest and reconstruction of the SPCT for a representative participant in coronal 
view. 
The first ROI is drawn around the subthalamic nucleus in T1 anatomical (A) and the second ROI is drawn 
around the contralateral pons region in a diffusion colour coded image (B). 
In some cases, where the methods described above were unsuccessful in delineating the 
SPCT or the DRTT, a different approach was taken: an ROI was drawn around the 
thalamus covering the posterior limb of the internal capsule in an axial view of the brain 
(Figure 4.3 (A)) and a second ROI around the contralateral cerebellar hemisphere at the 
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level of the pons was drawn also in the axial view of the brain as shown in (Figure 4.3 
(B & C)). Appropriate NOT ROIs were drawn to delineate the DRTT and the SPCT 
separately. A representative SPCT obtained using this alternative method is shown in 
(Figure 4.3 (D)). The right and left SPCTs are also shown in (Supplementary Figure 
4.2). 
 
Figure 4.3 Alternative ROIs used for reconstruction of DRTT and SPCT.  
The ROI around the thalamus covering the internal capsule is shown in (A), the ROI covering the 
contralateral cerebellar peduncle (B) & (C). An example of the SPCT obtained using this alternative 
method is shown in (D). 
Additionally, the main cerebellar tracts (middle, inferior and superior cerebellar 
peduncles: MCP, ICP and SCP) and the corticospinal tracts (CST) were reconstructed 
in order to investigate the tract overlap and to compare reliability indices. The 
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procedure for the reconstruction of the CST has been described previously in Chapter 
3 (Mole et al. 2016) and reconstruction of the cerebellar tracts were performed using 
descriptions from (Stieltjes et al. 2001; Oishi et al. 2011) and their reconstruction 
protocols are described in Chapter 5. 
4.4.3 Statistical Analysis  
4.4.3.1 Tract probability maps 
The probability maps of connections of the various tracts (DRTT, SPCT, CST, MCP, 
SCP and ICP) within the brain were mapped out using group-based probability maps 
for each tract. To create these maps, the NIfTI-exported (Neuroimaging Informatics 
Technology Initiative) tracts of each participant were registered to MNI space. This was 
done by first registering each participant's structural high-resolution T1-weighted 
image to MNI space, using FSL FNIRT (FSL version 5.0.9, warp resolution: 10 mm, 
10mm, 10mm) (Andersson et al. 2010; Jenkinson et al. 2012), and then applying the 
warp to the tract NIfTI file (which had already been registered to the high resolution 
structural scan as part of the pre-processing pipeline in ExploreDTIv4.8.3).  
4.4.3.2 Spatial overlap between tracts 
As the DRTT and SPCT lie in close proximity to other cerebellar tracts, I aimed to 
assess their spatial independence by looking at their spatial overlap with the MCP, SCP, 
ICP and CST. Spatial overlap was assessed by calculating overlap dice coefficient 
scores [see also (Zijdenbos et al. 1994)]. First the tracts were exported to binary NIfTI 
files, then the number of voxels for each tract and the number of voxels overlapping in 
two tracts were counted using the AFNI function 3DOverlap (Cox 1996). Finally, dice 
coefficients were calculated using the formula:  
(2 x number of overlapping voxels) / (number of voxels in tract 1 
+  number of voxels in tract 2) 
 And these were subsequently converted to percentage. This was performed in both 
directions to quantify what percentage of voxels in tract 1 were occupied by tract 2, and 
vice versa. Then the overlap dice coefficients were averaged across participants within 
each group. 
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4.4.3.3 Inter-operator reliability of tract reconstruction 
I reconstructed all tracts (DRTT, SPCT, MCP, ICP, SCP and CST) for all participants 
in all groups. A second operator (IL) independently reconstructed tracts for a subset of 
randomly selected participants (5 from each group) to assess reliability and 
reproducibility of reconstructions. Similar to the procedure for assessing spatial 
overlap, reliability was assessed by calculating overlap dice coefficient scores using the 
formula:  
(2 x number of overlapping voxels) / (number of voxels in tract by operator 1 
+  number of voxels in tract by operator 2) 
 And these were converted to percentage as before.   
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4.5 Results  
The DRTT and the SPCT was successfully reconstructed across all the three groups as 
shown in Table 4.1.  
Table 4.1 Number of successful reconstructions of the DRTT and SPCT tracts  
Tract Young Healthy 
Controls 
Parkinson’s 
Disease 
Matched Healthy 
Controls 
Number of 
participants 
20 24 26 
Number of directions 60 30 30 
Mean age ± SD 25.4 ± 4.84 63.42 ± 10.82 64.88 ± 8.06 
Number of L DRTT 
(%) 
16 (80%) 17 (71%) 18 (69%) 
Number of R DRTT      
(%) 
15 (75%) 16 (67%) 14 (54%) 
Number of L SPCT 
(%) 
11 (55%) 19 (79%) 22 (85%) 
Number of R SPCT 
(%) 
16 (80%) 19 (79%) 23 (89%) 
SD – Standard deviation, L - Left, R - Right, DRTT – Dentato-Rubro-Thalamic Tract, SPCT – 
Subthalamo-Ponto-Cerebellar Tract  
4.5.1 Tract probability maps 
The probability maps depicting the anatomical connections for all tracts across the 
whole brain for the YHC group are shown in Figure 4.4 and Figure 4.5, for the PD 
group and the MHC group in Supplementary Figure 4.3 and Supplementary Figure 4.4. 
The tract projection maps of the DRTT and the SPCT in the YHC group were visually 
assessed using atlases (Juelich Histological atlas, Harvard-Oxford Subcortical 
Structural Atlas, MNI Structural Atlas) in both hemispheres.  
The DRTT originates from the dentate nucleus and travels superiorly and medially 
through the SCP (Kwon et al. 2011; Surova et al. 2015; Meola et al. 2016) towards the 
midbrain. The DRTT showed extensive projections to the frontal lobe through the 
internal capsule. The DRTT also showed projections to the premotor cortex and the 
supplementary motor cortex, close but not overlapping with the corticospinal tract, with 
projections also towards the precentral, inferior and superior frontal gyri (Figure 4.4, 
Figure 4.5). There were no identifiable projections of the DRTT towards the occipital, 
parietal and temporal lobes. The DRTT is located medio-posteriorly to the CST in the 
internal capsule and then its cortical projections travel laterally anterior and posterior 
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to the CST (Figure 4.4, Figure 4.5). The current findings are in line with a previous 
study that found the DRTT projections are located medio-posteriorly to the CST (Hana 
et al. 2016). It was found that the DRTT also projects to the caudate and the putamen, 
which is again in line with the animal literature that reports projections into the motor 
regions of the putamen (Hoshi et al. 2005).  
The SPCT showed connections with the frontal lobe, primary motor cortex, primary 
somatosensory cortex, premotor cortex, and precentral cortex, inferior and superior 
frontal gyri. While there were no connections between the SPCT and the occipital and 
temporal lobes, there were connections with the superior parietal lobe (Figure 4.4, 
Figure 4.5). A diagrammatic representation of the connections of the reconstructed 
DRTT and the SPCT including their cortical connections is depicted in (Figure 4.6). 
The connections of the reconstructed DRTT and the SPCTs appear consistent across 
the groups in both hemispheres (Figure 4.4, Figure 4.5, Supplementary Figure 4.3 and 
Supplementary Figure 4.4). The key anatomical landmarks that the DRTT and the 
SPCT pass through, shown here in serial axial slices of the brain are also depicted in 
Figure 4.4. For the DRTT, the tract at the level of the dentate nucleus and decussation 
at the level of the red nucleus, and for the SPCT the tract decussation at the level of the 
pons. Other key features for both the DRTT and the SPCT was passage through the 
internal capsule and connections towards the various cortical regions. 
 
Figure 4.4 DRTT and SPCT anatomical connections shown as probability maps in axial slices in the 
YHC group. The range is from 1-50, hence areas of the brain showing yellow and light blue colours have 
at least 50% of participants’ tracts passing through those voxels. 
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Figure 4.6 Circuits interconnecting the cerebellum and the basal ganglia including the cerebral cortex 
connections.  
Based on findings from the current tractography reconstructions and probability maps in the YHC group 
[adapted and modified from (Bostan and Strick 2010)]. STN - Subthalamic nucleus, PN – Pontine nucleus 
and DN – Dentate nucleus  
4.5.2 Spatial overlap between tracts 
The spatial overlap between tracts (as percent of each of the tracts’ voxels occupying 
voxels of the DRTT or the SPCT) are shown in Table 4.2 and the results from the spatial 
overlap among all the tracts in both directions are depicted in the matrix plots (Figure 
4.7). The DRTT predominately overlaps with and travels through the SCP, with the 
YHC group showing that the left SCP occupies an average 15.59% of the left DRTT 
and the right SCP occupies an average 16.97% of the right DRTT (see Table 4.2). While 
the left and right DRTT occupy less than 2.92% of the left and right SCPs across all 
groups [hemisphere (mean ± standard deviation) in YHC, R(2.28 ± 2.02) L(1.95 ± 
1.91), in PD, R(2.62 ± 2.22) L(2.92 ± 2.58) and in MHC, R(1.37 ± 1.34) L(2.15 ± 
2.10)].  
The left and right SPCTs predominately overlap with the MCP, with the YHC group 
showing that the MCP occupies an average 32.28% of the left SPCT and occupies an 
average 29.61% of the right SPCT (see Table 4.2). While the left and right SPCTs 
occupy less than 4.93% of the MCPs across all groups [hemisphere (mean ± standard 
deviation) in YHC, R(1.88 ± 2.29) L(2.15 ± 1.61), in PD, R(2.82 ± 2.80) L(4.63 ± 3.46) 
and in MHC, R(4.30 ± 2.95) L(4.93 ± 2.78)]. 
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Table 4.2 Spatial overlap 
Dice similarity coefficient (DSC) (Mean ± SD) 
L DRTT 
   L CST  L DRTT  L ICP  MCP  L SCP  L SPCT 
YHC 
0.46% ± 
1.34%  
100% 
4.91% ± 
6.62%  
1.60% ± 
2.94%  
15.59% ± 
16.23%  
0.57% ± 
1.16%  
PD 0% 100% 
1.35% 
±2.02%  
0.66% ± 
1.24%  
8.25% ± 
6.09%  
1.16% ± 
1.94%  
MHC 
1.42% ± 
3.00%  
100% 
1.68% ± 
3.00%  
0.18% ± 
0.54%  
7.30% ± 
6.12%  
3.90% ± 
9.03%  
R DRTT 
   R  CST  R  DRTT  R  ICP  MCP  R  SCP  R  SPCT 
YHC 
0.10% ± 
0.28%  
100% 
4.22% ± 
5.88%  
1.28% ± 
2.78%  
16.97% ± 
19.26%  
0.77% ± 
1.22%  
PD 
0.03% ± 
0.09%  
100% 
1.70% ± 
2.70%  
0.13% ± 
0.30%  
9.86% ± 
6.88%  
0.65%± 
2.31%  
MHC 
1.47% ± 
2.84%  
100% 
0.80% ± 
1.46%  
0.17% ± 
0.45%  
9.06% ± 
9.45%  
0.70% ± 
1.69%  
L SPCT  
   L CST  L DRTT  L ICP   MCP  L SCP  L SPCT 
YHC 
1.63% ± 
1.69%  
0.97% ± 
2.34%  
0.52% ± 
0.63%  
32.28% ± 
13.96%  
0.39% ± 
0.93%  
100% 
PD 
1.02% ± 
0.85%  
1.05% ± 
1.75%  
0.57% ± 
1.24%  
22.87% ± 
11.70%  
0.17% ± 
0.61%  
100% 
MHC 
0.80% ± 
0.65%  
1.19% ± 
1.94%  
0.50% ± 
0.97%  
25.60% ± 
10.72%  
0.28% ± 
0.64%  
100% 
R SPCT 
   R  CST  R  DRTT  R  ICP   MCP  R  SCP  R  SPCT 
YHC 
1.78% ± 
1.60%  
1.31% ± 
2.63%  
1.70% ± 
2.70%   
29.61% ± 
12.52%  
0.58% ± 
0.86% 
100% 
PD 
1.38% ± 
1.06%  
0.70 % ± 
2.47%  
0.73% ± 
1.46%  
25.60% ± 
10.81%  
0.12% ± 
0.29%  
100% 
MHC 
1.69% ± 
1.12%  
0.99% ± 
2.81%  
0.29% ± 
0.72%  
27.18% ± 
10.06%  
0.11% ± 
0.31%  
100% 
YHC - Young Healthy Controls, PD – Parkinson’s disease, MHC – Matched Healthy Controls, SD - 
Standard deviation, L - Left, R - Right, DRTT – Dentato-Rubro-Thalamic Tract, SPCT – Subthalamo-
Ponto-Cerebellar Tract, CST – Corticospinal tract, ICP – Inferior Cerebellar Peduncle, SCP – Superior 
Cerebellar Peduncle, MCP - Middle Cerebellar Peduncle 
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Figure 4.7 Matrix plots representing the overlaps as group-averaged dice scores between the tracts in 
each group.  
L - Left, R - Right, DRTT – Dentato-Rubro-Thalamic Tract, SPCT – Subthalamo-Ponto-Cerebellar 
Tract, CST – Corticospinal tract, ICP – Inferior Cerebellar Peduncle, SCP – Superior Cerebellar 
Peduncle, MCP - Middle Cerebellar Peduncle 
 
4.5.3 Inter-rater reliability of tract reconstruction 
The inter-rater reliability of the reconstructed tracts was measured as the spatial 
agreement between the tracts reconstructed by operator 1 (JPM) and operator 2 (IL). 
On average the spatial agreement for all tracts was above 50% and comparable across 
tracts, with the exception of the MCP which showed particularly high agreement (CST: 
L: 64±28 (n = 15), R: 69±27 (n = 15); DRT: L: 61±25 (n = 10), R: 66±30 (n = 7); ICP: 
L: 58±22 (n = 15), R: 67±15 (n = 15); SCP: L: 66±15 (n = 15), R: 61±15 (n = 12); 
SPCT: L: 68±21 (n = 9), R: 75±25 (n = 8); MCP: 93±5 (n = 15)). Closer inspection 
revealed that tracts from one operator were consistently larger than tracts from the other 
operator, whose smaller tracts were mostly comprised within the larger ones (see 
Supplementary Table 4.1). However, the extracted fractional anisotropy values from 
the full reconstructed tracts showed high inter-class correlation across operators (PD, 
ICC 0.671, p=0.0286 and MHC, ICC 0.969, p=3.32e-07) (see Supplementary Table 4.3 
and Supplementary Table 4.4). 
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4.6 Discussion  
In this study, an anatomically guided tractography protocol was developed to 
reconstruct the DRTT (cerebellar output to the basal ganglia) and the SPCT (basal 
ganglia output to the cerebellum) using HARDI data (60 directions) from a group of 
young healthy participants. The anatomical protocol was then also used to successfully 
reconstruct these tracts in a dataset (30 directions) of Parkinson’s disease patients and 
matched controls. Most importantly and for the first time the tract probability maps and 
spatial overlap of the reconstructed tracts have been described in humans using 
diffusion tractography.  
4.6.1 Tract probability maps 
There was evidence of cortical motor and non-motor connections for the DRTT and the 
SPCT and to date this is the first study to report these cerebellar-cortical connections in 
humans.  
4.6.1.1 DRTT 
The projections of the DRTT followed the previously described animal literature (Hoshi 
et al. 2005) and various studies in humans using tractography, histology and post-
mortem dissection studies (Kwon et al. 2011; Sweet et al. 2014; Surova et al. 2015; 
Hana et al. 2016; Mollink et al. 2016; Fenoy et al. 2017). The DRTT originates in the 
dentate nucleus, ascending through the SCP towards the brainstem and then decussates 
in the mid brain at the level of the red nucleus towards the contralateral thalamus, with 
projections further on towards the cortical regions (Figure 4.1, Figure 4.4, Figure 4.5). 
One retrograde transneuronal virus tracer study has looked at the motor and non-motor 
cerebral cortex projections of the dentate nucleus and showed that it projects to the 
primary motor, premotor, prefrontal and posterior parietal areas of the cortex (Dum and 
Strick 2003). This is in line with the current tractography findings for the DRTT (Figure 
4.4), which suggest that these projections could be a result of neuronal connections 
between the dentate nucleus and the cortical regions via the DRTT. The DRTT 
cerebellar connections are also in line with the following studies using retrograde 
transneuronal transport in monkeys: firstly, disynaptic projections from the dentate 
nucleus to the SMA and pre-SMA have been found (Akkal et al. 2007). Secondly, the 
dentate nucleus has been found to project to and receive input from the primary motor 
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cortex and the dorsolateral prefrontal cortex (Kelly and Strick 2003). Furthermore, the 
dentate nucleus provides input to the frontal eye field (Lynch et al. 1994) and projects 
to the different regions of the prefrontal cortex via the thalamus (Middleton and Strick 
2001). Finally, a review has reported that cerebellar nuclei project to the subdivision of 
the thalamus which in turn project to neocortical regions including the premotor, 
prefrontal and posterior parietal areas of the cerebral cortex (Percheron et al. 1996). 
However, the inferior parietal lobule (Clower et al. 2001) and posterior parietal cortex 
(Clower et al. 2005) are targets for output from the dentate nucleus, but there were no 
similar DRTT connections to the parietal cortex in the current study.  
4.6.1.2 SPCT 
The connectivity of the SPCT also followed the animal literature (Bostan and Strick 
2010). The SPCT originates in the subthalamic nucleus descending though the 
brainstem and decussating in the upper and/or middle pons (Figure 4.2), before 
travelling into the contralateral cerebellar hemisphere. The SPCTs that were 
reconstructed in the current study did not however enter the contralateral cerebellar 
cortex via the SCP as described by the previous study in humans (Sweet et al. 2014), 
but through the MCP. The current findings have been replicated within different healthy 
participant groups and in the PD patient group with findings consistently showing that 
the SPCT overlaps with MCP and not the SCP (Table 4.2, Figure 4.7). The finding of 
cortical connections of the SPCT from the current data (Figure 4.4, Figure 4.5) are in 
support of the classical view that cerebellum receives input from widespread 
neocortical areas including portions of the frontal, parietal, temporal and occipital lobes 
(Glickstein et al. 1985; Schmahmann 1996).  
4.6.2 Spatial overlap 
It was observed that there was overall low spatial overlap between the main tracts of 
interest (the DRTT and the SPCT) with the CST, MCP, SCP and the ICP (Table 4.2). 
This is very encouraging as spatial independence suggests that these tracts are distinct 
pathways and not just part of the major cerebellar pathways even if the DRTT passes 
through the SCP and the SPCT through the MCP.   
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4.6.2.1 DRTT 
Of all the investigated tracts, the SCP showed highest spatial overlap with the DRTT 
(Table 4.2, Figure 4.7, and Supplementary Figure 4.5). This finding is in line with a 
recent human connectome-based tractography and microdissection study using 488 
subjects which found that the DRTT runs superiorly and medially inside the SCP and 
verified the same using microdissection (Meola et al. 2016). A probabilistic 
tractography study in 41 healthy subjects showed that the DRTT is a part of the SCP 
where the SCP acts as a channel for the DRTT leaving the cerebellum (Kwon et al. 
2011). Other studies showed that fibers arising from the dentate nuclei pass through 
ipsilateral SCP before decussating at the level of the inferior colliculi in the 
mesencephalic tegmentum (Parraga et al. 2016).  
4.6.2.2 SPCT 
The MCP showed the highest spatial overlap with the SPCTs (Table 4.2, Figure 4.7). 
The SPCT described previously in humans (Sweet et al. 2014) did not demonstrate a 
similar overlap. Here, the high overlap between SPCT and MCP is likely due to the 
decussation of the SPCT occurring at the level of the pons, where the MCP joins the 
two cerebellar hemispheres (Supplementary Figure 4.9).  
4.6.3 Inter-rater reliability 
Using the developed protocol a researcher new to tractography (operator 2/I.L.) was 
also able to reconstruct the DRTT and the SPCT using the developed protocol, as 
suggested by good inter-rater reliability. This was comparable to the inter-rater 
reliability for the more established tracts (CST, MCP, SCP and ICP). The tract with the 
highest inter-rater reliability was the MCP, which is a large tract and quite easy to 
reconstruct. It should be noted that although all the tracts were reliably reconstructed 
and were visually and anatomical accurate, the volume was thinner in most of the 
operator 2 tracts, suggesting that measures of tract size (and derived measures such as 
average fractional anisotropy across a tract) can depend on how an operator draws the 
ROIs, thereby highlighting the importance of consistent application of manual 
tractography protocols. Regardless of the limited spatial concordance across operators, 
the reliability of the obtained semi-quantitative measure of fractional anisotropy for 
each tract was good, which is an important prerequisite for any study looking at inter-
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individual or group (e.g., patients vs. controls) differences (Supplementary Table 4.3 
and Supplementary Table 4.4). 
4.6.4 Consistent reconstruction across data sets 
Although previous tractography papers have obtained the full DRTT including the 
cortical projections, the current study is the first to follow the cortical projections and 
verify its course in a larger participant sample, including different age groups, patients, 
and different acquisition protocols. Moreover, the tracts reconstructed in three different 
datasets were qualitatively comparable across groups (see tract probability maps in 
Figure 4.4, Figure 4.5, Supplementary Figure 4.3, Supplementary Figure 4.4). 
4.6.5 Limitations 
It was not possible to reconstruct the DRTT and the SPCT in all participants. This may 
be in part caused by their anatomical nature; for instance, they are smaller, longer and 
have more curvature than more well-established tracts (e.g. CST, MCP). Even though 
the data were correction for participant motion, eddy current and echo planar imaging 
distortion, residual noise and signal artefacts from free water and air tissue interfaces 
may have contributed to this. The choice of the imaging parameters, the image quality, 
the tracking algorithms and pre-processing pipelines are also known to affect the 
quality, precision and reliability of tractography results and contribute to false positive 
and false negative findings (Jbabdi and Johansen-Berg 2011). It has to be noted that not 
all tracts that could potentially overlap with the cortical connections of the DRTT and 
SPCT have been reconstructed in this study (e.g. the anterior thalamic radiation) as the 
focus was on looking at overlap with the main cerebellar tracts and the CST. 
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4.7 Conclusion 
The current study is the first to describe and develop anatomical protocols for the 
cerebellar output (DRTT) and cerebellar input (SPCT) connections that have been 
previously described in non-human primates in healthy young adults, older participants 
and PD patients. Also for the first time their cortical connections and spatial overlap 
with the major cerebellar pathways (MCP, ICP, SCP) and the CST are described.  
These findings are in support of previous studies suggesting that there are distinct and 
direct anatomical connections between the basal ganglia and the cerebellum (Hoshi et 
al. 2005; Bostan and Strick 2010). These findings also challenge the classical view that 
the cerebellum receives input from neocortical areas but then funnels this information 
back to only the primary motor cortex through the thalamus (Allen and Tsukahara 
1974), as there was distinct cerebral connections with various cortical regions in both 
DRTT and SPCT.   
Using the developed anatomical protocol one can now reconstruct the DRTT and the 
SPCT from data that is routinely obtained in clinical research studies. Clinical and 
research applications include anatomical localisation for deep brain stimulation (Sweet 
et al. 2014; Coenen et al. 2015; Hana et al. 2016; Fenoy et al. 2017) and identification 
of changes in these tracts in neurodegenerative and movement disorders (Jeong et al. 
2012; Jang and Kwon 2015; Surova et al. 2015).  
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 Investigating microstructural differences in the white 
matter of the main cerebellar and basal ganglia-cerebellar pathways 
in Parkinson’s disease 
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5.1 Abstract 
Objective 
To compare microstructural differences in a cohort of Parkinson’s disease (PD) patients 
and their matched healthy controls (MHC), in the three main cerebellar pathways (the 
middle, inferior and superior cerebellar peduncles) and in the two basal ganglia-
cerebellar connections (dentato-rubro-thalamic tract and subthalamo-ponto-cerebellar 
tract).  
Methods 
Diffusion weighted imaging data of 24 PD patients and 25 MHCs were analysed and 
deterministic tractography was performed using the spherical deconvolution-based 
damped Richardson-Lucy algorithm. Diffusion metrics reflecting the underlying white 
matter microstructure (fractional anisotropy (FA), mean, axial and radial diffusivity; 
(MD, AD, RD) and hindrance modulated orientational anisotropy (HMOA)) were 
extracted from the tracts of the interest and statistical analysis were performed. 
Results 
PD patients had higher FA in the right superior cerebellar peduncle, the right inferior 
cerebellar and significantly increased HMOA in the right superior cerebellar peduncle 
compared to MHCs.  
Conclusion 
This is the first study to explore the microstructural differences in the main cerebellar 
pathways and the two basal-ganglia cerebellar connections in PD. I found higher FA, 
and HMOA of the selected cerebellar tracts in patients compared to controls. Current 
results suggest that the microstructural characteristics of cerebellar input and output 
connections are altered in PD, however future studies are required to delineate the 
specific compensatory, pathological and/or disease progression contributions of these 
pathways to PD.  
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Key points  
1. In the PD cohort, there was significantly increased FA in the right superior cerebellar 
peduncle and the right inferior cerebellar peduncle.   
2. In the PD cohort, there was significantly increased hindrance modulated orientational 
anisotropy in the right superior cerebellar peduncle.  
3. These results suggest that microstructural characteristics of cerebellar input and 
output pathways are altered in PD. Future studies are required to delineate the specific 
compensatory, pathological and/or disease progression contributions of these pathways 
in PD. 
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5.2 Background and Rationale 
Research in PD has mostly targeted the basal ganglia ever since the finding of reduced 
dopamine levels in the striatum in the 1960s (Hornykiewicz 2006). Accumulating 
evidence from anatomical studies in animals and functional studies in humans show the 
influence of the cerebellum in parkinsonian motor symptoms such as akinesia/rigidity, 
tremor, dyskinesia, gait disturbances and some non-motor symptoms such as cognition 
and olfaction (Wu and Hallett 2013). Although the cerebellum is known to be involved 
in voluntary movement, gait, posture and motor functions, (Ghez and W Thomas 2000) 
research into the role of the cerebellum in PD has been very limited.  
For instance, a post-mortem study revealed reduced dopamine receptors in the 
cerebellum of PD patients compared to healthy participants highlighting its role in the 
symptoms of the disease (Hurley et al. 2003). In the rat brain, the cerebellum receives 
dopaminergic projections from the substantia nigra pars compacta and the ventral 
tegmental area which lies close to the substantia nigra and the red nucleus (Ikai et al. 
1992; Panagopoulos et al. 1991). One study showed that degeneration of nigrostriatal 
dopaminergic neurons caused decrease in neural activity in thalamo-cortical neurons 
receiving input from substantia nigra and cerebellum in primate models of PD; thereby 
suggesting both basal ganglia-thalamic and cerebellar-thalamic pathways are involved 
in PD symptoms (Rolland et al. 2007).  
The middle cerebellar peduncle (MCP) connects the two cerebellar hemispheres to the 
pons, the superior cerebellar peduncle (SCP) is the main output pathway from the 
cerebellum connecting it to the midbrain, and the inferior cerebellar peduncle (ICP) 
carries inputs from the spinal cord and the medulla oblongata into the cerebellum 
(Nieuwenhuys et al. 2008). Previous studies have found that the MCP and the SCP in 
addition to the basal ganglia contributed to differentiating PD from multiple system 
atrophy (MSA-P) and progressive supranuclear palsy (PSP) (Nair et al. 2013; Nicoletti 
et al. 2008; Nicoletti et al. 2006; Quattrone et al. 2008; Nicoletti et al. 2013).  
Moreover, recent animal tracing studies have found reciprocal interconnections 
between the cerebellum and the basal ganglia (Bostan and Strick 2010; Hoshi et al. 
2005), while previously the basal ganglia and the cerebellum were assumed to interact 
only at the level of the cerebral cortex (Percheron et al. 1996). In Chapter 4, I 
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successfully developed an anatomical protocol and reconstructed these basal ganglia-
cerebellar interconnections namely, the DRTT and SPCT. 
Despite the increasing evidence that the interplay between the basal ganglia and 
cerebellum plays an important role in mediating cognitive and motor functions in PD, 
no published studies to date have explored the role of the main cerebellar white matter 
tracts (MCP, SCP and ICP) and basal ganglia-cerebellar white matter connections 
(DRTT and SPCT) in PD. Hence, deterministic tractography using the spherical 
deconvolution based damped Richardson-Lucy (dRL) algorithm (Dell’acqua et al. 
2010), detailed in Chapter 2, was employed to reconstruct the main cerebellar pathways 
and basal ganglia-cerebellar white matter pathways and to characterize the average 
microstructural properties of these tracts.  
In addition to the standard diffusion metrics, hindrance modulated orientational 
anisotropy (HMOA), a novel tract-specific index of white matter microstructural 
organisation was implemented in the current study. The HMOA is defined as the 
absolute amplitude of the fibre orientation distribution and it provides a fibre population 
specific index of the diffusion properties along the reconstructed fibres (Dell’Acqua et 
al. 2013). So far only eight papers were present on PubMed central search using the 
criteria “Hindrance modulated orientational anisotropy” and/or “HMOA” on 24th 
September 2017, and this metric has not been used in PD. One paper reported that lower 
HMOA values of the fornix predicted brain structure and function suggesting that 
recognition memory performance may be influenced by underlying neuroanatomical 
alterations in very preterm born individuals (Tseng et al. 2017). Another study found 
that individual HMOA variation in post-commissural, but not pre-commissural, fibres 
of the fornix correlated positively with visual recall performance (Christiansen et al. 
2016). A study showed increased HMOA values in the superior longitudinal fasiculus 
(SLF) with abnormal lateralisation of occipito-frontal and parito-frontal pathways in 
developmental dyslexia (Zhao et al. 2016). Another recent paper that looked at human 
visuospatial attention found increased HMOA in the SLF (Cazzoli and Chechlacz 2017) 
and advised caution in interpreting increased HMOA as a surrogate for higher 
connectivity. A study that investigated perinatal brain injury (PBI) found significantly 
reduced HMOA in the dorsal cingulum of the PBI group compared with controls, but 
reported increased HMOA in the SLF  and suggested that this increase could be due to 
the possibility of lateral neuroanatomical compensation for medial structural deficits in 
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the PBI group (Froudist-Walsh et al. 2015). In a study that looked at visuospatial 
attention, individual differences in visual short-term memory (VSTM) were linked to 
variability in the HMOA of the inferior fronto-occipital fasciculus (IFOF) the SLF II 
and the SLF III (Chechlacz et al. 2015). From these studies, HMOA metric has been 
shown to be sensitive to individual variation in white matter microstructural 
organization (Chechlacz et al. 2015). It has been proposed to be more sensitive to 
changes in diffusion than conventional diffusion metrics (Dell’Acqua et al. 2013; 
Christiansen et al. 2016).  
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5.3 Aims 
The aim of this study was to explore the microstructural metrics in a cohort of PD 
patients and matched healthy controls, in the three main cerebellar pathways (the MCP, 
SCP and ICP) and in the two basal-ganglia cerebellar tracts (DRTT and SPCT). In 
addition, I investigated how the potential microstructural differences may be correlated 
with clinical and behavioural measures in the PD patient group.   
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5.4 Materials and Methods 
5.4.1 Data cohorts, MR acquisition and processing 
Full details of the MR data acquisition, diffusion MR pre-processing and the 
deterministic tractography algorithms used can be found in Chapter 2. The final 
participant sample in this chapter was comprised of contained 24 PD patients and 25 
MHCs as one participant from the MHC group did not have diffusion data that covered 
the cerebellum (Table 5.1).  
Table 5.1 Demographics of the participants for the cerebellar analyses 
Abbreviations: MOCA –The Montreal Cognitive Assessment; H & Y - Hoehn & Yahr Stage; LEDD – 
Levodopa Equivalent Daily Dose; PD - Parkinson’s disease patients; MHC – Matched Healthy Controls; 
M - Male; F - Female; R – Right; L - Left  
5.4.2 Reconstruction of the major cerebellar pathways 
5.4.2.1 Middle cerebellar peduncle (MCP) 
For the reconstruction of the MCP, AND regions were drawn around the pons on a 
coronal slice on both hemispheres as shown in (Figure 5.1, A). Appropriate NOT 
regions were drawn to eliminate any erroneous fibres. The MCP of a representative 
participant on axial and sagittal slices of a T1 anatomical image is shown in (Figure 
5.1, B and C), respectively. The anatomical accuracy of the MCP was checked by 
making sure that the tract connected the two cerebellar hemispheres and did not have 
tract projections towards the cortex or the lower part of the brainstem.   
 
 
PD (n=24) MHC (n=25) Analyses 
Age 63.42 ± 10.82 64.84 ± 8.22 P = 0.6065, Two sample t-test 
Sex (M:F) 22:2 16:9 P = 0.0203, Chi squared test 
H & Y Stage 1.75 ± 0.47 NA - 
MOCA 26.54 ± 2.01 NA - 
LEDD (mg) 537.64 ± 
340.69 
NA - 
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Figure 5.1 Reconstruction of the Middle Cerebellar Peduncle (MCP).  
The figure shows the AND region around the pons in green in a colour-coded fibre orientation image (A) 
of a representative participant for reconstruction of the MCP. The MCP on a T1 image of a representative 
participant is shown in axial (B) and sagittal (C) views, respectively.  
5.4.2.2 Superior cerebellar peduncle (SCP) 
The SCP was identified in the coronal plane of a colour-coded fibre orientation image, 
the AND region was drawn around the SCP (visible as a small light blue structure) as 
shown in (Figure 5.2, A). Additionally, two large NOT regions were drawn above 
(Figure 5.2, Red ROI 1) and in front of the fornix (Figure 5.2, Red ROI 2), to remove 
tracts going to the frontal and cortical regions. Two more NOT regions were drawn, 
one NOT region at longitudinal fissure to cut fibres that cross into the other hemisphere 
(Figure 5.2, Red ROI 3) and another to cut fibres that go into the brain stem (Figure 
5.2, Red ROI 4). This procedure was repeated for both hemispheres separately. The 
SCP of a representative participant in sagittal and coronal views is shown in (Figure 
5.2, A and B), respectively.  
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The anatomical accuracy for the reconstruction of the SCP was checked by making sure 
the ROIs were placed as described above in each hemisphere and that the resulting tract 
did not have any unwanted fibres going towards the cortex or the brain stem. 
 
Figure 5.2 Reconstruction of the Superior Cerebellar Peduncle (SCP).  
The figure shows the AND region in green (A) and the NOT regions along with the reconstructed SCP 
in the colour-coded fibre orientation image (B) and the reconstructed SCP on a T1 image (C) of a 
representative participant. Red NOT regions, ROI 1 and ROI 2 were drawn above and in front of the 
fornix, ROI 3 at the longitudinal fissure and ROI 4 to cut fibres towards the brainstem.  
5.4.2.3 Inferior cerebellar peduncle (ICP) 
For the reconstruction of the ICP, the large NOT region (Red ROI 1, ROI 2 and ROI 3) 
from the SCP reconstruction were retained. In a colour-coded fibre orientation image, 
an AND region was drawn in the axial slice around the ICP (visible as the small light 
blue structure) located by moving up slices from the bottom of the brain where the 
medial lemniscus and cerebellar peduncle is visible (Figure 5.3, A). Another AND gate 
was drawn around the region (visible as the light green structure) located at 
approximately five slices above the first AND gate (Figure 5.3, B). The ICP ROI 
placement used here was previously described in (Catani et al. 2008). The ICP of a 
representative participant in sagittal views of a colour-coded fibre orientation image 
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and a T1 image are shown in (Figure 5.3, C and D), respectively. Anatomical accuracy 
for reconstruction of the ICP was checked by making sure the ROI were placed 
correctly in each hemisphere as described above and that the tract did not have any 
unwanted fibres towards the other hemisphere or the cortical regions.  
 
Figure 5.3 Reconstruction of the Inferior Cerebellar Peduncle (ICP). 
The figure shows the first AND region (A), second AND region (B), the three retained NOT regions 
along with a reconstructed ICP tract in a colour-coded fibre orientation image (C) and the reconstructed 
ICP in a T1 anatomical image (D) of a representative participant. Red NOT regions, ROI 1 and ROI 2 
were drawn above and in front of the fornix and final ROI 3 at the longitudinal fissure.  
Each reconstructed tract was visually inspected and any obvious outlier streamlines that 
were not consistent with their known anatomy were excluded by drawing “NOT” 
regions and the entire reconstruction procedure was performed separately in the left and 
right hemispheres for the left and right SCP and ICP, respectively. 
5.4.2.4 DRTT and SPCT  
The full protocol for reconstruction of the DRTT and the SPCT is described in Chapter 
4. The reconstructed DRTT and SPCT also included their cortical projections and here 
they were then segmented using the Splitter tracts tool within ExploreDTI4.8.3. The 
splitter tracts tool is used to segment portions of a reconstructed tract by drawing SEED 
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and AND ROIs to specify the location of segmentation. This was used here to include 
only the portion of the DRTT between the dentate nucleus and the thalamus, and portion 
of the SPCT from the subthalamic nucleus to the cerebellum for extracting the diffusion 
metrics from these tracts. The number of DRTTs and SPCTs successfully reconstructed 
in the PD and MHC groups are shown in Chapter 4 (Table 4.1). A representative 
segmented DRTT and SPCT with the ROIs are shown in Figure 5.4. 
 
Figure 5.4 Reconstructed full and segmented DRTT and SPCT.  
The reconstructed DRTT with its cortical projections is shown in A and the segmented DRTT is shown 
in B along with the ROIs at the level of the thalamus and the dentate nucleus. The fully reconstructed 
SPCT with its cortical connections is shown in C and the segmented SPCT is shown in D along with the 
ROI at the level of the sub-thalamic nucleus.  
5.4.3 Statistical Analysis 
All statistical analyses were carried out in the R statistical software v3.0.0 (R Core 
Team 2014). Before data analysis, all variables were checked for Gaussian distribution 
using the Shapiro-Wilk test (p < 0.05) and visually assessed using the histogram 
function and appropriate transformations were performed as required. The data was 
checked for outliers and homogeneity of variance using the Levene’s test within R 
statistical software’s car package (R Core Team 2014).  
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To assess the microstructural differences, multivariate covariate analyses of variance 
(MANCOVAs) were performed for the major cerebellar tracts (MCP, left SCP, right 
SCP, right ICP, left ICP) with FA, MD, AD, RD and HMOA as dependent variables 
and group (PD and MHC) as independent variable, along with age and gender as 
covariates. All significant results (p<0.05) were further analysed using post-hoc 
univariate ANOVAs corrected for multiple comparisons using FDR correction.  
Separate MANCOVAs were also performed for the basal ganglia – cerebellar tracts 
(left DRTT, right DRTT, left SPCT, right SPCT) and all significant results (p<0.05) 
were further analysed using post-hoc univariate ANOVAs corrected for multiple 
comparisons using FDR correction. 
Post-hoc correlations were also performed in the PD group between the metrics and the 
tracts that showed significant group differences and the following clinical and 
behavioural measures: off medication baseline Unified Parkinson’s Disease Rating 
Scale (UPDRS) scores, duration since diagnosis (in months), scores from a standard 
finger tapping task and a four button finger sequence task measuring the correct number 
of responses and reaction time.  
Additionally, I performed analysis to investigate the macrostructural differences (the 
average tract volumes) in the main cerebellar tracts between PD patients and the MHCs 
(See Chapter 5 supplementary material for full details) 
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5.5 Results  
5.5.1 Microstructural differences  
Results from the MANCOVAs (Table 5.2) showed significant group effects for the 
right SCP (F(5,41) = 3.24, Pillai’s trace = 0.28, p = 0.0147), the right ICP (F(5,41) = 
4.22, Pillai’s trace = 0.34, p = 0.0034) and the left ICP (F(5,41) = 2.72, Pillai’s trace = 
0.25, p = 0.032).  
Table 5.2 Results from the MANCOVAs for the main cerebellar tracts 
Tract   
MHC (n=25) vs PD (n=24) 
F statistic 
Pillai's 
trace 
p-value 
Middle Cerebellar 
Peduncle 
        
  Group F(5,41)=1.32 0.14 0.27523 
  Age F(5,41)=2.26 0.22 0.06598 
  Gender F(5,41)=0.83 0.09 0.53914 
Left Superior Cerebellar 
Peduncle 
        
  Group F(5,41)=1.47 0.15 0.2223 
  Age F(5,41)=1.58 0.16 0.1876 
  Gender F(5,41)=1.03 0.11 0.4126 
Right Superior Cerebellar 
Peduncle 
        
  Group F(5,41)=3.24 0.28 0.014787 
  Age F(5,41)=5.56 0.40 0.000535 
  Gender F(5,41)=1.29 0.14 0.288652 
Left Inferior Cerebellar 
Peduncle 
        
  Group F(5,41)=2.72 0.25 0.03274 
  Age F(5,41)=1.30 0.14 0.28192 
  Gender F(5,41)=1.19 0.13 0.33141 
Right Inferior Cerebellar 
Peduncle 
        
  Group F(5,41)=4.22 0.34 0.003465 
  Age F(5,41)=2.06 0.20 0.090584 
  Gender F(5,41)=0.65 0.07 0.661444 
MHC – Matched healthy controls, PD - Parkinson’s disease patients 
Results from the post-hoc ANCOVAs (Table 5.3) of these three tracts showed 
significantly increased FA in the PD patients compared to MHCs in the right SCP (0.44 
± 0.020 [MHC, mean±SD], 0.46 ± 0.029 [PD, mean±sd], F(3,45) = 10.89, FDR 
corrected p-value = 0.014), right ICP (0.43 ± 0.030 [MHC, mean±sd], 0.45 ± 0.027 
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[PD, mean±sd], F(1,47) = 8.23, FDR corrected p-value = 0.031) and significantly 
increased HMOA in the PD patients compared to MHCs in the right SCP (0.17 ± 0.013 
[MHC, mean±sd], 0.19 ± 0.019 [PD, mean±sd], F(3,45) = 11.03, FDR corrected p-
value = 0.014). 
Table 5.3 Post-hoc ANCOVAs for the main cerebellar tracts 
Tract 
 
MHC (n=25) vs Session 1 PD 
(n=24) 
F statistic Uncorrected p-
value 
Left Superior Cerebellar 
Peduncle 
   
FA Group 2.236 0.14181 
 
Age 3.8201 0.05687 
 
Gender 3.1594 0.08225 
MD Group 1.5827 0.21486 
 
Age 3.2599 0.07768 
 
Gender 0.1308 0.71935 
RD Group 3.8497 0.05596 
 
Age 0.588 0.44721 
 
Gender 1.0659 0.30739 
AD Group 0.0456 0.83185 
 
Age 5.754 0.02066 
 
Gender 0.1733 0.67915 
 HMOA Group 6.4048 0.01495 
  Age 0.1551 0.69557 
  Gender 1.6853 0.20084 
Right Superior Cerebellar 
Peduncle 
   
FA Group 10.899 0.001889 
 
Age 11.1258 0.001713 
 
Gender 4.2952 0.043979 
MD Group 0.0725 0.789 
 
Age 2.3568 0.1317 
 
Gender 0.6415 0.4274 
RD Group 2.4664 0.1233 
 
Age 0.0044 0.9475 
 
Gender 1.8768 0.1775 
AD Group 2.4923 0.121409 
 
Age 10.5162 0.002232 
 
Gender 0.0216 0.883797 
 HMOA Group 11.031 0.001785 
  Age 0.6467 0.425515 
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  Gender 3.3324 0.07457 
Right Inferior Cerebellar 
Peduncle 
   
FA Group 8.2384 0.006229 
 
Age 1.0264 0.316422 
 
Gender 0.3943 0.533245 
MD Group 1.3385 0.2534 
 
Age 0.3654 0.5486 
 
Gender 1.3473 0.2519 
RD Group 6.2952 0.01578 
 
Age 0.2136 0.64616 
 
Gender 2.0705 0.15709 
AD Group 0.0806 0.7778 
 
Age 0.4236 0.5185 
 
Gender 0.5333 0.469 
 HMOA Group 5.6614 0.02164 
  Age 0.0786 0.78055 
  Gender 0.4186 0.52094 
MHC – Matched healthy controls, PD - Parkinson’s disease patients, FA – Fractional anisotropy, MD    
– Mean diffusivity, RD – Radial diffusivity, AD – Axial diffusivity, HMOA – Hindrance Modulated    
orientational anisotropy  
The correlation analyses and the separate MANCOVAs for the DRTT and SPCT tracts 
did not show any significant results (see supplementary table 5.3 and supplementary 
table 5.4).  
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5.6 Discussion  
Patients with early stage PD relative to matched healthy controls showed increased FA 
in the right superior and right inferior cerebellar peduncles and increased HMOA in the 
right superior cerebellar peduncles. However, there were no significant differences in 
the basal ganglia-cerebellar connections of the dentato-rubro-thalamic tracts and the 
subthalamo-ponto-cerebellar tracts between the PD patients and their matched controls. 
Additionally, there were no significant correlations between any of the diffusion 
metrics in the cerebellar tracts and the clinical and behavioural measures in the PD 
group.  
5.6.1 Increased FA in the Right SCP and Right ICP 
The current increased FA findings are consistent with our previous finding of increased 
FA in the motor tracts i.e., the bilateral corticospinal tract (right; corrected p = 0.0003, 
left; corrected p = 0.03), bilateral thalamus-motor cortex tract (right; corrected p = 0.02, 
left; corrected p = 0.004) and the right supplementary area-putamen tract (corrected 
p = 0.001) compared to non-motor tracts in PD patients as demonstrated in Chapter 3. 
This could be due to potential compensatory and/or selective neurodegenerative 
mechanisms in the motor pathways that occur at pre-symptomatic stages of the disease 
(Mole et al. 2016). The current findings of increased FA in the right SCP and the right 
ICP oppose the several findings from previous studies. One study reported decreased 
FA in the entire white matter of the cerebellar hemispheres in PD patients suggesting 
damaged white matter microstructure (Mormina et al. 2015). Another study found 
decreased FA and increased MD in PD cerebellum and a positive correlation with the 
decrease in FA and thresholds of olfactory identification (K. Zhang et al. 2011); 
however, there were no measures of olfaction available within the current PD cohort to 
explore similar correlations. Previous studies have also reported no significant FA 
alterations in the SCP and the MCP (Nicoletti et al. 2006; Nicoletti et al. 2008; Wang 
et al. 2011; Rizzo et al. 2008; Blain et al. 2006; Nicoletti et al. 2013).  
Interpreting the results in the literature in context of our current results is challenging 
due to the various differences in methodology, processing and analysis of the diffusion 
data. In addition all the aforementioned studies used whole brain voxel based or region 
of interest based analysis rather than a priori selection of individual tracts. Taking all 
this into context with the current results, the specific increase in FA in just the input 
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and output from the cerebellum (ICP and SCP) might be either be related to 
compensatory mechanisms that help mask the disease during the pre-symptomatic 
stages but eventually fail as the pathological damage becomes severe (Jankovic 2005) 
or selective neurodegenerative processes that affect the different regions of the brain at 
different stages. Functional studies have showed task specific hyperactivation in the 
cerebellum during performance of finger sequence tasks and motor learning (Sen et al. 
2010; Yu et al. 2007b). Previous functional MRI studies have demonstrated increased 
activation of the cerebellum in PD and interpreted this as early compensatory 
mechanism that seems to decrease as the disease progresses possibly due to cerebellar 
degeneration process (Yu et al. 2007a; Wu and Hallett 2013; Jankovic and Kapadia 
2001). It was suggested that the cerebellar involvement might vary according to the 
various clinical stages of the disease. Therefore, in the preclinical stage, the cerebellum 
might be fully compensating for the loss in basal ganglia function, and later cerebellar 
compensation may reduce as the severity of the PD symptoms accumulates (Wu and 
Hallett 2013). One functional MRI study showed hyperactivation of the ipsilateral 
cerebellum in PD as a compensatory mechanism for defective basal ganglia motor 
controls signals (Yu et al. 2007a). There was also increased recruitment of the 
cerebello-thalamo-cortical circuit as the disease progresses suggesting its involvement 
in compensatory effects (Sen et al. 2010). The right lateralised effect in the current 
results may be due to the ipsilateral control of body movements in the cerebellum and 
its compensatory effects in PD as our PD cohort was predominately right-handed (Table 
3.1). However, there were no FA differences between the affected vs unaffected 
hemisphere in the motor tracts and cerebellar tracts (See Table 3.6, Supplementary 
Table 3.2 and Supplementary Table 5.2).  
5.6.2 Increased HMOA in the right SCP 
There was significantly increased HMOA in the right SCP, left and right ICP, the MCP, 
the DRTTs, and the SPCTs. whereas in the current study there were no correlations 
between HMOA and PD patients’ clinical and behavioural data. This in context with 
the current results could also suggest similar lateralised neuroanatomical compensation 
as there was statistically significant increase in the PD group’s HMOA metric only in 
the right SCP but not in the other main cerebellar tracts or the basal ganglia-cerebellar 
pathways.  
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It has been shown that HMOA decreases with increasing radial diffusivity and axonal 
radius; thus, it is likely that increased myelination decreases HMOA (Tournier et al. 
2004; Dell’Acqua et al. 2013). This could suggest that the current increased HMOA 
could be due to decreases in myelination in the right SCP which is the main output 
pathway from the cerebellum to the mid brain and also through which the DRTT leaves 
the cerebellum. While the HMOA index characterises microstructural properties of the 
specific white matter tract, it still depends on several white matter properties (as with 
FA). Therefore, despite the sensitivity of HMOA, it is influenced by myelination, axon 
density, axon diameter, and fibre dispersion, and is problematic to interpret it in way 
that a higher HMOA index explicitly means stronger connectivity (Dell’Acqua et al. 
2013; Jones et al. 2013; Beaulieu 2002). Nevertheless, as HMOA is specific to the 
direction followed by tractography, this index measures how much water is diffusing 
in the tractography reconstruction direction independently of other directions and is 
therefore a true tract specific index, being less influenced by crossing fibres and partial 
volume effects (Dell’Acqua et al. 2013). Based on the results from the current data, I 
speculate that a higher HMOA index combined together with the higher FA in the same 
tract represents white matter microstructural alterations associated with compensatory 
mechanisms, rather than pathological or neurodegenerative processes in the PD cohort. 
Nevertheless no substantial conclusions can be drawn due to lack of HMOA 
correlations with clinical and behavioural measures in this cohort.   
A direct comparison between the FA index from DTI tractography and the HMOA 
index from SD tractography models was performed to verify that SD provides unique 
and additive information especially in regions of crossing fibres (Vanderauwera et al. 
2015). The FA model was more confounded by crossing fibres than the SD model, 
however there did not seem to be a direct influence of crossing fibres on the metrics as 
both the FA and HMOA were highly correlated. Nevertheless, the HMOA index seems 
to provide an advantage for the quantitative study of white matter changes over FA, as 
confirmed by simulation and inter-individual variability studies (Dell’Acqua et al. 
2013; Christiansen et al. 2016; Chechlacz et al. 2015).  
5.6.3 DRTT and SPCT 
The microstructural  measures from the DRTT and SPCT did not show any significant 
differences (Supplementary table 5.4) even though various studies have shown the 
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influence of cerebello-cortical circuits to have impact on PD (Sweet et al. 2014; 
Martinu and Monchi 2013). Both the basal ganglia and the cerebellum are known to 
influence activity in the cerebral cortices via the thalamus with their recurrent circuitry, 
known to affect motor, cognitive and affective behaviour (Alexander et al. 1986; 
Middleton and Strick 2000; Lewis et al. 2013). Outputs from basal ganglia and the 
cerebellum project to the ventro anterior and ventro lateral thalamic nuclei respectively 
with differential involvement in external and internal guided tasks (Middleton and 
Strick 2000; MacMillan et al. 2004; Vaillancourt et al. 2003).  
Since the motor symptoms in PD only occur after 50% of dopaminergic nigral cells and 
60-80% of striatal dopamine levels are depleted (Fearnley and Lees 1991; Lee et al. 
2000) and the lack of observed motor symptoms despite this cell loss indicates 
redundant and compensatory mechanisms that may be preserving optimal level of 
motor function (Zigmond et al. 1990; Bezard et al. 2001). One possible compensatory 
mechanism for the generation of movement in PD has been suggested as the recruitment 
of cortico-cerebellar networks (Martinu and Monchi 2013; Rascol et al. 1997; Palmer 
et al. 2009). 
In a study that explored the neurofunctional basis of externally and internally guided 
movements in PD patients, there was increased signal in the cerebellum, putamen, 
supplementary motor area and the thalamus during the externally guided task (Cerasa 
et al. 2006). Another study showed that increased cerebello-thalamo-cortical activity 
could reflect compensation for breakdown of the striato-thalamo-cortical pathway to 
successfully perform internally guided task (Sen et al. 2010). They could not 
definitively delineate between compensatory and/or pathological processes so they 
suggested that this could be due to disease progression in PD as the patients transitioned 
from unilateral to bilateral symptoms therefore (Sen et al. 2010). From these previous 
studies it is clear that the cerebellum plays a role in compensation and symptomology 
in PD.  
The DRTT has been shown to play an important role in the PD symptoms as placing a 
Deep Brain Stimulation (DBS) contact at close proximity to the DRTT has been shown 
to be efficient in relieving symptoms especially the tremor (Sweet et al. 2014). This 
suggests that the tract may be a more suitable target to be stimulated by DBS and may 
hence lead to better therapeutic outcomes in PD. Differences in cerebellar activity may 
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be considered a pathological mechanism related to basal ganglia dysfunction, or a 
compensatory mechanism. The nature of the cerebellar involvement is complex and is 
likely influenced by dopamine, patient subtypes, and the particular symptom or 
function assessed. Lastly, given that PD is largely heterogeneous in nature, a combined 
approach would help clarify whether particular symptoms of PD are mediated by 
particular white matter pathways. Ultimately, this could lead to stronger conclusions 
regarding whether the cerebellum plays a pathological role driven by striatal 
dysfunction or a compensatory role to overcome striatal dysfunction.  
5.6.4 Limitations and future directions  
There were no significant correlations between the diffusion metrics and the clinical 
and behavioural data from the clinical PD data. This is very likely due to the limited 
sample size which could also be why we do not see any significant correlations in our 
sample of 24 PD patients and 25 healthy controls as well. This is based on previous 
studies that report smaller sample sizes as limitations for correlational analyses in PD 
(Mischley et al. 2017; Heinzel et al. 2016).  Any results observed from such correlations 
should be interpreted with caution and further validation assessments would still be 
needed (Mokkink et al. 2010).  
The current results also show asymmetry and right lateralised significant effects in 
HMOA and FA which are in line with previous studies showing that the asymmetry of 
white matter pathways varies across different diffusion MRI derived measures (De 
Santis et al. 2014). One study found that the HMOA and the tract volume differentially 
contributed to the anatomical lateralization of frontoparietal attention networks and 
individual differences in attention, but did not find any correlations (Chechlacz et al. 
2015). They attributed this to large number of right-handed participants which may also 
be the case for our current PD cohort (Table 3.1).  
It should be noted that the HMOA is estimated based on several white matter 
characteristics, including myelination, axon density, axon diameter, and fibre 
dispersion with each factor contributing differentially to HMOA (Dell’Acqua et al. 
2013). Therefore, interpreting that higher HMOA is equivalent to higher connectivity 
should be avoided (Beaulieu 2002; Jones et al. 2013; Dell’Acqua et al. 2013).  
The current knowledge of the role of cerebellum in PD is limited. Future studies that 
can ascertain the specific degenerative and/or compensatory effects in cerebellum are 
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required to better understand its contribution to the disease and also to inform better 
treatments and interventions. Furthermore, investigation of the white matter 
connections between the basal ganglia and the cerebellum in a larger sample of PD data 
is warranted.  
5.7 Conclusion 
In summary, this is the first study to explore the microstructural differences in the main 
cerebellar pathways and the two basal-ganglia cerebellar connections between PD 
patients and matched healthy controls. I found increased FA in the superior and inferior 
cerebellar peduncles and increased HMOA in the superior cerebellar peduncle. This 
shows that the cerebellar input and output connections are altered in PD, however future 
studies that explicitly probe the functions of the cerebellum would help to shed light 
onto the specific contributions of the white matter connections in PD.  
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 General discussion 
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6.1 Summary of findings  
The work described in this thesis utilised diffusion tractography methods to explore 
selected white matter connections of the basal ganglia circuitry to increase our 
understanding of the underlying pathophysiology in PD.  
As PD is clinically classified as a motor disorder affecting the basal ganglia circuitry, 
it was of particular interest to explore the basal ganglia white matter motor connections 
in PD. Therefore in Chapter 3, I investigated for the first time the differences in 
diffusion metrics in selected motor tracts of the basal ganglia circuitry; Corticospinal 
tract (CST), and the white matter connections between the supplementary motor area-
putamen (SMA-PUT) and the thalamus-motor cortex (THAL-MC), and selected non-
motor tracts; uncinate fasiculus (UNF), supero-lateral medial forebrain bundle (slMFB) 
in PD. Increased FA was found in all the basal ganglia motor tracts while there was 
decreased FA in the UNF and no differences in the slMFB. Additionally, I also 
investigated differences in subcortical volumes between PD patients and MHCs and 
found no such volumes differences.  
Furthermore, it was found that the basal ganglia and the cerebellum have direct 
anatomical connections between them via the denato-rubto-thalamic tract (DRTT) and 
the subthalamo-ponto-cerebellar tract (SPCT) and these connections had not been 
anatomically well defined in humans. Therefore in Chapter 4, I developed an 
anatomically guided tractography protocol to reconstruct the DRTT and the SPCT and 
demonstrated feasibility of transferring this protocol to reconstruct these tracts in a 
cohort of PD patients. And for the first time, I also assess the spatial independence and 
map the cortical connections of these tracts in humans.  
Recent evidence show the involvement of the cerebellum in PD, and that the non-motor 
symptoms of the disease in most cases precede the motor symptoms. This in addition 
to the reconstructed basal ganglia-cerebellar connections from Chapter 4 provided the 
opportunity and rationale for investigation of these tracts and the main cerebellar 
pathways (the middle, inferior and superior cerebellar peduncles) in PD. Hence in 
Chapter 5, I investigated the differences in diffusion metrics in the main cerebellar 
pathways and the two basal ganglia-cerebellar connections and found increased FA in 
the superior and inferior cerebellar peduncles and increased HMOA in the superior 
cerebellar peduncle. 
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Overall, the results of increased FA in the motor and cerebellar tracts in PD suggest that 
the basal ganglia motor pathways and the cerebellar input and output connections are 
altered in PD. These alterations may suggest selective neurodegeneration due to 
consequences of the disease or compensation along these pathways due to extended and 
adaptive neuroplasticity. Using the developed anatomical protocol, one can now 
reconstruct and study the DRTT and the SPCT from data that is routinely obtained in 
clinical research studies.  
Together, the findings highlight the importance of white matter connections of the basal 
ganglia circuitry and their connections with the cerebellum in PD. The novel findings 
support the involvement of structures such as the putamen, thalamus, SMA, dentate 
nucleus, subthalamic nucleus and the motor cortex through their white matter 
interconnections. Although there were no significant results from the correlational 
analyses within this thesis, one can still see that the tracts of interest showed marked 
changes in the diffusion metrics indicating their involvement in compensatory and 
neurodegenerative process within the disease. This suggests that a better understanding 
of PD at the level of brain circuitry can be derived by not just studying the individual 
grey matter structures but also studying the interconnections among them in brain 
imaging studies but also in post-mortem brains, cellular models and mechanistic models 
of the disease.   
The individual white matter connections investigated here offer patient/participant 
specific, brain region specific as well as symptom specific results that show motor 
symptoms in PD may progress differently compared to non-motor symptoms and their 
involved structures may also undergo very specific changes, respectively. The study 
methodology to delineate the white matter connections of interest manually is also very 
important for instance in deep brain simulation surgery for PD. The method used within 
this thesis for detecting individual differences in brain specific areas is also important 
for instance in stroke patients. This also shows that group average and automated atlas 
based studies may limit detecting true differences due to averaging of voxels across 
participants. Replicating the findings from this thesis in these white matter connections 
in larger databases with more clinical and behavioural information can help unravel the 
exact aetiology of PD and thereby enable the research community to get a step closer 
to finding therapeutic interventions that delay disease progression.  
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Results from this thesis now provide the background and foundation for future studies 
in PD that explicitly probe the functions of these specific white matter connections, 
their correlation with clinical and behavioural measures as well as their functions in 
healthy and diseased states. Moreover, the developed anatomical protocol for 
delineation of the DRTT and SPCT not only suggests the importance of studying grey 
matter structures such as the cerebellum and the basal ganglia as a whole but also the 
importance of their sub-structures such as the dentate nucleus, the putamen and the 
thalamus as well as the exploration of their white matter interconnections in PD.  
6.2 Limitations and future research in PD 
Several methodological considerations were needed to be taken to avoid 
misinterpretation of results. Diffusion metrics though sensitive to underlying changes 
in white matter microstructure are not specific to change in any particular component 
of white matter microstructure or specific biological mechanism. Both the FA and the 
HMOA metrics are estimated based on several white matter characteristics, including 
myelination, axon density, axon diameter, and fibre dispersion with each factor 
contributing differentially to FA and HMOA (Dell’Acqua et al. 2013). Therefore, 
interpreting higher FA and higher HMOA as higher connectivity or stronger/healthier 
white matter connections should be avoided (Beaulieu 2002; Jones et al. 2013; 
Dell’Acqua et al. 2013). To better understand and delineate the specific contributions 
of axonal microstructural changes and myelination changes in the white matter 
architecture in PD, future studies could apply complex diffusion microstructural models 
such as Composite Hindered and Restricted Model of Diffusion (CHARMED) or 
AxCaliber (Assaf 2008; Assaf and Basser 2005). Myelin water fraction mapping and 
quantitative magnetization transfer techniques could also be used in future studies to 
better quantify myelination (Levesque et al. 2010).  
There were no significant correlations between the diffusion metrics and the clinical 
and behavioural data from the clinical PD data, making it very difficult to interpret the 
increased FA results in the PD cohort. This is very likely due to the limited sample size 
of 24 PD patients. Therefore, it would also be of particular interest to investigate the 
connections between the basal ganglia and the cerebellum in a larger sample of PD data, 
as current data may have been under sampled to detect any significant differences in 
these pathways.  
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Future studies that explicitly probe the functions of the cerebellum and the cerebellar 
pathways would help to shed light into the specific contribution of cerebellar white 
matter in PD. Tractography analysis should be incorporated in future longitudinal 
imaging studies in PD to evaluate the specific role of white matter changes in 
neurodegenerative and neuroplastic processes as the disease progresses. I propose to do 
by this investigating these connections from a larger dataset of PD and healthy controls 
from the Parkinson’s Progression Marker’s Initiative (PPMI) database (PPMI 2011). 
This study would be performed in an attempt to replicate the current findings in this 
thesis. This would not only give us more power to detect differences but also look at 
longitudinal data that may help provide further information.  
Although PD is clinically diagnosed based on the presence of motor signs, it is now 
recognised that this is preceded by significant neurodegeneration and compensatory 
neuroplasticity within and outside the basal ganglia (Bezard et al. 2003) which is also 
reflected in alterations in white matter connections in early PD as reported in this thesis 
(Mole et al. 2016). The prodromal phase of PD may be present for over a decade before 
clinical diagnosis. Although symptomatic treatment exists, clinical studies mainly 
depend on motor clinical markers and there is of lack disease modifying or curative 
therapies for PD. Therefore identifying markers during prodromal PD could identify 
patients earlier and enable the development of high impact interventions and 
prophylactic treatments that help prevent clinical PD. I propose to evaluate imaging 
biomarkers of disease progression in patients with REM-sleep behaviour disorder 
(RBD). RBD is the strongest clinical marker for prodromal PD (Postuma and Berg 
2016) and over 80% of patients with RBD develop neurodegenerative disease within 
10 years (PD, Dementia with Lewy bodies or Multiple System Atrophy) (Boeve et al. 
2013). This also constitutes a potential for longitudinal studies of disease progression 
as RBD to PD conversion is ~10% per year hence the number of PD identified from a 
cohort of 50 patients with RBDs followed up for five years would further the 
understanding of transition from prodromal to the clinical motor phase. 
Future studies should also attempt to delineate the compensatory changes and the 
disease pathology related changes in PD. For instance, one could use behavioural tests 
that require patients to perform tasks that are challenging for them or tasks that increase 
in difficulty. The assumption is that there would be no change or improvement in the 
performance of the task if it is disease pathology related but if the performance is 
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maintain and/or improved this could be due to compensatory mechanisms that are in 
place.   
Further advances in the development of higher order diffusion models as well as of 
techniques that can target specific microstructural properties could help to further 
increase the understanding of the contribution that white matter microstructure plays in 
PD. However, the advanced and higher order diffusion models will have to be 
researched in healthy developing and healthy aging brain to provide better 
interpretation of the extracted metrics in diseased states.    
6.3 Wider clinical relevance of investigated BG white matter connections 
The investigated tracts within this thesis have clinical importance and relevance in a wide 
range of disorders and in understanding healthy developing and aging human brain (Zhao 
et al. 2016; Callaghan et al. 2014; Metzler-Baddeley et al. 2011; Inuggi et al. 2011; 
Christiansen et al. 2016). Detailed knowledge of the anatomy of the basal ganglia 
circuitry in humans would not only be important in understanding the pathophysiology 
of neurological and neurodegenerative disorders such as Parkinson’s disease, 
Huntington’s disease, Progressive supranuclear palsy, Wilson’s disease, Fahr’s disease 
and Gilles de la Tourette's syndrome (Worbe et al. 2015; van Wassenaer-van Hall et al. 
1995; Phillips et al. 2014; DeLong 1990; Surova et al. 2015; Nicoletti et al. 2013) but 
also identification of changes in these tracts in neurodegenerative and movement 
disorders (Jeong et al. 2012; Jang and Kwon 2015; Surova et al. 2015).  
The basal ganglia circuitry is also involved in neuropsychiatric disorders such as 
Schizophrenia, Bipolar disorder, Obsessive-compulsive disorder, depression and 
addiction (Ring 2002; Middleton and Strick 2000; Dirnberger and Jahanshahi 2013; 
Obeso, Rodríguez-Oroz, et al. 2008). The basal ganglia circuitry is thus not only involved 
in motor functions and implicated in their impairment but also in different levels of non-
motor and cognitive impairment as well as varying degrees of non-motor signs and 
symptoms. Clinical and research applications include anatomical localisation for deep 
brain stimulation (Sweet et al. 2014; Coenen et al. 2015; Hana et al. 2016; Fenoy et al. 
2017; Anthofer et al. 2017; Hacker et al. 2015; Torres et al. 2014; Rodriguez et al. 1998; 
Calabrese et al. 2015) and tractography guided surgery (Torres et al. 2014; Parraga et al. 
2016; Papagno et al. 2011; Linhares and Tasker 2000; Coenen et al. 2011; Feigl et al. 
2014).  
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6.4 Conclusion 
In conclusion, this thesis demonstrates that white matter connections of the basal 
ganglia motor system and the cerebellar system are involved in Parkinson’s disease.  
The microstructural differences observed could be due to compensation and/or disease 
pathology related. This warrants the need for future cross-sectional and longitudinal 
imaging studies with tractography analysis that explicitly probe the functions of the 
basal ganglia and cerebellum in PD.  
Furthermore, future studies that study the specific motor and non-motor white matter 
connections in Parkinson’s as well as the connections between the basal ganglia and 
the cerebellum need to be investigated at a much higher resolution using novel diffusion 
and brain imaging techniques. This would shed light into the specific role of white 
matter changes in the neurodegenerative and neuroplastic processes.    
Studying the underlying structural connections of the basal ganglia with the cortex in 
humans within the context of the basal ganglia circuitry and the connections between 
the basal ganglia and the cerebellum and exploring their functions in relation to heath 
and disease would better our understanding of a wide range of disorders.  
This thesis not only demonstrates the importance and novelty of studying individual 
white matter connections in PD within the basal ganglia circuitry in order to understand 
the underlying pathophysiology but also the importance of these individual connections 
for surgical procedures such as DBS and therefore their contribution to effective and 
timely treatment strategies and novel therapies for rehabilitation.  
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 Supplementary material  
8.1 Chapter 3 Supplementary material 
Supplementary Table 3.1 Affected versus unaffected hemisphere analysis 
PD Tracts FA in affected hemisphere 
 (mean ± SD) 
FA in unaffected hemisphere 
 (mean ± SD) 
t-value df p-value 
CST 0.5687 ±  0.033 0.5705 ± 0.024 -0.2861 21 0.7776 
SMA-PUT 0.4612 ± 0.032 0.4701 ± 0.034 -1.3333 21 0.1967 
THAL-MC 0.5200 ± 0.033 0.5137 ± 0.041 0.9283 21 0.3638 
UNF 0.4037 ± 0.023  0.4045 ± 0.020 -0.1787 21 0.8599 
MFB 0.4480 ± 0.028 0.4488 ± 0.031 -0.1251 21 0.9016 
 
Supplementary Table 3.1 shows paired-t-tests between the FA values of the affected and 
unaffected hemispheres of the PD patients. The affected hemisphere calculation was done from 
the motor scale of the pre intervention off medication UPDRS scores. Of the 24 PD patients, 
10 were affected on the left hemisphere and 12 were affected on the right hemisphere while 
two were affected bilaterally. The results show no differences in FA. 
Supplementary Table 3.2 Additional tractography measures 
ADDITIONAL 
TRACTOGRAPHY 
MEASURES 
26 HC 
mean ± sd 
24 PD 
mean ± sd 
Uncorrected 
p value 
Bonferroni 
corrected  p 
value 
Number of 
reconstructed  
streamlines 
    
L-CST 226.08 ± 114.02 388.4583 ± 144.21 7.00E-05 0.00448128 
R-CST 150.8 ± 74.59 301.38 ± 154.31 0.0001313 0.0084032 
L-UNF 122.6538 ± 77.41 319.375 ± 120.81 4.32E-08 2.77E-06 
R-UNF 127.3077 ± 89.29 245.4167 ± 115.81 0.000233 0.014912 
L-THAL-MC 511.7692 ± 213.29 861.6667 ± 286.66 1.62E-05 0.00103936 
R-THAL-MC 482.5 ±  206.54 845.5 ± 342.39 6.60E-05 0.00422464 
L-SMA-PUT 309.1538 ± 304.34 387.125 ± 243.01 0.3202 1 
R-SMA-PUT 412.2692 ± 258.92 305.4583 ± 226.61 0.1265 1 
Number of voxels 
occupied 
    
L-CST 55144.92 ± 31355.74 101776  ±  39556.99 3.66E-05 0.0023392 
R-CST 36720.04 ± 19048.19 76711.96 ± 39201.36 7.48E-05 0.004784 
L-UNF 21796.31 ± 14363.91 51676.46 ± 22440.19 2.20E-06 0.00014099 
R-UNF 20803 ± 15147.96 36972.25 ± 19556.66715 0.002251 0.144064 
L-THAL-MC 70840.92 ± 31314.81 123591.33 ± 45097.07 2.41E-05 0.00154112 
R-THAL-MC 65971.58 ±  30102.2 118596.58 ±  51327.33 9.70E-05 0.00620608 
L-SMA-PUT 41776.5 ± 41788.07 51178.96 ± 33445.52 0.3825 1 
R-SMA-PUT 52861.46 ± 32879.99 40739.88 ± 2281.64 0.1856 1 
Tract volume 
    
L-CST 4062.192 ± 1331.57 5679.39 ± 1631.49 0.000409 0.026176 
R-CST 3225.038 ± 1069.84 4783.381 ± 1848.04 0.0009185 0.058784 
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L-UNF 2321.385 ± 1199.01 4917.796 ± 1725.59 2.92E-07 2.92E-07 
R-UNF 2626.654 ± 1399.54 4269.982 ± 1709.79 0.0005878 0.0376192 
L-THAL-MC 4523.423 ± 1634.04 6965.428 ± 1962.54 2.04E-05 0.00130624 
R-THAL-MC 4435.346 ±  1600.88 7031.932 ±  2365.56 5.59E-05 0.00357888 
L-SMA-PUT 3699.692 ± 2806.51 4029.246 ± 1979.24 0.6317 1 
R-SMA-PUT 4900.962 ± 2281.64 3600.541 ± 1877.41 0.03217 1 
Tract length 
    
L-CST 118.0652 ± 11.45 129.1263  ±  9.52 0.0005202 0.0332928 
R-CST 119.9535 ± 12.09 125.7192 ±  10.24 0.07447 1 
L-UNF 89.70457 ± 10.08 78.89722 ± 8.42 0.000148 0.009472 
R-UNF 80.14056 ± 14.32 72.86341 ± 8.34 0.03234 1 
L-THAL-MC 68.47292 ± 5.42 70.43006 ± 4.68 0.1771 1 
R-THAL-MC 67.47677 ±  5.63 68.82386 ± 6.28 0.43 1 
L-SMA-PUT 63.44871 ± 7.12 64.1478 ± 6.95 0.727 1 
R-SMA-PUT 63.05385 ± 5.71 65.63078 ± 7.25 0.1636 1 
 
Supplementary Table 3.2 shows the two-samples t-tests between PD and controls for each 
extracted additional tractography measure. PD-Parkinson’s disease patients, HC-Healthy 
Controls. CST - Corticospinal tract, SMA-PUT - Supplementary motor area-putamen tract, 
THAL-MC - Thalamus-motor cortex tract, UNF - Uncinate Fasiculus. L-Left, R-Right. 
Bonferroni corrected p < 0.05 (0.05/32=0.00156), SD - Standard deviation. 
Supplementary Table 3.3 Correlation analysis results  
Tract and 
metrics 
R-CST-FA L-CST-FA R-SMA-PUT-FA 
 
t p-value t p-value t p-value 
Finger sequence 
task - Reaction 
time 
0.6677 0.5116 0.8498 0.405 -1.0423 0.3091 
Finger sequence 
task - Correct 
number of taps 
-1.2174 0.2392 -1.4636 0.1605 -1.4333 0.1689 
Duration since 
diagnosis (in 
months) 
-0.9167 0.3697 -1.1495 0.2633 -1.0893 0.2884 
Pre intervention 
off medication 
UPDRS scores 
1.6902 0.1051 1.4594 0.1586 0.8887 0.3838 
Finger tapping 
on dominant 
hand 
0.8135 0.4247 0.6358 0.5315 0.6302 0.5351 
Finger tapping 
on non-
dominant hand 
-1.4504 0.1611 -0.457 0.6521 -1.0759 0.2936 
Finger tapping 
on both hands 
-0.325 0.7483 0.1245 0.9021 -0.2344 0.8169 
R-CST-FA – Right corticospinal tract fractional anisotropy, L-CST-FA – left corticospinal tract fractional 
anisotropy, R-SMA-PUT-FA, Right supplementary motor area-putamen fractional anisotropy 
 
Supplementary table 3.4 Correlation analyses results  
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Tract and metrics R-THAL-MC-FA            L-THAL-MC-FA           R-UNF-FA 
 t p-value t p-value t p-value 
Finger sequence 
task - Reaction 
time 
0.5087 0.6162 -0.0388 0.9694 2.2022 0.03896 
Finger sequence 
task - Correct 
number of taps 
-0.7364 0.471 -1.4031 0.1776 0.3975 0.6956 
Duration since 
diagnosis (in 
months) 
-1.4269 0.1683 -1.5508 0.1359 1.9158 0.0691 
Pre intervention 
off medication 
UPDRS scores 
1.8738 0.07431 1.5235 0.1419 0.7046 0.4884 
Finger tapping on 
dominant hand 
-0.1591 0.8751 0.8458 0.4067 1.1152 0.2768 
Finger tapping on 
non-dominant 
hand 
-0.9068 0.3743 -1.1512 0.262 0.9712 0.342 
Finger tapping on 
both hands 
-0.6383 0.5298 -0.1448 0.8862 1.2986 0.2075 
R-THAL-MC-FA – Right thalamus-motor cortex fractional anisotropy, L-THAL-MC-FA – Left thalamus-
motor cortex fractional anisotropy, R-UNF-FA – Right uncinated fasciculus fractional anisotropy.  
TBSS analysis 
The FSL tool “TBSS” (Tract-based spatial statistics) (Jenkinson et al. 2012; Smith et al. 2006) 
was used to compare diffusion measures between PD patients and controls. Subjects' individual 
FA images were first registered to a common template. As PD is a neurodegenerative disease, 
some degree of atrophy is often present, which can result in enlarged ventricles. With normal 
ageing, there can also be atrophy and enlargement of the ventricles. Registration to a study-
specific image was chosen with the aim of more accurate alignment of the centre of tracts 
across subjects. Subjects' FA images were therefore registered to the FA image of the most 
“representative” subject, which is automatically detected by TBSS according to which image 
requires the least transformation to the FA images of all other subjects. After subjects' 
individual FA images were registered to this initial template, they were registered to MNI152 
space for convenience of display and reporting. The mean FA skeleton, a representation of the 
centre of the white matter tracts common to all subjects, was created and with a threshold FA 
> 0.2. Subjects' MNI152-registered FA images were projected onto the skeleton before 
statistics were performed on each skeleton voxel using permutations testing with the FSL tool 
“Randomise”.  
A design matrix was generated using the FSL tool “Glm”, in which images were categorised 
according to subject group (PD patient or control). The repeated measures element of the design 
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was specified using the “group” option in the Glm tool. Age and gender were added as 
covariates and were demeaned within options of the Randomise tool. 
This design matrix was used to analyse subjects' FA images using the FSL tool randomise, with 
500 permutations. The randomise option threshold-free cluster enhancement (TFCE) was 
applied (Smith and Nichols 2009). All statistic images were corrected for multiple 
comparisons, FWE (family-wise error) with threshold of p<0.05. Any regions on the skeleton 
showing significant clusters were localised using the “John Hopkins University ICBM-DTI-81 
White Matter Labels” and “John Hopkins University White Matter Tractography” atlases in 
FSL. 
TBSS results 
 
Supplementary Figure 3.1 shows FA values in PD>Controls. There was higher FA in the right corticospinal tract 
compared to healthy controls (p<0.05, FWE) and there was also higher FA in the right thalamus, right putamen 
and right cortex regions however this did not reach significance (p<0.07, FWE).   
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Supplementary Figure 3.2 shows TBSS results for FA values in Controls > PD, p<0.05 Family wise error 
corrected.  In controls, there was higher FA in the left and right Uncinate fasiculus, , left and right superior 
longitudinal fasiculus, left and right inferior occipital fasiculus, Forceps minor and major, and anterior thalamic 
radiation. 
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8.2 Chapter 4 Supplementary material 
 
Supplementary Figure 4.1 The left and right DRTT on axial and coronal views in T1 anatomical scan 
of representative subject. A shows the tracts passing though the dentate nucleus on left and right side, B 
shows the decussation of the tracts to the contralateral hemispheres, C shows the tracts passing through 
the thalamus and in this example passing on to the supplementary motor area and the primary motor 
cortex. D shows the two tracts in the coronal view. 
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Supplementary Figure 4.2 The reconstructed SPCT in an axial view of a representative subject, A 
shows the left SPCT with the alternative ROIs 1 and 2, B shows the left SPCT, C shows the right SPCT, 
and D shows both the right and the left SPCTs.  
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Probability maps  
Supplementary Figure 4.3 The probability maps in axial slices, showing the probability (in percent) of 
projections of the DRTT, SPCT, CST, ICP, SCP and MCP tracts in the PD group. The range is from 1-50, hence 
areas of the brain showing yellow have at least 50% of participants’ tracts passing through those voxels. 
 
Supplementary Figure 4.4 The probability maps in axial slices, showing the probability (in percent) of 
projections of the DRTT, SPCT, CST, ICP, SCP and MCP tracts in the MHC group. The range is from 1-50, 
hence areas of the brain showing yellow have at least 50% of participants’ tracts passing through those voxels. 
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Spatial overlap  
 
Supplementary Figure 4.5 DRTT (red) and SCP (white) overlap 
 
 
Supplementary Figure 4.6 DRTT (red) and ICP (white)  
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Supplementary Figure 4.7 DRTT (red) and MCP (green)  
 
Supplementary Figure 4.8 DRTT (red) and SPCT (white) 
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Supplementary Figure 4.9 SPCT (red) and MCP (white) overlap 
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Supplementary Table 4.1 Inter-rater reliability of reconstructions for individual fiber tracts  
Tract Group Min. 
Dice 
score 
Max. 
Dice 
score 
Dice score 
mean ± SD 
 Percent of ILs 
tract voxels in 
JMs tract 
 Percent of JMs 
tract voxels in 
ILs tract 
L DRTT YHC 50 62 58 ± 7 92 ± 14 42 ± 4 
 MHC 52 100 72 ± 22  93 ± 14 62 ± 28 
 PD 1 72 48 ± 41 58 ± 47 45 ± 40 
R DRTT YHC 27 96 50 ± 40 100 41 ± 44 
 MHC 58 100 79 ± 30 100 70 ± 42 
 PD 64 86 75 ± 16 100 62 ± 21 
L SPCT YHC 90 90 90 100 82 
 MHC 77 79 78 ± 1 84 ± 17 77 ± 20 
 PD 30 91 58 ± 24 84 ± 30 56 ± 29  
R SPCT YHC 50 100 83 ± 22 96 ± 8 78 ± 32 
 MHC 68 72 70 ± 3 89 ± 2 58 ± 4 
 PD 30 100 65 ± 49 100 59 ± 58 
L CST YHC 18 66 44 ± 20 69 ± 21 36 ± 18 
 MHC 13 95 70 ± 34 74 ± 30 68 ± 35 
 PD 37 95 76 ± 25 75 ± 30 89 ± 18 
R CST YHC 4 95 54 ± 39 62 ± 40 50 ± 38 
 MHC 40 84 63 ± 16 72 ± 17 63 ± 25 
 PD 86 94 89 ± 3 92 ± 8 88 ± 9 
L ICP YHC 28 72 51 ± 18 82 ± 21 38 ± 17 
 MHC 69 95 80 ± 10 74 ± 16 88 ± 3 
 PD 19 56 42 ± 18 48 ± 28 40 ± 19 
R ICP YHC 46 70 56 ± 10 89 ± 9 42 ± 11 
 MHC 55 78 73 ± 12 76 ± 15 71 ± 13 
 PD 44 86 70 ± 17 76 ± 11 69 ± 24 
L SCP YHC 47 70 59 ± 11 76 ± 14 50 ± 13 
 MHC 31 82 65 ± 24 78 ± 6 62 ± 32 
 PD 65 79 73 ±  5 81 ±  13 70 ±  16 
R SCP YHC 52 75 64 ± 11 81 ± 10 55 ± 14 
 MHC 43 69 54 ± 18 80 ± 14 45 ± 23 
 PD 62 76 70 ± 7 77 ± 23 68 ± 11 
MCP YHC 85 97 90 ± 4 89 ± 7 91 ± 8 
 MHC 88 99 85 ± 5 99 ± 1 92 ± 8 
 PD 89 98 95 ± 4 98 ± 2 93 ± 8 
YHC - Young Healthy Controls, PD – Parkinson’s disease, MHC – Matched Healthy Controls, SD - Standard 
deviation, L - Left, R - Right, DRTT – Dentato-Rubro-Thalamic Tract, SPCT – Subthalamo-Ponto-Cerebellar 
Tract, CST – Corticospinal tract, ICP – Inferior Cerebellar Peduncle, SCP – Superior Cerebellar Peduncle, MCP 
- Middle Cerebellar Peduncle 
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Supplementary Table 4.2 Spatial tractography measures  
Tract Group Number of 
streamlines 
(Mean ± SD) 
Number of points 
(from all tracts) 
(Mean ± SD) 
Mean tract 
length (in mm) 
(Mean ± SD) 
Approximate tract 
volume (in mm^3) 
(Mean ± SD) 
L DRTT YHC 13.38 ± 9.85 3245 ± 2473.25 119.60 ± 19.18 862.89 ± 567.37  
PD 21.29 ± 17.18 5088.88 ± 4020.24 122.98 ± 23.73 1107.89 ± 681.18  
MHC 17.28 ± 17.89 4386.5 ± 4641.52 125.89 ± 18.89 1005.06 ± 692.56 
R DRTT YHC 21.27 ± 20.45 4967.73 ± 5563.26 107.22 ± 23.63 1091.12 ± 888.57  
PD 18.63 ± 16.99 3906.75 ± 3370.91 115.18 ± 26.46 996.62 ± 688.91  
MHC 11.07 ±  10.59 2718.14 ± 2716.34 122.44 ± 19.52 708 ± 545.68 
L SPCT YHC 17.09 ± 20.45 4310.46 ± 5138.32 139.75 ± 33.27 1037.53 ± 856.37  
PD 21.84 ± 18.40 6473.68 ± 5916.88  142.23 ±  20.83 1409.86 ± 983.63  
MHC 30.36 ± 28.29 8863.36 ± 8710.77 144.55 ± 17.59 1859.95 ± 1257.85 
R SPCT YHC 22.31 ± 24.19 6304.31 ± 6914.50 148.13 ± 31.74 1411.99 ± 1148.62  
PD 33.37 ± 36.28 10566.74 ± 12412.98 149.84 ±  27.72 1893.36 ±  1458.36  
MHC 29.83 ± 31.69 9236.91 ± 9887.11 148.45 ± 20.15 1798.74 ± 1378.39 
YHC - Young Healthy Controls, PD – Parkinson’s disease, MHC – Matched Healthy Controls, SD - Standard 
deviation, L - Left, R - Right, DRTT – Dentato-Rubro-Thalamic Tract, SPCT – Subthalamo-Ponto-Cerebellar 
Tract 
 
Supplementary Table 4.3 Inter-rater reliability test for extracted FA from the full DRTT and SPCT 
PD FA values Rater 1 
(JPM) 
Rater 2 
(IL) 
MHC FA values Rater 1 
(JPM) 
Rater 2 
(IL) 
L DRTT   L DRTT   
 
0.46701 0.48657 
 
0.4628 0.46276  
0.50817 0.51433 
 
0.425 0.42318  
0.50261 0.54599 
 
0.50532 0.50532 
R DRTT   
 
0.48335 0.48897  
0.47127 0.48777 R DRTT   
 
0.47694 0.46683 
 
0.46072 0.4628  
0.49164 0.50797 
 
0.43552 0.45284 
L SPCT   L SPCT   
 
0.52505 0.48587 
 
0.46237 0.45837  
0.52096 0.52219 
 
0.5047 0.51392  
0.50294 0.50508 
 
0.49435 0.48482  
0.47266 0.47492 R SPCT   
 
0.51444 0.48728 
 
0.49614 0.5191 
R SPCT   
 
0.49458 0.50101  
0.48003 0.50411 
 
0.49741 0.49261  
0.47408 0.47408 
   
      
ICC  0.786 ICC 0.969 
p-value p = 0.00487 p-value p = 3.32e-07 
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Supplementary Table 4.3 shows the IRR for the full DRTTs and the SPCTs and to check if 
variation in the FA values were due to inclusion of the cortical connections of these tracts, the 
tracts were chopped to include only the portion of the DRTT between the dentate nucleus and 
the thalamus and the portion of the SPCT from the sub-thalamic nucleus to the cerebellum. 
And the IRR extracted values from the chopped tracts are shown in Supplementary Table 4.4. 
 
Supplementary Table 4.4 Inter-rater reliability for the extracted FA from the chopped DRTT and 
SPCT 
PD FA values Rater 1 
(JPM) 
Rater 2 (IL) MHC FA values Rater 1 
(JPM) 
Rater 2 
(IL) 
L DRTT   L DRTT    
0.49178 0.49629 
 
0.51106 0.48851  
0.59715 0.5865 
 
0.40573 0.40192  
0.5561 0.57004 
 
0.50816 0.51649 
R DRTT   
 
0.54704 0.55294  
0.53295 0.51123 R DRTT   
 
0.47694 0.45537 
 
0.48622 0.48988  
0.49164 0.53783 
 
0.4873 0.4859 
L SPCT   L SPCT    
0.42577 0.41867 
 
0.52649 0.45062  
0.48934 0.4992 
 
0.48441 0.48093  
0.46495 0.48166 
 
0.48624 0.48636  
0.45142 0.42771 R SPCT   
 
0.51444 0.51069 
 
0.46921 0.47054 
R SPCT   
 
0.46355 0.46963  
0.48003 0.4919 
 
0.50987 0.47652  
0.46635 0.46677 
 
  
 
  
 
  
ICC  0.96 ICC 0.861 
p-value  p = 5.58e-07 p-value p = 0.000973 
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8.3 Chapter 5 supplementary material 
Macrostructural differences  
Additionally, previous studies have found that the MCP and the SCP in addition to the 
basal ganglia contributed to the differentiating PD from multiple system atrophy (MSA-
P) and progressive supranuclear palsy (PSP) (Nair et al. 2013; Nicoletti et al. 2008; 
Nicoletti et al. 2006; Quattrone et al. 2008; Nicoletti et al. 2013) while another recent 
study found that the disease duration correlated negatively with MCP width in PD 
without tremor onset (Sako et al. 2015) suggesting progressive degeneration of 
cerebellar pathways. As these previous studies have found differences in the 
macrostructure of the main cerebellar tracts (eg: MCP width) in PD, the average tract 
volume which denotes the space occupied by the tract, calculated as the number of 
voxels occupied by the reconstructed streamlines was also derived from the main 
cerebellar tracts. To assess the macrostructural differences, the tract volumes of the 
MCP, ICP and SCP between PD and MHCs were also compared using two-sample t-
tests.  
Results  
I found volume differences with higher volumes in the PD group for the MCP (mean ± 
standard deviation PD , MHC (12323.65 ± 4112.48, 9009.08  ± 2115.72) t = 3.5259, df 
= 34.065, p-value = 0.001228), left ICP ((1918.65 ± 569.03,1291.28 ± 639.25) t = 
3.632, df = 46.741, p-value = 0.0006965) and the right ICP ((1792.57 ± 710.93, 1187.2 
± 485.63) t = 3.4667, df = 40.444, p-value = 0.001263) but not for the left and right 
SCP (p=0.21 and p=0.049, respectively) (Supplementary Table 5.1). 
Supplementary Table 5.1 Macrostructural differences between the PD and MHC groups 
Tract Group Number of 
streamlines 
Mean tract length 
(in mm) 
Approximate tract 
volume (in mm^3) 
MCP PD 610.54 ± 273.35 125.21 ± 11.62 12323.65 ± 4112.48  
MHC 397.84 ±  118.72 121.57  ± 7.44 9009.08  ± 2115.72 
L ICP PD 126.04 ± 46.26 45.85 ± 7.85 1918.65 ± 569.03  
MHC 83.4 ± 46.08 40.17 ± 9.59 1291.28 ± 639.25 
R ICP PD 121.13  ± 47.94 45.1 ± 8.84 1792.57 ± 710.93  
MHC 79.92 ± 36.78 39.65 ± 7.99 1187.2 ± 485.63 
L SCP PD 170.67 ± 81.86 56.68 ± 9.20 3112.5 ± 1058.16  
MHC 196.4 ± 52.12 54.79 ± 6.98 3458.36 ± 866.23 
R SCP PD 136.34 ± 58.04 55.84 ± 6.06 2795.95 ± 871.76  
MHC 164.16 ± 58.44 52.46 ± 6.60 3287.84 ± 830.84 
172 
 
L DRTT PD 17.53 ± 12.14 46.41  ± 8.92 234.35  ± 117.75 
 MHC 15.22 ± 17.70 57.11 ± 7.76 282.56 ± 168.47 
R DRTT PD 15.25 ± 13.27 50.2 ± 14 254.5 ± 168.67 
 MHC 8.43 ± 8.98 57.16 ± 6.17 194.71 ± 110.91 
L SPCT PD 23.2 ± 19.72 75.4 ± 17.93 591.6 ± 399.35 
 MHC 29.45 ± 27.40 75.86 ± 12.37 763.27 ± 473.16 
R SPCT PD 38.67 ± 45.91 80.75 ± 16.89 832.94 ± 609.21 
 MHC 28.22 ± 29.79 75.17 ± 13.36 643 ± 439.80 
L DRTT PD 17.53 ± 12.14 46.41  ± 8.92 234.35  ± 117.75 
 MHC 15.22 ± 17.70 57.11 ± 7.76 282.56 ± 168.47 
R- Right, L- Left, MCP – Middle cerebellar peduncle, SCP – Superior cerebellar peduncle, ICP – Inferior 
cerebellar peduncle, DRTT – Dentato-rubro-thalamic tract, SPCT – Subthalamo-ponto-cerebellar tract 
Discussion 
Increased volume of the MCPs and the ICPs 
The results demonstrated larger tract volumes in the middle cerebellar peduncle and 
both the inferior peduncles of the PD patients compared to healthy controls. Even 
though there was increased volume in the MCP, left and right ICPs, there was no 
correlation between the significant increased FA in the right ICPs with the ICP volumes 
in the PD group (t=-1.72,d.f=22,p-value=0.1002). There is inconsistency regarding the 
direction of cerebellar changes in PD across imaging studies (Borghammer et al. 2009) 
(Linder et al. 2009; Messina et al. 2011). Some studies have found differences in the 
MCP width and correlation with disease duration (Sako et al. 2015), while others 
showed that width of the MCP and SCP to be useful for differential diagnosis of PD 
from multiple system atrophy and Progressive supranuclear palsy (Nair et al. 2013; 
Nicoletti et al. 2013; Quattrone et al. 2008), however here there were no significant 
correlations as these previous studies. Although the tract volume is a tract specific 
average measure of the space occupied by a tract, its relationship to axonal number, 
axonal diameter, and density has yet to be established (Beaulieu 2002).  
A study that investigated perinatal brain injury (PBI) found significantly reduced 
volume and HMOA of the dorsal cingulum PBI group compared with controls, but 
reported increased HMOA in the ventral component of the superior longitudinal 
fasiculus (SLF III) and suggested that this increase could be due to the possibility of 
lateral neuroanatomical compensation for medial structural deficits in the PBI group 
(Froudist-Walsh et al. 2015). This in context with the current results could also suggest 
similar lateralised neuroanatomical compensation as there was statistically significant 
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increase in the PD group’s HMOA metric in the right SCP but not in the left SCP or 
both the ICPs or even the MCP which connects the cerebellar hemispheres.   
HMOA and FA represent a markers of tissue microstructure (Dell’Acqua et al. 2013) 
while the tract volume, representing the space occupied by the tract (macrostructure) 
(Beaulieu 2002). One study found that the HMOA and the tract volume differentially 
contributed to the anatomical lateralization of frontoparietal attentional networks and 
individual differences in attention (Chechlacz et al. 2015). Their findings agree with 
previous studies showing that the asymmetry of white matter pathways varies across 
different diffusion MRI derived measures (De Santis et al. 2014). The current results 
also show asymmetry and right lateralised significant effects in HMOA and FA but not 
the tract volumes. Additional correlations between the significant HMOA metrics and 
the FA values in the PD group with the corresponding tract volumes were also 
performed as previous studies reported tract volume correlations with age especially in 
the SCP and ICP (Nair et al. 2013; Nicoletti et al. 2008), but there were  no significant 
differences. This is in line with the attention study (Chechlacz et al. 2015) which also 
did not get any correlations and attributed this to large number of right-handed 
participants, which is also the case for the current PD cohort (Table 3.1). 
Affected vs Unaffected hemisphere analysis 
Supplementary Table 5.2 Affected vs Unaffected hemisphere analysis  
PD Tracts FA in affected 
hemisphere 
 (mean ± sd) 
FA in unaffected 
hemisphere 
 (mean ± sd) 
t-value df p-value 
SCP 0.459 ± 0.032 
 
0.452 ± 0.024 
 
0.8496 21 0.4051 
ICP 0.449 ± 0.027 
 
0.444 ± 0.025 
 
0.7284 21 0.4744 
 
Correlation analysis results  
Supplementary table 5.3 Correlation analysis results  
Tract and metrics R-SCP-FA R-ICP-FA R-SCP-HMOA 
 
t p-value t p-value t p-value 
Finger sequence task 
- Reaction time 
2.1123 0.04681 1.8926 0.07228 1.8137 0.08404 
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Finger sequence task 
- Correct number of 
taps 
0.5462 0.5916 -0.1704 0.8666 0.4602 0.6509 
Duration since 
diagnosis (in months) 
-0.1083 0.9148 0.2438 0.8098 0.0587 0.9537 
Pre intervention off 
medication UPDRS 
scores 
-0.48 0.636 0.3944 0.6971 -0.4893 0.6295 
Finger tapping on 
dominant hand 
1.1073 0.2801 0.2378 0.8143 0.8227 0.4195 
Finger tapping on 
non-dominant hand 
1.4516 0.1607 1.4656 0.1569 1.5598 0.1331 
Finger tapping on 
both hands 
1.592 0.1257 1.0085 0.3242 1.4613 0.1581 
R-SCP-FA – Right superior cerebellar peduncle fractional anisotropy, R-ICP-FA – Right inferior cerebellar 
peduncle fractional anisotropy, R-SCP-HMOA – Right superior cerebellar peduncle hindrance 
modulated orientational anisotropy 
Supplementary Table 5.4 Results from the MANCOVAs for the BG-cerebellar tracts 
Tract   
MHC (n=25) vs PD (n=24) 
F statistic 
Pillai's 
trace 
p-value 
 L DRTT         
  Group F(5,27)=2.58 0.32 0.04935 
  Age F(5,27)=0.61 0.10 0.68922 
  Gender F(5,27)=0.07 0.01 0.99532 
R DRTT       
  Group F(5,27)=3.20 0.42 0.025222 
  Age F(5,27)=4.94 0.52 0.003505 
  Gender F(5,27)=0.96 0.18 0.458007 
L SPCT       
  Group F(5,27)=1.51 0.18 0.2110 
  Age F(5,27)=1.06 0.13 0.3997 
  Gender F(5,27)=0.88 0.11 0.5013 
R SPCT       
  Group F(5,27)=0.77 0.10 0.5743 
  Age F(5,27)=1.32 0.16 0.2774 
  Gender F(5,27)=1.48 0.18 0.2209 
MHC – Matched healthy controls, PD - Parkinson’s disease patients, L – Left, R- Right, DRTT – Dentato-
rubro-thalamic tract, SPCT – Subthalamo-ponto-cerebellar tract 
 
